Location,Sex,Age,Mean/Expected_Mortality,Mortality,Excess_mortality,STANDARD_DEVIATION,Z-Score(95%),SIGNIFICANT,Conf_interval,Lower_bound_Mean/Expected_Mortality,Upper_bound_Mean/Expected_Mortality,P_Score,P_Score_fluctuation,Mean/Expected_Mortality ±,Excess_mortality ±,P_Score ±
Blagoevgrad,Female,(0-4),7.0,2,-5.0,4.7,-1.1,Not Significant,9.3,-2.3,16.3,-71.4,16.3,7.0 (±9.3),-5.0 (±9.3),-71.4% (±16.3%)
Blagoevgrad,Female,(10-14),0.2,0,-0.2,1.3,-0.2,Not Significant,2.5,-2.3,2.7,-100.0,0.0,0.2 (±2.5),-0.2 (±2.5),-100.0% (±0.0%)
Blagoevgrad,Female,(15-19),0.2,1,0.8,2.2,0.4,Not Significant,4.4,-4.2,4.6,400.0,478.3,0.2 (±4.4),0.8 (±4.4),400.0% (±478.3%)
Blagoevgrad,Female,(20-24),0.8,5,4.2,1.7,2.5,Significant Increase,3.3,-2.5,4.1,525.0,503.0,0.8 (±3.3),4.2 (±3.3),525.0% (±503.0%)
Blagoevgrad,Female,(25-29),4.8,4,-0.8,3.0,-0.3,Not Significant,5.9,-1.1,10.7,-16.7,45.9,4.8 (±5.9),-0.8 (±5.9),-16.7% (±45.9%)
Blagoevgrad,Female,(30-34),4.6,3,-1.6,4.2,-0.4,Not Significant,8.3,-3.7,12.9,-34.8,41.9,4.6 (±8.3),-1.6 (±8.3),-34.8% (±41.9%)
Blagoevgrad,Female,(35-39),2.4,9,6.6,5.1,1.3,Not Significant,10.0,-7.6,12.4,275.0,302.4,2.4 (±10.0),6.6 (±10.0),275.0% (±302.4%)
Blagoevgrad,Female,(40-44),4.0,18,14.0,5.4,2.6,Significant Increase,10.6,-6.6,14.6,350.0,326.7,4.0 (±10.6),14.0 (±10.6),350.0% (±326.7%)
Blagoevgrad,Female,(45-49),21.0,35,14.0,8.4,1.7,Not Significant,16.4,4.6,37.4,66.7,73.1,21.0 (±16.4),14.0 (±16.4),66.7% (±73.1%)
Blagoevgrad,Female,(5-9),-0.8,0,0.8,1.5,0.5,Not Significant,2.9,-3.7,2.1,-100.0,0.0,-0.8 (±2.9),0.8 (±2.9),-100.0% (±0.0%)
Blagoevgrad,Female,(50-54),53.4,59,5.6,10.7,0.5,Not Significant,20.9,32.5,74.3,10.5,31.1,53.4 (±20.9),5.6 (±20.9),10.5% (±31.1%)
Blagoevgrad,Female,(55-59),74.0,110,36.0,12.3,2.9,Significant Increase,24.2,49.8,98.2,48.6,36.6,74.0 (±24.2),36.0 (±24.2),48.6% (±36.6%)
Blagoevgrad,Female,(60-64),96.0,145,49.0,16.5,3.0,Significant Increase,32.4,63.6,128.4,51.0,38.1,96.0 (±32.4),49.0 (±32.4),51.0% (±38.1%)
Blagoevgrad,Female,(65-69),132.2,228,95.8,19.9,4.8,Significant Increase,39.1,93.1,171.3,72.5,39.4,132.2 (±39.1),95.8 (±39.1),72.5% (±39.4%)
Blagoevgrad,Female,(70-74),192.2,307,114.8,21.8,5.3,Significant Increase,42.7,149.5,234.9,59.7,29.0,192.2 (±42.7),114.8 (±42.7),59.7% (±29.0%)
Blagoevgrad,Female,(75-79),278.8,427,148.2,30.6,4.8,Significant Increase,59.9,218.9,338.7,53.2,27.1,278.8 (±59.9),148.2 (±59.9),53.2% (±27.1%)
Blagoevgrad,Female,(80-84),404.6,523,118.4,36.0,3.3,Significant Increase,70.6,334.0,475.2,29.3,19.2,404.6 (±70.6),118.4 (±70.6),29.3% (±19.2%)
Blagoevgrad,Female,(85-89),410.0,538,128.0,31.4,4.1,Significant Increase,61.6,348.4,471.6,31.2,17.1,410.0 (±61.6),128.0 (±61.6),31.2% (±17.1%)
Blagoevgrad,Female,(90+),246.4,284,37.6,26.5,1.4,Not Significant,52.0,194.4,298.4,15.3,20.1,246.4 (±52.0),37.6 (±52.0),15.3% (±20.1%)
Blagoevgrad,Male,(0-4),-0.6,7,7.6,4.8,1.6,Not Significant,9.4,-10.0,8.8,-1266.7,-1246.2,-0.6 (±9.4),7.6 (±9.4),-1266.7% (±-1246.2%)
Blagoevgrad,Male,(10-14),3.2,2,-1.2,2.4,-0.5,Not Significant,4.6,-1.4,7.8,-37.5,36.9,3.2 (±4.6),-1.2 (±4.6),-37.5% (±36.9%)
Blagoevgrad,Male,(15-19),-0.4,0,0.4,3.2,0.1,Not Significant,6.4,-6.8,6.0,-100.0,0.0,-0.4 (±6.4),0.4 (±6.4),-100.0% (±0.0%)
Blagoevgrad,Male,(20-24),-2.8,8,10.8,4.4,2.5,Significant Increase,8.5,-11.3,5.7,-385.7,-426.1,-2.8 (±8.5),10.8 (±8.5),-385.7% (±-426.1%)
Blagoevgrad,Male,(25-29),8.8,5,-3.8,4.0,-0.9,Not Significant,7.9,0.9,16.7,-43.2,26.9,8.8 (±7.9),-3.8 (±7.9),-43.2% (±26.9%)
Blagoevgrad,Male,(30-34),9.0,16,7.0,6.3,1.1,Not Significant,12.4,-3.4,21.4,77.8,103.0,9.0 (±12.4),7.0 (±12.4),77.8% (±103.0%)
Blagoevgrad,Male,(35-39),19.8,24,4.2,7.6,0.6,Not Significant,14.8,5.0,34.6,21.2,51.8,19.8 (±14.8),4.2 (±14.8),21.2% (±51.8%)
Blagoevgrad,Male,(40-44),45.8,49,3.2,10.0,0.3,Not Significant,19.6,26.2,65.4,7.0,32.1,45.8 (±19.6),3.2 (±19.6),7.0% (±32.1%)
Blagoevgrad,Male,(45-49),58.0,92,34.0,13.7,2.5,Significant Increase,26.9,31.1,84.9,58.6,50.2,58.0 (±26.9),34.0 (±26.9),58.6% (±50.2%)
Blagoevgrad,Male,(5-9),1.2,3,1.8,2.1,0.8,Not Significant,4.2,-3.0,5.4,150.0,194.4,1.2 (±4.2),1.8 (±4.2),150.0% (±194.4%)
Blagoevgrad,Male,(50-54),102.2,131,28.8,16.9,1.7,Not Significant,33.0,69.2,135.2,28.2,31.3,102.2 (±33.0),28.8 (±33.0),28.2% (±31.3%)
Blagoevgrad,Male,(55-59),156.2,212,55.8,20.6,2.7,Significant Increase,40.3,115.9,196.5,35.7,27.8,156.2 (±40.3),55.8 (±40.3),35.7% (±27.8%)
Blagoevgrad,Male,(60-64),205.2,325,119.8,26.0,4.6,Significant Increase,50.9,154.3,256.1,58.4,31.5,205.2 (±50.9),119.8 (±50.9),58.4% (±31.5%)
Blagoevgrad,Male,(65-69),297.6,410,112.4,28.9,3.9,Significant Increase,56.6,241.0,354.2,37.8,22.0,297.6 (±56.6),112.4 (±56.6),37.8% (±22.0%)
Blagoevgrad,Male,(70-74),317.0,502,185.0,28.8,6.4,Significant Increase,56.5,260.5,373.5,58.4,24.0,317.0 (±56.5),185.0 (±56.5),58.4% (±24.0%)
Blagoevgrad,Male,(75-79),327.0,446,119.0,29.5,4.0,Significant Increase,57.9,269.1,384.9,36.4,20.5,327.0 (±57.9),119.0 (±57.9),36.4% (±20.5%)
Blagoevgrad,Male,(80-84),255.8,484,228.2,31.2,7.3,Significant Increase,61.1,194.7,316.9,89.2,36.5,255.8 (±61.1),228.2 (±61.1),89.2% (±36.5%)
Blagoevgrad,Male,(85-89),278.4,315,36.6,24.7,1.5,Not Significant,48.4,230.0,326.8,13.1,16.7,278.4 (±48.4),36.6 (±48.4),13.1% (±16.7%)
Blagoevgrad,Male,(90+),128.8,171,42.2,17.4,2.4,Significant Increase,34.2,94.6,163.0,32.8,27.9,128.8 (±34.2),42.2 (±34.2),32.8% (±27.9%)
Blagoevgrad,Total,(0-4),6.4,9,2.6,6.9,0.4,Not Significant,13.5,-7.1,19.9,40.6,95.4,6.4 (±13.5),2.6 (±13.5),40.6% (±95.4%)
Blagoevgrad,Total,(10-14),3.4,2,-1.4,2.7,-0.5,Not Significant,5.3,-1.9,8.7,-41.2,35.8,3.4 (±5.3),-1.4 (±5.3),-41.2% (±35.8%)
Blagoevgrad,Total,(15-19),-0.2,1,1.2,3.8,0.3,Not Significant,7.5,-7.7,7.3,-600.0,-513.7,-0.2 (±7.5),1.2 (±7.5),-600.0% (±-513.7%)
Blagoevgrad,Total,(20-24),-2.0,13,15.0,4.7,3.2,Significant Increase,9.1,-11.1,7.1,-750.0,-833.1,-2.0 (±9.1),15.0 (±9.1),-750.0% (±-833.1%)
Blagoevgrad,Total,(25-29),13.6,9,-4.6,5.2,-0.9,Not Significant,10.2,3.4,23.8,-33.8,28.4,13.6 (±10.2),-4.6 (±10.2),-33.8% (±28.4%)
Blagoevgrad,Total,(30-34),13.6,19,5.4,7.9,0.7,Not Significant,15.6,-2.0,29.2,39.7,74.6,13.6 (±15.6),5.4 (±15.6),39.7% (±74.6%)
Blagoevgrad,Total,(35-39),22.2,33,10.8,9.5,1.1,Not Significant,18.6,3.6,40.8,48.6,67.7,22.2 (±18.6),10.8 (±18.6),48.6% (±67.7%)
Blagoevgrad,Total,(40-44),49.8,67,17.2,11.3,1.5,Not Significant,22.2,27.6,72.0,34.5,41.4,49.8 (±22.2),17.2 (±22.2),34.5% (±41.4%)
Blagoevgrad,Total,(45-49),79.0,127,48.0,16.7,2.9,Significant Increase,32.6,46.4,111.6,60.8,47.0,79.0 (±32.6),48.0 (±32.6),60.8% (±47.0%)
Blagoevgrad,Total,(5-9),0.4,3,2.6,2.8,0.9,Not Significant,5.5,-5.1,5.9,650.0,699.2,0.4 (±5.5),2.6 (±5.5),650.0% (±699.2%)
Blagoevgrad,Total,(50-54),155.6,190,34.4,20.0,1.7,Not Significant,39.2,116.4,194.8,22.1,24.6,155.6 (±39.2),34.4 (±39.2),22.1% (±24.6%)
Blagoevgrad,Total,(55-59),230.2,322,91.8,25.1,3.7,Significant Increase,49.2,181.0,279.4,39.9,24.7,230.2 (±49.2),91.8 (±49.2),39.9% (±24.7%)
Blagoevgrad,Total,(60-64),301.2,470,168.8,32.1,5.3,Significant Increase,62.9,238.3,364.1,56.0,26.9,301.2 (±62.9),168.8 (±62.9),56.0% (±26.9%)
Blagoevgrad,Total,(65-69),429.8,638,208.2,36.0,5.8,Significant Increase,70.5,359.3,500.3,48.4,20.9,429.8 (±70.5),208.2 (±70.5),48.4% (±20.9%)
Blagoevgrad,Total,(70-74),509.2,809,299.8,35.8,8.4,Significant Increase,70.1,439.1,579.3,58.9,19.2,509.2 (±70.1),299.8 (±70.1),58.9% (±19.2%)
Blagoevgrad,Total,(75-79),605.8,873,267.2,42.7,6.3,Significant Increase,83.7,522.1,689.5,44.1,17.5,605.8 (±83.7),267.2 (±83.7),44.1% (±17.5%)
Blagoevgrad,Total,(80-84),660.4,1007,346.6,47.3,7.3,Significant Increase,92.7,567.7,753.1,52.5,18.8,660.4 (±92.7),346.6 (±92.7),52.5% (±18.8%)
Blagoevgrad,Total,(85-89),688.4,853,164.6,38.1,4.3,Significant Increase,74.8,613.6,763.2,23.9,12.1,688.4 (±74.8),164.6 (±74.8),23.9% (±12.1%)
Blagoevgrad,Total,(90+),375.2,455,79.8,33.9,2.4,Significant Increase,66.4,308.8,441.6,21.3,18.3,375.2 (±66.4),79.8 (±66.4),21.3% (±18.3%)
Burgas,Female,(0-4),3.6,20,16.4,6.0,2.7,Significant Increase,11.8,-8.2,15.4,455.6,425.7,3.6 (±11.8),16.4 (±11.8),455.6% (±425.7%)
Burgas,Female,(10-14),1.8,1,-0.8,2.0,-0.4,Not Significant,3.9,-2.1,5.7,-44.4,38.1,1.8 (±3.9),-0.8 (±3.9),-44.4% (±38.1%)
Burgas,Female,(15-19),3.6,6,2.4,3.6,0.7,Not Significant,7.1,-3.5,10.7,66.7,110.6,3.6 (±7.1),2.4 (±7.1),66.7% (±110.6%)
Burgas,Female,(20-24),-3.8,2,5.8,3.0,1.9,Not Significant,5.9,-9.7,2.1,-152.6,-147.8,-3.8 (±5.9),5.8 (±5.9),-152.6% (±-147.8%)
Burgas,Female,(25-29),5.8,8,2.2,3.9,0.6,Not Significant,7.7,-1.9,13.5,37.9,78.6,5.8 (±7.7),2.2 (±7.7),37.9% (±78.6%)
Burgas,Female,(30-34),7.2,14,6.8,4.4,1.5,Not Significant,8.6,-1.4,15.8,94.4,105.8,7.2 (±8.6),6.8 (±8.6),94.4% (±105.8%)
Burgas,Female,(35-39),19.6,18,-1.6,7.0,-0.2,Not Significant,13.7,5.9,33.3,-8.2,37.7,19.6 (±13.7),-1.6 (±13.7),-8.2% (±37.7%)
Burgas,Female,(40-44),35.6,33,-2.6,8.5,-0.3,Not Significant,16.7,18.9,52.3,-7.3,29.6,35.6 (±16.7),-2.6 (±16.7),-7.3% (±29.6%)
Burgas,Female,(45-49),43.8,63,19.2,10.6,1.8,Not Significant,20.8,23.0,64.6,43.8,46.3,43.8 (±20.8),19.2 (±20.8),43.8% (±46.3%)
Burgas,Female,(5-9),2.0,3,1.0,1.8,0.6,Not Significant,3.4,-1.4,5.4,50.0,94.4,2.0 (±3.4),1.0 (±3.4),50.0% (±94.4%)
Burgas,Female,(50-54),48.0,79,31.0,11.9,2.6,Significant Increase,23.3,24.7,71.3,64.6,53.8,48.0 (±23.3),31.0 (±23.3),64.6% (±53.8%)
Burgas,Female,(55-59),79.8,134,54.2,17.8,3.1,Significant Increase,34.8,45.0,114.6,67.9,51.0,79.8 (±34.8),54.2 (±34.8),67.9% (±51.0%)
Burgas,Female,(60-64),154.6,190,35.4,20.6,1.7,Not Significant,40.3,114.3,194.9,22.9,25.4,154.6 (±40.3),35.4 (±40.3),22.9% (±25.4%)
Burgas,Female,(65-69),214.8,321,106.2,24.2,4.4,Significant Increase,47.5,167.3,262.3,49.4,27.0,214.8 (±47.5),106.2 (±47.5),49.4% (±27.0%)
Burgas,Female,(70-74),295.2,459,163.8,27.5,5.9,Significant Increase,54.0,241.2,349.2,55.5,24.1,295.2 (±54.0),163.8 (±54.0),55.5% (±24.1%)
Burgas,Female,(75-79),383.2,542,158.8,31.7,5.0,Significant Increase,62.1,321.1,445.3,41.4,19.7,383.2 (±62.1),158.8 (±62.1),41.4% (±19.7%)
Burgas,Female,(80-84),472.8,683,210.2,39.6,5.3,Significant Increase,77.6,395.2,550.4,44.5,20.4,472.8 (±77.6),210.2 (±77.6),44.5% (±20.4%)
Burgas,Female,(85-89),539.6,640,100.4,37.3,2.7,Significant Increase,73.2,466.4,612.8,18.6,14.2,539.6 (±73.2),100.4 (±73.2),18.6% (±14.2%)
Burgas,Female,(90+),429.8,434,4.2,32.2,0.1,Not Significant,63.0,366.8,492.8,1.0,12.9,429.8 (±63.0),4.2 (±63.0),1.0% (±12.9%)
Burgas,Male,(0-4),18.2,13,-5.2,6.6,-0.8,Not Significant,12.9,5.3,31.1,-28.6,29.6,18.2 (±12.9),-5.2 (±12.9),-28.6% (±29.6%)
Burgas,Male,(10-14),4.0,3,-1.0,2.6,-0.4,Not Significant,5.2,-1.2,9.2,-25.0,42.4,4.0 (±5.2),-1.0 (±5.2),-25.0% (±42.4%)
Burgas,Male,(15-19),3.0,5,2.0,4.0,0.5,Not Significant,7.9,-4.9,10.9,66.7,120.8,3.0 (±7.9),2.0 (±7.9),66.7% (±120.8%)
Burgas,Male,(20-24),13.4,10,-3.4,4.6,-0.7,Not Significant,9.1,4.3,22.5,-25.4,30.2,13.4 (±9.1),-3.4 (±9.1),-25.4% (±30.2%)
Burgas,Male,(25-29),14.4,15,0.6,6.0,0.1,Not Significant,11.8,2.6,26.2,4.2,46.9,14.4 (±11.8),0.6 (±11.8),4.2% (±46.9%)
Burgas,Male,(30-34),11.4,25,13.6,6.8,2.0,Significant Increase,13.3,-1.9,24.7,119.3,118.1,11.4 (±13.3),13.6 (±13.3),119.3% (±118.1%)
Burgas,Male,(35-39),28.6,35,6.4,8.1,0.8,Not Significant,16.0,12.6,44.6,22.4,43.9,28.6 (±16.0),6.4 (±16.0),22.4% (±43.9%)
Burgas,Male,(40-44),70.2,59,-11.2,12.7,-0.9,Not Significant,25.0,45.2,95.2,-16.0,22.0,70.2 (±25.0),-11.2 (±25.0),-16.0% (±22.0%)
Burgas,Male,(45-49),98.0,127,29.0,15.4,1.9,Not Significant,30.2,67.8,128.2,29.6,30.5,98.0 (±30.2),29.0 (±30.2),29.6% (±30.5%)
Burgas,Male,(5-9),5.2,3,-2.2,3.2,-0.7,Not Significant,6.3,-1.1,11.5,-42.3,31.6,5.2 (±6.3),-2.2 (±6.3),-42.3% (±31.6%)
Burgas,Male,(50-54),138.0,171,33.0,20.0,1.7,Not Significant,39.1,98.9,177.1,23.9,27.3,138.0 (±39.1),33.0 (±39.1),23.9% (±27.3%)
Burgas,Male,(55-59),202.0,246,44.0,25.0,1.8,Not Significant,48.9,153.1,250.9,21.8,23.8,202.0 (±48.9),44.0 (±48.9),21.8% (±23.8%)
Burgas,Male,(60-64),262.2,387,124.8,29.8,4.2,Significant Increase,58.4,203.8,320.6,47.6,26.9,262.2 (±58.4),124.8 (±58.4),47.6% (±26.9%)
Burgas,Male,(65-69),411.4,557,145.6,37.0,3.9,Significant Increase,72.6,338.8,484.0,35.4,20.3,411.4 (±72.6),145.6 (±72.6),35.4% (±20.3%)
Burgas,Male,(70-74),474.6,655,180.4,32.5,5.6,Significant Increase,63.7,410.9,538.3,38.0,16.3,474.6 (±63.7),180.4 (±63.7),38.0% (±16.3%)
Burgas,Male,(75-79),416.8,576,159.2,31.3,5.1,Significant Increase,61.3,355.5,478.1,38.2,17.7,416.8 (±61.3),159.2 (±61.3),38.2% (±17.7%)
Burgas,Male,(80-84),370.8,506,135.2,35.3,3.8,Significant Increase,69.1,301.7,439.9,36.5,21.5,370.8 (±69.1),135.2 (±69.1),36.5% (±21.5%)
Burgas,Male,(85-89),318.0,387,69.0,34.9,2.0,Significant Increase,68.5,249.5,386.5,21.7,21.6,318.0 (±68.5),69.0 (±68.5),21.7% (±21.6%)
Burgas,Male,(90+),205.2,211,5.8,20.7,0.3,Not Significant,40.6,164.6,245.8,2.8,17.0,205.2 (±40.6),5.8 (±40.6),2.8% (±17.0%)
Burgas,Total,(0-4),21.8,33,11.2,8.7,1.3,Not Significant,17.0,4.8,38.8,51.4,66.3,21.8 (±17.0),11.2 (±17.0),51.4% (±66.3%)
Burgas,Total,(10-14),5.8,4,-1.8,3.2,-0.6,Not Significant,6.3,-0.5,12.1,-31.0,35.9,5.8 (±6.3),-1.8 (±6.3),-31.0% (±35.9%)
Burgas,Total,(15-19),6.6,11,4.4,5.2,0.8,Not Significant,10.2,-3.6,16.8,66.7,101.2,6.6 (±10.2),4.4 (±10.2),66.7% (±101.2%)
Burgas,Total,(20-24),9.6,12,2.4,5.2,0.5,Not Significant,10.3,-0.7,19.9,25.0,64.7,9.6 (±10.3),2.4 (±10.3),25.0% (±64.7%)
Burgas,Total,(25-29),20.2,23,2.8,7.1,0.4,Not Significant,14.0,6.2,34.2,13.9,46.6,20.2 (±14.0),2.8 (±14.0),13.9% (±46.6%)
Burgas,Total,(30-34),18.6,39,20.4,8.4,2.4,Significant Increase,16.4,2.2,35.0,109.7,98.3,18.6 (±16.4),20.4 (±16.4),109.7% (±98.3%)
Burgas,Total,(35-39),48.2,53,4.8,11.3,0.4,Not Significant,22.1,26.1,70.3,10.0,34.6,48.2 (±22.1),4.8 (±22.1),10.0% (±34.6%)
Burgas,Total,(40-44),105.8,92,-13.8,15.8,-0.9,Not Significant,30.9,74.9,136.7,-13.0,19.7,105.8 (±30.9),-13.8 (±30.9),-13.0% (±19.7%)
Burgas,Total,(45-49),141.8,190,48.2,18.9,2.6,Significant Increase,37.0,104.8,178.8,34.0,27.7,141.8 (±37.0),48.2 (±37.0),34.0% (±27.7%)
Burgas,Total,(5-9),7.2,6,-1.2,3.7,-0.3,Not Significant,7.2,-0.0,14.4,-16.7,41.6,7.2 (±7.2),-1.2 (±7.2),-16.7% (±41.6%)
Burgas,Total,(50-54),186.0,250,64.0,22.6,2.8,Significant Increase,44.2,141.8,230.2,34.4,25.8,186.0 (±44.2),64.0 (±44.2),34.4% (±25.8%)
Burgas,Total,(55-59),281.8,380,98.2,31.6,3.1,Significant Increase,61.9,219.9,343.7,34.8,24.2,281.8 (±61.9),98.2 (±61.9),34.8% (±24.2%)
Burgas,Total,(60-64),416.8,577,160.2,36.5,4.4,Significant Increase,71.4,345.4,488.2,38.4,20.2,416.8 (±71.4),160.2 (±71.4),38.4% (±20.2%)
Burgas,Total,(65-69),626.2,878,251.8,43.5,5.8,Significant Increase,85.3,540.9,711.5,40.2,16.8,626.2 (±85.3),251.8 (±85.3),40.2% (±16.8%)
Burgas,Total,(70-74),769.8,1114,344.2,43.5,7.9,Significant Increase,85.2,684.6,855.0,44.7,14.4,769.8 (±85.2),344.2 (±85.2),44.7% (±14.4%)
Burgas,Total,(75-79),800.0,1118,318.0,46.4,6.9,Significant Increase,90.9,709.1,890.9,39.8,14.3,800.0 (±90.9),318.0 (±90.9),39.8% (±14.3%)
Burgas,Total,(80-84),843.6,1189,345.4,53.5,6.5,Significant Increase,104.9,738.7,948.5,40.9,15.5,843.6 (±104.9),345.4 (±104.9),40.9% (±15.5%)
Burgas,Total,(85-89),857.6,1027,169.4,52.3,3.2,Significant Increase,102.4,755.2,960.0,19.8,12.8,857.6 (±102.4),169.4 (±102.4),19.8% (±12.8%)
Burgas,Total,(90+),635.0,645,10.0,37.5,0.3,Not Significant,73.4,561.6,708.4,1.6,10.5,635.0 (±73.4),10.0 (±73.4),1.6% (±10.5%)
Dobrich,Female,(0-4),7.2,4,-3.2,3.9,-0.8,Not Significant,7.7,-0.5,14.9,-44.4,28.8,7.2 (±7.7),-3.2 (±7.7),-44.4% (±28.8%)
Dobrich,Female,(10-14),-1.6,1,2.6,1.5,1.8,Not Significant,2.9,-4.5,1.3,-162.5,-139.4,-1.6 (±2.9),2.6 (±2.9),-162.5% (±-139.4%)
Dobrich,Female,(15-19),0.2,0,-0.2,1.6,-0.1,Not Significant,3.1,-2.9,3.3,-100.0,0.0,0.2 (±3.1),-0.2 (±3.1),-100.0% (±0.0%)
Dobrich,Female,(20-24),-0.2,1,1.2,1.6,0.8,Not Significant,3.1,-3.3,2.9,-600.0,-534.5,-0.2 (±3.1),1.2 (±3.1),-600.0% (±-534.5%)
Dobrich,Female,(25-29),0.6,4,3.4,2.2,1.6,Not Significant,4.3,-3.7,4.9,566.7,585.1,0.6 (±4.3),3.4 (±4.3),566.7% (±585.1%)
Dobrich,Female,(30-34),2.4,5,2.6,3.2,0.8,Not Significant,6.2,-3.8,8.6,108.3,150.2,2.4 (±6.2),2.6 (±6.2),108.3% (±150.2%)
Dobrich,Female,(35-39),15.6,5,-10.6,4.3,-2.5,Significant Decrease,8.4,7.2,24.0,-67.9,11.3,15.6 (±8.4),-10.6 (±8.4),-67.9% (±11.3%)
Dobrich,Female,(40-44),13.6,12,-1.6,6.1,-0.3,Not Significant,12.0,1.6,25.6,-11.8,41.3,13.6 (±12.0),-1.6 (±12.0),-11.8% (±41.3%)
Dobrich,Female,(45-49),17.6,37,19.4,7.3,2.7,Significant Increase,14.3,3.3,31.9,110.2,94.2,17.6 (±14.3),19.4 (±14.3),110.2% (±94.2%)
Dobrich,Female,(5-9),-0.2,1,1.2,1.3,0.9,Not Significant,2.5,-2.7,2.3,-600.0,-543.5,-0.2 (±2.5),1.2 (±2.5),-600.0% (±-543.5%)
Dobrich,Female,(50-54),41.6,50,8.4,9.7,0.9,Not Significant,19.0,22.6,60.6,20.2,37.7,41.6 (±19.0),8.4 (±19.0),20.2% (±37.7%)
Dobrich,Female,(55-59),48.2,83,34.8,11.8,3.0,Significant Increase,23.1,25.1,71.3,72.2,55.8,48.2 (±23.1),34.8 (±23.1),72.2% (±55.8%)
Dobrich,Female,(60-64),65.2,120,54.8,13.7,4.0,Significant Increase,26.9,38.3,92.1,84.0,53.7,65.2 (±26.9),54.8 (±26.9),84.0% (±53.7%)
Dobrich,Female,(65-69),97.6,189,91.4,17.9,5.1,Significant Increase,35.1,62.5,132.7,93.6,51.2,97.6 (±35.1),91.4 (±35.1),93.6% (±51.2%)
Dobrich,Female,(70-74),187.0,247,60.0,19.9,3.0,Significant Increase,39.0,148.0,226.0,32.1,22.8,187.0 (±39.0),60.0 (±39.0),32.1% (±22.8%)
Dobrich,Female,(75-79),226.0,328,102.0,26.6,3.8,Significant Increase,52.2,173.8,278.2,45.1,27.2,226.0 (±52.2),102.0 (±52.2),45.1% (±27.2%)
Dobrich,Female,(80-84),269.0,307,38.0,30.5,1.2,Not Significant,59.8,209.2,328.8,14.1,20.7,269.0 (±59.8),38.0 (±59.8),14.1% (±20.7%)
Dobrich,Female,(85-89),231.6,283,51.4,26.3,2.0,Not Significant,51.6,180.0,283.2,22.2,22.3,231.6 (±51.6),51.4 (±51.6),22.2% (±22.3%)
Dobrich,Female,(90+),142.0,168,26.0,19.5,1.3,Not Significant,38.2,103.8,180.2,18.3,25.1,142.0 (±38.2),26.0 (±38.2),18.3% (±25.1%)
Dobrich,Male,(0-4),7.8,6,-1.8,4.5,-0.4,Not Significant,8.8,-1.0,16.6,-23.1,40.8,7.8 (±8.8),-1.8 (±8.8),-23.1% (±40.8%)
Dobrich,Male,(10-14),-1.0,1,2.0,1.7,1.2,Not Significant,3.3,-4.3,2.3,-200.0,-143.5,-1.0 (±3.3),2.0 (±3.3),-200.0% (±-143.5%)
Dobrich,Male,(15-19),7.6,3,-4.6,4.1,-1.1,Not Significant,8.0,-0.4,15.6,-60.5,20.3,7.6 (±8.0),-4.6 (±8.0),-60.5% (±20.3%)
Dobrich,Male,(20-24),4.2,6,1.8,3.4,0.5,Not Significant,6.7,-2.5,10.9,42.9,87.9,4.2 (±6.7),1.8 (±6.7),42.9% (±87.9%)
Dobrich,Male,(25-29),5.4,9,3.6,4.7,0.8,Not Significant,9.2,-3.8,14.6,66.7,105.1,5.4 (±9.2),3.6 (±9.2),66.7% (±105.1%)
Dobrich,Male,(30-34),12.0,9,-3.0,5.1,-0.6,Not Significant,9.9,2.1,21.9,-25.0,33.9,12.0 (±9.9),-3.0 (±9.9),-25.0% (±33.9%)
Dobrich,Male,(35-39),16.2,20,3.8,7.1,0.5,Not Significant,13.8,2.4,30.0,23.5,56.8,16.2 (±13.8),3.8 (±13.8),23.5% (±56.8%)
Dobrich,Male,(40-44),18.2,35,16.8,8.3,2.0,Significant Increase,16.2,2.0,34.4,92.3,90.6,18.2 (±16.2),16.8 (±16.2),92.3% (±90.6%)
Dobrich,Male,(45-49),53.0,56,3.0,12.2,0.2,Not Significant,23.9,29.1,76.9,5.7,32.9,53.0 (±23.9),3.0 (±23.9),5.7% (±32.9%)
Dobrich,Male,(5-9),1.4,0,-1.4,2.0,-0.7,Not Significant,3.9,-2.5,5.3,-100.0,0.0,1.4 (±3.9),-1.4 (±3.9),-100.0% (±0.0%)
Dobrich,Male,(50-54),63.0,113,50.0,13.6,3.7,Significant Increase,26.7,36.3,89.7,79.4,53.4,63.0 (±26.7),50.0 (±26.7),79.4% (±53.4%)
Dobrich,Male,(55-59),121.6,153,31.4,16.9,1.9,Not Significant,33.1,88.5,154.7,25.8,26.9,121.6 (±33.1),31.4 (±33.1),25.8% (±26.9%)
Dobrich,Male,(60-64),153.6,223,69.4,22.2,3.1,Significant Increase,43.5,110.1,197.1,45.2,32.1,153.6 (±43.5),69.4 (±43.5),45.2% (±32.1%)
Dobrich,Male,(65-69),260.4,258,-2.4,25.9,-0.1,Not Significant,50.8,209.6,311.2,-0.9,16.2,260.4 (±50.8),-2.4 (±50.8),-0.9% (±16.2%)
Dobrich,Male,(70-74),220.6,381,160.4,24.0,6.7,Significant Increase,47.1,173.5,267.7,72.7,30.4,220.6 (±47.1),160.4 (±47.1),72.7% (±30.4%)
Dobrich,Male,(75-79),241.6,320,78.4,24.2,3.2,Significant Increase,47.3,194.3,288.9,32.5,21.7,241.6 (±47.3),78.4 (±47.3),32.5% (±21.7%)
Dobrich,Male,(80-84),157.0,245,88.0,25.1,3.5,Significant Increase,49.2,107.8,206.2,56.1,37.3,157.0 (±49.2),88.0 (±49.2),56.1% (±37.3%)
Dobrich,Male,(85-89),157.6,192,34.4,20.6,1.7,Not Significant,40.3,117.3,197.9,21.8,24.8,157.6 (±40.3),34.4 (±40.3),21.8% (±24.8%)
Dobrich,Male,(90+),66.8,104,37.2,14.5,2.6,Significant Increase,28.4,38.4,95.2,55.7,46.5,66.8 (±28.4),37.2 (±28.4),55.7% (±46.5%)
Dobrich,Total,(0-4),15.0,10,-5.0,5.9,-0.8,Not Significant,11.6,3.4,26.6,-33.3,29.1,15.0 (±11.6),-5.0 (±11.6),-33.3% (±29.1%)
Dobrich,Total,(10-14),-2.6,2,4.6,2.1,2.1,Significant Increase,4.2,-6.8,1.6,-176.9,-201.9,-2.6 (±4.2),4.6 (±4.2),-176.9% (±-201.9%)
Dobrich,Total,(15-19),7.8,3,-4.8,4.4,-1.1,Not Significant,8.6,-0.8,16.4,-61.5,20.2,7.8 (±8.6),-4.8 (±8.6),-61.5% (±20.2%)
Dobrich,Total,(20-24),4.0,7,3.0,4.0,0.7,Not Significant,7.8,-3.8,11.8,75.0,115.7,4.0 (±7.8),3.0 (±7.8),75.0% (±115.7%)
Dobrich,Total,(25-29),6.0,13,7.0,5.2,1.3,Not Significant,10.2,-4.2,16.2,116.7,136.5,6.0 (±10.2),7.0 (±10.2),116.7% (±136.5%)
Dobrich,Total,(30-34),14.4,14,-0.4,6.0,-0.1,Not Significant,11.8,2.6,26.2,-2.8,43.8,14.4 (±11.8),-0.4 (±11.8),-2.8% (±43.8%)
Dobrich,Total,(35-39),31.8,25,-6.8,8.2,-0.8,Not Significant,16.1,15.7,47.9,-21.4,26.4,31.8 (±16.1),-6.8 (±16.1),-21.4% (±26.4%)
Dobrich,Total,(40-44),31.8,47,15.2,10.4,1.5,Not Significant,20.5,11.3,52.3,47.8,57.9,31.8 (±20.5),15.2 (±20.5),47.8% (±57.9%)
Dobrich,Total,(45-49),70.6,93,22.4,14.6,1.5,Not Significant,28.6,42.0,99.2,31.7,38.0,70.6 (±28.6),22.4 (±28.6),31.7% (±38.0%)
Dobrich,Total,(5-9),1.2,1,-0.2,2.4,-0.1,Not Significant,4.6,-3.4,5.8,-16.7,66.1,1.2 (±4.6),-0.2 (±4.6),-16.7% (±66.1%)
Dobrich,Total,(50-54),104.6,163,58.4,17.2,3.4,Significant Increase,33.7,70.9,138.3,55.8,37.9,104.6 (±33.7),58.4 (±33.7),55.8% (±37.9%)
Dobrich,Total,(55-59),169.8,236,66.2,21.9,3.0,Significant Increase,42.9,126.9,212.7,39.0,28.0,169.8 (±42.9),66.2 (±42.9),39.0% (±28.0%)
Dobrich,Total,(60-64),218.8,343,124.2,28.0,4.4,Significant Increase,54.8,164.0,273.6,56.8,31.4,218.8 (±54.8),124.2 (±54.8),56.8% (±31.4%)
Dobrich,Total,(65-69),358.0,447,89.0,32.1,2.8,Significant Increase,62.8,295.2,420.8,24.9,18.7,358.0 (±62.8),89.0 (±62.8),24.9% (±18.7%)
Dobrich,Total,(70-74),407.6,628,220.4,30.6,7.2,Significant Increase,60.0,347.6,467.6,54.1,19.8,407.6 (±60.0),220.4 (±60.0),54.1% (±19.8%)
Dobrich,Total,(75-79),467.6,648,180.4,34.4,5.2,Significant Increase,67.4,400.2,535.0,38.6,17.5,467.6 (±67.4),180.4 (±67.4),38.6% (±17.5%)
Dobrich,Total,(80-84),426.0,552,126.0,41.6,3.0,Significant Increase,81.5,344.5,507.5,29.6,20.8,426.0 (±81.5),126.0 (±81.5),29.6% (±20.8%)
Dobrich,Total,(85-89),389.2,475,85.8,33.9,2.5,Significant Increase,66.4,322.8,455.6,22.0,17.7,389.2 (±66.4),85.8 (±66.4),22.0% (±17.7%)
Dobrich,Total,(90+),208.8,272,63.2,25.9,2.4,Significant Increase,50.7,158.1,259.5,30.3,25.5,208.8 (±50.7),63.2 (±50.7),30.3% (±25.5%)
Gabrovo,Female,(0-4),2.2,4,1.8,2.6,0.7,Not Significant,5.1,-2.9,7.3,81.8,127.0,2.2 (±5.1),1.8 (±5.1),81.8% (±127.0%)
Gabrovo,Female,(10-14),-0.6,1,1.6,0.7,2.1,Significant Increase,1.5,-2.1,0.9,-266.7,-277.8,-0.6 (±1.5),1.6 (±1.5),-266.7% (±-277.8%)
Gabrovo,Female,(15-19),-0.4,0,0.4,1.8,0.2,Not Significant,3.4,-3.8,3.0,-100.0,0.0,-0.4 (±3.4),0.4 (±3.4),-100.0% (±0.0%)
Gabrovo,Female,(20-24),0.2,0,-0.2,1.3,-0.2,Not Significant,2.5,-2.3,2.7,-100.0,0.0,0.2 (±2.5),-0.2 (±2.5),-100.0% (±0.0%)
Gabrovo,Female,(25-29),1.2,2,0.8,2.1,0.4,Not Significant,4.2,-3.0,5.4,66.7,129.7,1.2 (±4.2),0.8 (±4.2),66.7% (±129.7%)
Gabrovo,Female,(30-34),-1.0,3,4.0,1.7,2.4,Significant Increase,3.3,-4.3,2.3,-400.0,-430.4,-1.0 (±3.3),4.0 (±3.3),-400.0% (±-430.4%)
Gabrovo,Female,(35-39),-0.0,4,4.0,2.8,1.4,Not Significant,5.5,-5.5,5.5,-98849860126757.1,-98849860126729.8,-0.0 (±5.5),4.0 (±5.5),-98849860126757.1% (±-98849860126729.8%)
Gabrovo,Female,(40-44),6.4,3,-3.4,4.1,-0.8,Not Significant,8.0,-1.6,14.4,-53.1,26.1,6.4 (±8.0),-3.4 (±8.0),-53.1% (±26.1%)
Gabrovo,Female,(45-49),16.6,13,-3.6,5.3,-0.7,Not Significant,10.3,6.3,26.9,-21.7,30.0,16.6 (±10.3),-3.6 (±10.3),-21.7% (±30.0%)
Gabrovo,Female,(5-9),-0.6,1,1.6,0.7,2.1,Significant Increase,1.5,-2.1,0.9,-266.7,-277.8,-0.6 (±1.5),1.6 (±1.5),-266.7% (±-277.8%)
Gabrovo,Female,(50-54),19.8,16,-3.8,5.6,-0.7,Not Significant,10.9,8.9,30.7,-19.2,28.7,19.8 (±10.9),-3.8 (±10.9),-19.2% (±28.7%)
Gabrovo,Female,(55-59),21.8,51,29.2,7.9,3.7,Significant Increase,15.6,6.2,37.4,133.9,97.5,21.8 (±15.6),29.2 (±15.6),133.9% (±97.5%)
Gabrovo,Female,(60-64),41.8,61,19.2,10.9,1.8,Not Significant,21.4,20.4,63.2,45.9,49.4,41.8 (±21.4),19.2 (±21.4),45.9% (±49.4%)
Gabrovo,Female,(65-69),73.0,95,22.0,14.3,1.5,Not Significant,27.9,45.1,100.9,30.1,35.9,73.0 (±27.9),22.0 (±27.9),30.1% (±35.9%)
Gabrovo,Female,(70-74),144.8,205,60.2,17.6,3.4,Significant Increase,34.6,110.2,179.4,41.6,27.3,144.8 (±34.6),60.2 (±34.6),41.6% (±27.3%)
Gabrovo,Female,(75-79),158.6,259,100.4,22.4,4.5,Significant Increase,43.9,114.7,202.5,63.3,35.4,158.6 (±43.9),100.4 (±43.9),63.3% (±35.4%)
Gabrovo,Female,(80-84),208.6,324,115.4,29.0,4.0,Significant Increase,56.9,151.7,265.5,55.3,33.3,208.6 (±56.9),115.4 (±56.9),55.3% (±33.3%)
Gabrovo,Female,(85-89),210.4,290,79.6,25.3,3.1,Significant Increase,49.6,160.8,260.0,37.8,26.3,210.4 (±49.6),79.6 (±49.6),37.8% (±26.3%)
Gabrovo,Female,(90+),168.6,192,23.4,20.6,1.1,Not Significant,40.4,128.2,209.0,13.9,22.0,168.6 (±40.4),23.4 (±40.4),13.9% (±22.0%)
Gabrovo,Male,(0-4),1.8,2,0.2,2.4,0.1,Not Significant,4.6,-2.8,6.4,11.1,79.8,1.8 (±4.6),0.2 (±4.6),11.1% (±79.8%)
Gabrovo,Male,(10-14),0.4,0,-0.4,1.1,-0.4,Not Significant,2.1,-1.7,2.5,-100.0,0.0,0.4 (±2.1),-0.4 (±2.1),-100.0% (±0.0%)
Gabrovo,Male,(15-19),2.2,2,-0.2,1.8,-0.1,Not Significant,3.6,-1.4,5.8,-9.1,56.4,2.2 (±3.6),-0.2 (±3.6),-9.1% (±56.4%)
Gabrovo,Male,(20-24),2.0,5,3.0,3.0,1.0,Not Significant,5.8,-3.8,7.8,150.0,185.9,2.0 (±5.8),3.0 (±5.8),150.0% (±185.9%)
Gabrovo,Male,(25-29),2.4,2,-0.4,3.2,-0.1,Not Significant,6.3,-3.9,8.7,-16.7,60.3,2.4 (±6.3),-0.4 (±6.3),-16.7% (±60.3%)
Gabrovo,Male,(30-34),0.4,5,4.6,2.8,1.6,Not Significant,5.6,-5.2,6.0,1150.0,1166.7,0.4 (±5.6),4.6 (±5.6),1150.0% (±1166.7%)
Gabrovo,Male,(35-39),5.8,11,5.2,4.1,1.3,Not Significant,8.1,-2.3,13.9,89.7,110.6,5.8 (±8.1),5.2 (±8.1),89.7% (±110.6%)
Gabrovo,Male,(40-44),10.4,24,13.6,6.6,2.1,Significant Increase,13.0,-2.6,23.4,130.8,128.2,10.4 (±13.0),13.6 (±13.0),130.8% (±128.2%)
Gabrovo,Male,(45-49),17.4,36,18.6,7.8,2.4,Significant Increase,15.2,2.2,32.6,106.9,96.5,17.4 (±15.2),18.6 (±15.2),106.9% (±96.5%)
Gabrovo,Male,(5-9),-0.6,0,0.6,1.3,0.5,Not Significant,2.5,-3.1,1.9,-100.0,0.0,-0.6 (±2.5),0.6 (±2.5),-100.0% (±0.0%)
Gabrovo,Male,(50-54),33.8,51,17.2,10.8,1.6,Not Significant,21.3,12.5,55.1,50.9,58.3,33.8 (±21.3),17.2 (±21.3),50.9% (±58.3%)
Gabrovo,Male,(55-59),58.4,67,8.6,12.9,0.7,Not Significant,25.4,33.0,83.8,14.7,34.7,58.4 (±25.4),8.6 (±25.4),14.7% (±34.7%)
Gabrovo,Male,(60-64),90.8,120,29.2,16.5,1.8,Not Significant,32.2,58.6,123.0,32.2,34.6,90.8 (±32.2),29.2 (±32.2),32.2% (±34.6%)
Gabrovo,Male,(65-69),139.8,168,28.2,18.5,1.5,Not Significant,36.3,103.5,176.1,20.2,24.8,139.8 (±36.3),28.2 (±36.3),20.2% (±24.8%)
Gabrovo,Male,(70-74),186.0,218,32.0,23.2,1.4,Not Significant,45.5,140.5,231.5,17.2,23.0,186.0 (±45.5),32.0 (±45.5),17.2% (±23.0%)
Gabrovo,Male,(75-79),151.4,217,65.6,19.8,3.3,Significant Increase,38.8,112.6,190.2,43.3,29.2,151.4 (±38.8),65.6 (±38.8),43.3% (±29.2%)
Gabrovo,Male,(80-84),159.2,223,63.8,22.6,2.8,Significant Increase,44.3,114.9,203.5,40.1,30.5,159.2 (±44.3),63.8 (±44.3),40.1% (±30.5%)
Gabrovo,Male,(85-89),152.2,213,60.8,18.6,3.3,Significant Increase,36.4,115.8,188.6,39.9,27.0,152.2 (±36.4),60.8 (±36.4),39.9% (±27.0%)
Gabrovo,Male,(90+),56.0,86,30.0,14.9,2.0,Significant Increase,29.2,26.8,85.2,53.6,52.7,56.0 (±29.2),30.0 (±29.2),53.6% (±52.7%)
Gabrovo,Total,(0-4),4.0,6,2.0,3.7,0.5,Not Significant,7.2,-3.2,11.2,50.0,96.4,4.0 (±7.2),2.0 (±7.2),50.0% (±96.4%)
Gabrovo,Total,(10-14),-0.2,1,1.2,1.3,0.9,Not Significant,2.5,-2.7,2.3,-600.0,-543.5,-0.2 (±2.5),1.2 (±2.5),-600.0% (±-543.5%)
Gabrovo,Total,(15-19),1.8,2,0.2,2.5,0.1,Not Significant,4.9,-3.1,6.7,11.1,81.2,1.8 (±4.9),0.2 (±4.9),11.1% (±81.2%)
Gabrovo,Total,(20-24),2.2,5,2.8,3.2,0.9,Not Significant,6.3,-4.1,8.5,127.3,168.5,2.2 (±6.3),2.8 (±6.3),127.3% (±168.5%)
Gabrovo,Total,(25-29),3.6,4,0.4,4.0,0.1,Not Significant,7.8,-4.2,11.4,11.1,76.0,3.6 (±7.8),0.4 (±7.8),11.1% (±76.0%)
Gabrovo,Total,(30-34),-0.6,8,8.6,3.3,2.6,Significant Increase,6.5,-7.1,5.9,-1433.3,-1468.9,-0.6 (±6.5),8.6 (±6.5),-1433.3% (±-1468.9%)
Gabrovo,Total,(35-39),5.8,15,9.2,4.8,1.9,Not Significant,9.5,-3.7,15.3,158.6,160.6,5.8 (±9.5),9.2 (±9.5),158.6% (±160.6%)
Gabrovo,Total,(40-44),16.8,27,10.2,8.0,1.3,Not Significant,15.6,1.2,32.4,60.7,77.4,16.8 (±15.6),10.2 (±15.6),60.7% (±77.4%)
Gabrovo,Total,(45-49),34.0,49,15.0,9.2,1.6,Not Significant,18.0,16.0,52.0,44.1,49.9,34.0 (±18.0),15.0 (±18.0),44.1% (±49.9%)
Gabrovo,Total,(5-9),-1.2,1,2.2,1.5,1.5,Not Significant,2.9,-4.1,1.7,-183.3,-142.1,-1.2 (±2.9),2.2 (±2.9),-183.3% (±-142.1%)
Gabrovo,Total,(50-54),53.6,67,13.4,12.0,1.1,Not Significant,23.5,30.1,77.1,25.0,38.1,53.6 (±23.5),13.4 (±23.5),25.0% (±38.1%)
Gabrovo,Total,(55-59),80.2,118,37.8,14.8,2.5,Significant Increase,29.1,51.1,109.3,47.1,39.1,80.2 (±29.1),37.8 (±29.1),47.1% (±39.1%)
Gabrovo,Total,(60-64),132.6,181,48.4,19.4,2.5,Significant Increase,38.0,94.6,170.6,36.5,30.4,132.6 (±38.0),48.4 (±38.0),36.5% (±30.4%)
Gabrovo,Total,(65-69),212.8,263,50.2,24.1,2.1,Significant Increase,47.3,165.5,260.1,23.6,22.5,212.8 (±47.3),50.2 (±47.3),23.6% (±22.5%)
Gabrovo,Total,(70-74),330.8,423,92.2,28.4,3.2,Significant Increase,55.7,275.1,386.5,27.9,18.5,330.8 (±55.7),92.2 (±55.7),27.9% (±18.5%)
Gabrovo,Total,(75-79),310.0,476,166.0,29.4,5.7,Significant Increase,57.6,252.4,367.6,53.5,24.0,310.0 (±57.6),166.0 (±57.6),53.5% (±24.0%)
Gabrovo,Total,(80-84),367.8,547,179.2,40.5,4.4,Significant Increase,79.4,288.4,447.2,48.7,26.4,367.8 (±79.4),179.2 (±79.4),48.7% (±26.4%)
Gabrovo,Total,(85-89),362.6,503,140.4,30.5,4.6,Significant Increase,59.8,302.8,422.4,38.7,19.6,362.6 (±59.8),140.4 (±59.8),38.7% (±19.6%)
Gabrovo,Total,(90+),224.6,278,53.4,25.8,2.1,Significant Increase,50.5,174.1,275.1,23.8,22.7,224.6 (±50.5),53.4 (±50.5),23.8% (±22.7%)
Haskovo,Female,(0-4),6.2,5,-1.2,4.4,-0.3,Not Significant,8.7,-2.5,14.9,-19.4,47.0,6.2 (±8.7),-1.2 (±8.7),-19.4% (±47.0%)
Haskovo,Female,(10-14),0.4,0,-0.4,1.1,-0.4,Not Significant,2.1,-1.7,2.5,-100.0,0.0,0.4 (±2.1),-0.4 (±2.1),-100.0% (±0.0%)
Haskovo,Female,(15-19),5.2,3,-2.2,2.8,-0.8,Not Significant,5.5,-0.3,10.7,-42.3,29.7,5.2 (±5.5),-2.2 (±5.5),-42.3% (±29.7%)
Haskovo,Female,(20-24),-0.4,1,1.4,2.0,0.7,Not Significant,4.0,-4.4,3.6,-350.0,-277.8,-0.4 (±4.0),1.4 (±4.0),-350.0% (±-277.8%)
Haskovo,Female,(25-29),2.4,1,-1.4,2.6,-0.5,Not Significant,5.1,-2.7,7.5,-58.3,28.4,2.4 (±5.1),-1.4 (±5.1),-58.3% (±28.4%)
Haskovo,Female,(30-34),5.0,5,-0.0,3.9,-0.0,Not Significant,7.7,-2.7,12.7,-0.0,60.6,5.0 (±7.7),-0.0 (±7.7),-0.0% (±60.6%)
Haskovo,Female,(35-39),10.0,8,-2.0,4.8,-0.4,Not Significant,9.3,0.7,19.3,-20.0,38.5,10.0 (±9.3),-2.0 (±9.3),-20.0% (±38.5%)
Haskovo,Female,(40-44),11.2,23,11.8,5.5,2.2,Significant Increase,10.7,0.5,21.9,105.4,100.4,11.2 (±10.7),11.8 (±10.7),105.4% (±100.4%)
Haskovo,Female,(45-49),20.8,40,19.2,7.7,2.5,Significant Increase,15.1,5.7,35.9,92.3,80.9,20.8 (±15.1),19.2 (±15.1),92.3% (±80.9%)
Haskovo,Female,(5-9),1.6,3,1.4,1.5,0.9,Not Significant,2.9,-1.3,4.5,87.5,120.8,1.6 (±2.9),1.4 (±2.9),87.5% (±120.8%)
Haskovo,Female,(50-54),19.8,47,27.2,9.5,2.9,Significant Increase,18.6,1.2,38.4,137.4,115.0,19.8 (±18.6),27.2 (±18.6),137.4% (±115.0%)
Haskovo,Female,(55-59),50.4,73,22.6,12.7,1.8,Not Significant,24.9,25.5,75.3,44.8,47.9,50.4 (±24.9),22.6 (±24.9),44.8% (±47.9%)
Haskovo,Female,(60-64),85.0,121,36.0,15.9,2.3,Significant Increase,31.1,53.9,116.1,42.4,38.2,85.0 (±31.1),36.0 (±31.1),42.4% (±38.2%)
Haskovo,Female,(65-69),125.4,221,95.6,20.6,4.6,Significant Increase,40.4,85.0,165.8,76.2,42.9,125.4 (±40.4),95.6 (±40.4),76.2% (±42.9%)
Haskovo,Female,(70-74),137.4,278,140.6,20.9,6.7,Significant Increase,41.0,96.4,178.4,102.3,46.5,137.4 (±41.0),140.6 (±41.0),102.3% (±46.5%)
Haskovo,Female,(75-79),199.2,358,158.8,27.7,5.7,Significant Increase,54.3,144.9,253.5,79.7,38.5,199.2 (±54.3),158.8 (±54.3),79.7% (±38.5%)
Haskovo,Female,(80-84),366.6,484,117.4,35.3,3.3,Significant Increase,69.2,297.4,435.8,32.0,20.9,366.6 (±69.2),117.4 (±69.2),32.0% (±20.9%)
Haskovo,Female,(85-89),419.4,511,91.6,37.7,2.4,Significant Increase,73.9,345.5,493.3,21.8,18.2,419.4 (±73.9),91.6 (±73.9),21.8% (±18.2%)
Haskovo,Female,(90+),275.4,322,46.6,26.6,1.7,Not Significant,52.2,223.2,327.6,16.9,18.6,275.4 (±52.2),46.6 (±52.2),16.9% (±18.6%)
Haskovo,Male,(0-4),9.0,5,-4.0,5.7,-0.7,Not Significant,11.2,-2.2,20.2,-44.4,30.8,9.0 (±11.2),-4.0 (±11.2),-44.4% (±30.8%)
Haskovo,Male,(10-14),0.0,0,-0.0,2.0,-0.0,Not Significant,3.9,-3.9,3.9,-100.0,0.0,0.0 (±3.9),-0.0 (±3.9),-100.0% (±0.0%)
Haskovo,Male,(15-19),3.8,6,2.2,3.0,0.7,Not Significant,6.0,-2.2,9.8,57.9,96.7,3.8 (±6.0),2.2 (±6.0),57.9% (±96.7%)
Haskovo,Male,(20-24),4.0,8,4.0,3.9,1.0,Not Significant,7.7,-3.7,11.7,100.0,131.6,4.0 (±7.7),4.0 (±7.7),100.0% (±131.6%)
Haskovo,Male,(25-29),5.2,7,1.8,3.9,0.5,Not Significant,7.7,-2.5,12.9,34.6,80.3,5.2 (±7.7),1.8 (±7.7),34.6% (±80.3%)
Haskovo,Male,(30-34),6.8,9,2.2,5.2,0.4,Not Significant,10.2,-3.4,17.0,32.4,79.5,6.8 (±10.2),2.2 (±10.2),32.4% (±79.5%)
Haskovo,Male,(35-39),15.8,15,-0.8,6.6,-0.1,Not Significant,12.9,2.9,28.7,-5.1,42.6,15.8 (±12.9),-0.8 (±12.9),-5.1% (±42.6%)
Haskovo,Male,(40-44),41.4,33,-8.4,7.8,-1.1,Not Significant,15.3,26.1,56.7,-20.3,21.5,41.4 (±15.3),-8.4 (±15.3),-20.3% (±21.5%)
Haskovo,Male,(45-49),39.6,65,25.4,11.8,2.2,Significant Increase,23.1,16.5,62.7,64.1,60.4,39.6 (±23.1),25.4 (±23.1),64.1% (±60.4%)
Haskovo,Male,(5-9),-1.0,0,1.0,1.6,0.6,Not Significant,3.1,-4.1,2.1,-100.0,0.0,-1.0 (±3.1),1.0 (±3.1),-100.0% (±0.0%)
Haskovo,Male,(50-54),88.8,88,-0.8,15.2,-0.1,Not Significant,29.9,58.9,118.7,-0.9,25.0,88.8 (±29.9),-0.8 (±29.9),-0.9% (±25.0%)
Haskovo,Male,(55-59),131.2,163,31.8,20.3,1.6,Not Significant,39.7,91.5,170.9,24.2,28.8,131.2 (±39.7),31.8 (±39.7),24.2% (±28.8%)
Haskovo,Male,(60-64),192.4,260,67.6,22.1,3.1,Significant Increase,43.3,149.1,235.7,35.1,24.8,192.4 (±43.3),67.6 (±43.3),35.1% (±24.8%)
Haskovo,Male,(65-69),274.4,349,74.6,26.6,2.8,Significant Increase,52.1,222.3,326.5,27.2,20.3,274.4 (±52.1),74.6 (±52.1),27.2% (±20.3%)
Haskovo,Male,(70-74),256.8,422,165.2,24.3,6.8,Significant Increase,47.6,209.2,304.4,64.3,25.7,256.8 (±47.6),165.2 (±47.6),64.3% (±25.7%)
Haskovo,Male,(75-79),270.6,435,164.4,28.6,5.8,Significant Increase,56.0,214.6,326.6,60.8,27.6,270.6 (±56.0),164.4 (±56.0),60.8% (±27.6%)
Haskovo,Male,(80-84),228.6,368,139.4,29.6,4.7,Significant Increase,58.1,170.5,286.7,61.0,32.6,228.6 (±58.1),139.4 (±58.1),61.0% (±32.6%)
Haskovo,Male,(85-89),280.4,285,4.6,25.8,0.2,Not Significant,50.6,229.8,331.0,1.6,15.5,280.4 (±50.6),4.6 (±50.6),1.6% (±15.5%)
Haskovo,Male,(90+),142.8,187,44.2,18.4,2.4,Significant Increase,36.0,106.8,178.8,31.0,26.4,142.8 (±36.0),44.2 (±36.0),31.0% (±26.4%)
Haskovo,Total,(0-4),15.2,10,-5.2,7.2,-0.7,Not Significant,14.1,1.1,29.3,-34.2,31.7,15.2 (±14.1),-5.2 (±14.1),-34.2% (±31.7%)
Haskovo,Total,(10-14),0.4,0,-0.4,2.2,-0.2,Not Significant,4.4,-4.0,4.8,-100.0,0.0,0.4 (±4.4),-0.4 (±4.4),-100.0% (±0.0%)
Haskovo,Total,(15-19),9.0,9,0.0,4.2,0.0,Not Significant,8.2,0.8,17.2,0.0,47.7,9.0 (±8.2),0.0 (±8.2),0.0% (±47.7%)
Haskovo,Total,(20-24),3.6,9,5.4,4.4,1.2,Not Significant,8.5,-4.9,12.1,150.0,175.6,3.6 (±8.5),5.4 (±8.5),150.0% (±175.6%)
Haskovo,Total,(25-29),7.6,8,0.4,4.7,0.1,Not Significant,9.2,-1.6,16.8,5.3,57.7,7.6 (±9.2),0.4 (±9.2),5.3% (±57.7%)
Haskovo,Total,(30-34),11.8,14,2.2,6.6,0.3,Not Significant,12.8,-1.0,24.6,18.6,61.7,11.8 (±12.8),2.2 (±12.8),18.6% (±61.7%)
Haskovo,Total,(35-39),25.8,23,-2.8,8.3,-0.3,Not Significant,16.2,9.6,42.0,-10.9,34.3,25.8 (±16.2),-2.8 (±16.2),-10.9% (±34.3%)
Haskovo,Total,(40-44),52.6,56,3.4,9.6,0.4,Not Significant,18.8,33.8,71.4,6.5,28.1,52.6 (±18.8),3.4 (±18.8),6.5% (±28.1%)
Haskovo,Total,(45-49),60.4,105,44.6,13.4,3.3,Significant Increase,26.3,34.1,86.7,73.8,52.7,60.4 (±26.3),44.6 (±26.3),73.8% (±52.7%)
Haskovo,Total,(5-9),0.6,3,2.4,2.2,1.1,Not Significant,4.3,-3.7,4.9,400.0,438.8,0.6 (±4.3),2.4 (±4.3),400.0% (±438.8%)
Haskovo,Total,(50-54),108.6,135,26.4,17.9,1.5,Not Significant,35.2,73.4,143.8,24.3,30.4,108.6 (±35.2),26.4 (±35.2),24.3% (±30.4%)
Haskovo,Total,(55-59),181.6,236,54.4,23.5,2.3,Significant Increase,46.0,135.6,227.6,30.0,26.3,181.6 (±46.0),54.4 (±46.0),30.0% (±26.3%)
Haskovo,Total,(60-64),277.4,381,103.6,27.2,3.8,Significant Increase,53.3,224.1,330.7,37.3,22.1,277.4 (±53.3),103.6 (±53.3),37.3% (±22.1%)
Haskovo,Total,(65-69),399.8,570,170.2,33.4,5.1,Significant Increase,65.4,334.4,465.2,42.6,20.1,399.8 (±65.4),170.2 (±65.4),42.6% (±20.1%)
Haskovo,Total,(70-74),394.2,700,305.8,33.5,9.1,Significant Increase,65.6,328.6,459.8,77.6,25.4,394.2 (±65.6),305.8 (±65.6),77.6% (±25.4%)
Haskovo,Total,(75-79),469.8,793,323.2,40.4,8.0,Significant Increase,79.3,390.5,549.1,68.8,24.4,469.8 (±79.3),323.2 (±79.3),68.8% (±24.4%)
Haskovo,Total,(80-84),595.2,852,256.8,47.1,5.5,Significant Increase,92.3,502.9,687.5,43.1,19.2,595.2 (±92.3),256.8 (±92.3),43.1% (±19.2%)
Haskovo,Total,(85-89),699.8,796,96.2,48.6,2.0,Significant Increase,95.3,604.5,795.1,13.7,13.6,699.8 (±95.3),96.2 (±95.3),13.7% (±13.6%)
Haskovo,Total,(90+),418.2,509,90.8,32.6,2.8,Significant Increase,63.9,354.3,482.1,21.7,16.1,418.2 (±63.9),90.8 (±63.9),21.7% (±16.1%)
Kardzhali,Female,(0-4),4.4,8,3.6,3.3,1.1,Not Significant,6.5,-2.1,10.9,81.8,108.4,4.4 (±6.5),3.6 (±6.5),81.8% (±108.4%)
Kardzhali,Female,(10-14),0.0,1,1.0,0.0,,Undetermined,0.0,0.0,0.0,0.0,,0.0 (±0.0),1.0 (±0.0),0.0% (±nan%)
Kardzhali,Female,(15-19),1.0,2,1.0,1.3,0.8,Not Significant,2.5,-1.5,3.5,100.0,142.9,1.0 (±2.5),1.0 (±2.5),100.0% (±142.9%)
Kardzhali,Female,(20-24),2.0,2,0.0,1.8,0.0,Not Significant,3.6,-1.6,5.6,0.0,64.3,2.0 (±3.6),0.0 (±3.6),0.0% (±64.3%)
Kardzhali,Female,(25-29),2.2,1,-1.2,1.9,-0.6,Not Significant,3.7,-1.5,5.9,-54.5,28.6,2.2 (±3.7),-1.2 (±3.7),-54.5% (±28.6%)
Kardzhali,Female,(30-34),8.4,2,-6.4,2.8,-2.3,Significant Decrease,5.4,3.0,13.8,-76.2,9.3,8.4 (±5.4),-6.4 (±5.4),-76.2% (±9.3%)
Kardzhali,Female,(35-39),2.0,5,3.0,4.8,0.6,Not Significant,9.3,-7.3,11.3,150.0,205.8,2.0 (±9.3),3.0 (±9.3),150.0% (±205.8%)
Kardzhali,Female,(40-44),6.4,15,8.6,3.9,2.2,Significant Increase,7.6,-1.2,14.0,134.4,127.3,6.4 (±7.6),8.6 (±7.6),134.4% (±127.3%)
Kardzhali,Female,(45-49),7.8,12,4.2,5.5,0.8,Not Significant,10.8,-3.0,18.6,53.8,89.3,7.8 (±10.8),4.2 (±10.8),53.8% (±89.3%)
Kardzhali,Female,(5-9),1.4,0,-1.4,1.3,-1.1,Not Significant,2.5,-1.1,3.9,-100.0,0.0,1.4 (±2.5),-1.4 (±2.5),-100.0% (±0.0%)
Kardzhali,Female,(50-54),19.2,20,0.8,7.6,0.1,Not Significant,15.0,4.2,34.2,4.2,45.7,19.2 (±15.0),0.8 (±15.0),4.2% (±45.7%)
Kardzhali,Female,(55-59),10.8,50,39.2,9.3,4.2,Significant Increase,18.2,-7.4,29.0,363.0,290.6,10.8 (±18.2),39.2 (±18.2),363.0% (±290.6%)
Kardzhali,Female,(60-64),50.2,81,30.8,10.8,2.8,Significant Increase,21.3,28.9,71.5,61.4,48.1,50.2 (±21.3),30.8 (±21.3),61.4% (±48.1%)
Kardzhali,Female,(65-69),72.8,117,44.2,14.4,3.1,Significant Increase,28.2,44.6,101.0,60.7,44.9,72.8 (±28.2),44.2 (±28.2),60.7% (±44.9%)
Kardzhali,Female,(70-74),87.8,180,92.2,16.5,5.6,Significant Increase,32.4,55.4,120.2,105.0,55.2,87.8 (±32.4),92.2 (±32.4),105.0% (±55.2%)
Kardzhali,Female,(75-79),139.4,203,63.6,21.6,2.9,Significant Increase,42.3,97.1,181.7,45.6,33.9,139.4 (±42.3),63.6 (±42.3),45.6% (±33.9%)
Kardzhali,Female,(80-84),225.8,295,69.2,24.3,2.8,Significant Increase,47.7,178.1,273.5,30.6,22.7,225.8 (±47.7),69.2 (±47.7),30.6% (±22.7%)
Kardzhali,Female,(85-89),187.8,245,57.2,22.0,2.6,Significant Increase,43.1,144.7,230.9,30.5,24.4,187.8 (±43.1),57.2 (±43.1),30.5% (±24.4%)
Kardzhali,Female,(90+),112.6,123,10.4,17.6,0.6,Not Significant,34.6,78.0,147.2,9.2,25.6,112.6 (±34.6),10.4 (±34.6),9.2% (±25.6%)
Kardzhali,Male,(0-4),3.0,3,-0.0,3.8,-0.0,Not Significant,7.4,-4.4,10.4,-0.0,71.2,3.0 (±7.4),-0.0 (±7.4),-0.0% (±71.2%)
Kardzhali,Male,(10-14),-0.2,2,2.2,1.3,1.7,Not Significant,2.5,-2.7,2.3,-1100.0,-1087.0,-0.2 (±2.5),2.2 (±2.5),-1100.0% (±-1087.0%)
Kardzhali,Male,(15-19),2.0,3,1.0,2.3,0.4,Not Significant,4.5,-2.5,6.5,50.0,103.8,2.0 (±4.5),1.0 (±4.5),50.0% (±103.8%)
Kardzhali,Male,(20-24),2.2,4,1.8,2.0,0.9,Not Significant,3.9,-1.7,6.1,81.8,116.2,2.2 (±3.9),1.8 (±3.9),81.8% (±116.2%)
Kardzhali,Male,(25-29),3.2,4,0.8,3.0,0.3,Not Significant,5.8,-2.6,9.0,25.0,80.6,3.2 (±5.8),0.8 (±5.8),25.0% (±80.6%)
Kardzhali,Male,(30-34),5.8,12,6.2,4.6,1.4,Not Significant,8.9,-3.1,14.7,106.9,125.3,5.8 (±8.9),6.2 (±8.9),106.9% (±125.3%)
Kardzhali,Male,(35-39),7.8,9,1.2,5.9,0.2,Not Significant,11.5,-3.7,19.3,15.4,68.8,7.8 (±11.5),1.2 (±11.5),15.4% (±68.8%)
Kardzhali,Male,(40-44),19.2,25,5.8,6.5,0.9,Not Significant,12.7,6.5,31.9,30.2,51.8,19.2 (±12.7),5.8 (±12.7),30.2% (±51.8%)
Kardzhali,Male,(45-49),28.4,41,12.6,9.0,1.4,Not Significant,17.7,10.7,46.1,44.4,55.5,28.4 (±17.7),12.6 (±17.7),44.4% (±55.5%)
Kardzhali,Male,(5-9),1.0,2,1.0,1.7,0.6,Not Significant,3.3,-2.3,4.3,100.0,153.5,1.0 (±3.3),1.0 (±3.3),100.0% (±153.5%)
Kardzhali,Male,(50-54),45.6,57,11.4,11.6,1.0,Not Significant,22.8,22.8,68.4,25.0,41.7,45.6 (±22.8),11.4 (±22.8),25.0% (±41.7%)
Kardzhali,Male,(55-59),71.6,90,18.4,14.1,1.3,Not Significant,27.7,43.9,99.3,25.7,35.1,71.6 (±27.7),18.4 (±27.7),25.7% (±35.1%)
Kardzhali,Male,(60-64),113.6,140,26.4,17.7,1.5,Not Significant,34.6,79.0,148.2,23.2,28.7,113.6 (±34.6),26.4 (±34.6),23.2% (±28.7%)
Kardzhali,Male,(65-69),127.8,200,72.2,17.6,4.1,Significant Increase,34.6,93.2,162.4,56.5,33.3,127.8 (±34.6),72.2 (±34.6),56.5% (±33.3%)
Kardzhali,Male,(70-74),130.0,229,99.0,19.8,5.0,Significant Increase,38.9,91.1,168.9,76.2,40.6,130.0 (±38.9),99.0 (±38.9),76.2% (±40.6%)
Kardzhali,Male,(75-79),145.6,205,59.4,20.4,2.9,Significant Increase,40.0,105.6,185.6,40.8,30.3,145.6 (±40.0),59.4 (±40.0),40.8% (±30.3%)
Kardzhali,Male,(80-84),175.2,244,68.8,23.5,2.9,Significant Increase,46.1,129.1,221.3,39.3,29.0,175.2 (±46.1),68.8 (±46.1),39.3% (±29.0%)
Kardzhali,Male,(85-89),143.0,168,25.0,19.4,1.3,Not Significant,38.1,104.9,181.1,17.5,24.7,143.0 (±38.1),25.0 (±38.1),17.5% (±24.7%)
Kardzhali,Male,(90+),64.6,62,-2.6,12.1,-0.2,Not Significant,23.7,40.9,88.3,-4.0,25.8,64.6 (±23.7),-2.6 (±23.7),-4.0% (±25.8%)
Kardzhali,Total,(0-4),7.4,11,3.6,4.7,0.8,Not Significant,9.3,-1.9,16.7,48.6,82.7,7.4 (±9.3),3.6 (±9.3),48.6% (±82.7%)
Kardzhali,Total,(10-14),-0.2,3,3.2,1.3,2.5,Significant Increase,2.5,-2.7,2.3,-1600.0,-1630.4,-0.2 (±2.5),3.2 (±2.5),-1600.0% (±-1630.4%)
Kardzhali,Total,(15-19),3.0,5,2.0,2.6,0.8,Not Significant,5.1,-2.1,8.1,66.7,105.0,3.0 (±5.1),2.0 (±5.1),66.7% (±105.0%)
Kardzhali,Total,(20-24),4.2,6,1.8,2.7,0.7,Not Significant,5.3,-1.1,9.5,42.9,79.7,4.2 (±5.3),1.8 (±5.3),42.9% (±79.7%)
Kardzhali,Total,(25-29),5.4,5,-0.4,3.5,-0.1,Not Significant,6.9,-1.5,12.3,-7.4,51.9,5.4 (±6.9),-0.4 (±6.9),-7.4% (±51.9%)
Kardzhali,Total,(30-34),14.2,14,-0.2,5.2,-0.0,Not Significant,10.2,4.0,24.4,-1.4,41.2,14.2 (±10.2),-0.2 (±10.2),-1.4% (±41.2%)
Kardzhali,Total,(35-39),9.8,14,4.2,7.6,0.6,Not Significant,14.9,-5.1,24.7,42.9,86.2,9.8 (±14.9),4.2 (±14.9),42.9% (±86.2%)
Kardzhali,Total,(40-44),25.6,40,14.4,7.9,1.8,Not Significant,15.4,10.2,41.0,56.3,58.7,25.6 (±15.4),14.4 (±15.4),56.3% (±58.7%)
Kardzhali,Total,(45-49),36.2,53,16.8,10.3,1.6,Not Significant,20.2,16.0,56.4,46.4,52.4,36.2 (±20.2),16.8 (±20.2),46.4% (±52.4%)
Kardzhali,Total,(5-9),2.4,2,-0.4,2.1,-0.2,Not Significant,4.2,-1.8,6.6,-16.7,53.0,2.4 (±4.2),-0.4 (±4.2),-16.7% (±53.0%)
Kardzhali,Total,(50-54),64.8,77,12.2,13.6,0.9,Not Significant,26.6,38.2,91.4,18.8,34.6,64.8 (±26.6),12.2 (±26.6),18.8% (±34.6%)
Kardzhali,Total,(55-59),82.4,140,57.6,16.1,3.6,Significant Increase,31.6,50.8,114.0,69.9,47.1,82.4 (±31.6),57.6 (±31.6),69.9% (±47.1%)
Kardzhali,Total,(60-64),163.8,221,57.2,21.4,2.7,Significant Increase,42.0,121.8,205.8,34.9,27.5,163.8 (±42.0),57.2 (±42.0),34.9% (±27.5%)
Kardzhali,Total,(65-69),200.6,317,116.4,23.6,4.9,Significant Increase,46.3,154.3,246.9,58.0,29.6,200.6 (±46.3),116.4 (±46.3),58.0% (±29.6%)
Kardzhali,Total,(70-74),217.8,409,191.2,25.3,7.5,Significant Increase,49.6,168.2,267.4,87.8,34.8,217.8 (±49.6),191.2 (±49.6),87.8% (±34.8%)
Kardzhali,Total,(75-79),285.0,408,123.0,31.0,4.0,Significant Increase,60.8,224.2,345.8,43.2,25.2,285.0 (±60.8),123.0 (±60.8),43.2% (±25.2%)
Kardzhali,Total,(80-84),401.0,539,138.0,35.5,3.9,Significant Increase,69.6,331.4,470.6,34.4,19.9,401.0 (±69.6),138.0 (±69.6),34.4% (±19.9%)
Kardzhali,Total,(85-89),330.8,413,82.2,29.1,2.8,Significant Increase,56.9,273.9,387.7,24.8,18.3,330.8 (±56.9),82.2 (±56.9),24.8% (±18.3%)
Kardzhali,Total,(90+),177.2,185,7.8,21.0,0.4,Not Significant,41.1,136.1,218.3,4.4,19.7,177.2 (±41.1),7.8 (±41.1),4.4% (±19.7%)
Kyustendil,Female,(0-4),0.6,1,0.4,3.4,0.1,Not Significant,6.6,-6.0,7.2,66.7,152.8,0.6 (±6.6),0.4 (±6.6),66.7% (±152.8%)
Kyustendil,Female,(10-14),-0.4,3,3.4,1.1,3.2,Significant Increase,2.1,-2.5,1.7,-850.0,-926.5,-0.4 (±2.1),3.4 (±2.1),-850.0% (±-926.5%)
Kyustendil,Female,(15-19),1.0,0,-1.0,1.3,-0.8,Not Significant,2.5,-1.5,3.5,-100.0,0.0,1.0 (±2.5),-1.0 (±2.5),-100.0% (±0.0%)
Kyustendil,Female,(20-24),-0.8,2,2.8,1.1,2.7,Significant Increase,2.1,-2.9,1.3,-350.0,-403.8,-0.8 (±2.1),2.8 (±2.1),-350.0% (±-403.8%)
Kyustendil,Female,(25-29),0.8,3,2.2,2.1,1.1,Not Significant,4.0,-3.2,4.8,275.0,312.5,0.8 (±4.0),2.2 (±4.0),275.0% (±312.5%)
Kyustendil,Female,(30-34),1.4,2,0.6,2.9,0.2,Not Significant,5.7,-4.3,7.1,42.9,114.7,1.4 (±5.7),0.6 (±5.7),42.9% (±114.7%)
Kyustendil,Female,(35-39),5.6,8,2.4,3.4,0.7,Not Significant,6.6,-1.0,12.2,42.9,77.3,5.6 (±6.6),2.4 (±6.6),42.9% (±77.3%)
Kyustendil,Female,(40-44),10.0,10,-0.0,4.7,-0.0,Not Significant,9.3,0.7,19.3,-0.0,48.2,10.0 (±9.3),-0.0 (±9.3),-0.0% (±48.2%)
Kyustendil,Female,(45-49),6.2,29,22.8,6.7,3.4,Significant Increase,13.1,-6.9,19.3,367.7,317.4,6.2 (±13.1),22.8 (±13.1),367.7% (±317.4%)
Kyustendil,Female,(5-9),0.0,1,1.0,0.0,,Undetermined,0.0,0.0,0.0,0.0,,0.0 (±0.0),1.0 (±0.0),0.0% (±nan%)
Kyustendil,Female,(50-54),13.4,33,19.6,7.2,2.7,Significant Increase,14.2,-0.8,27.6,146.3,126.7,13.4 (±14.2),19.6 (±14.2),146.3% (±126.7%)
Kyustendil,Female,(55-59),37.8,52,14.2,10.1,1.4,Not Significant,19.8,18.0,57.6,37.6,47.3,37.8 (±19.8),14.2 (±19.8),37.6% (±47.3%)
Kyustendil,Female,(60-64),48.8,74,25.2,11.9,2.1,Significant Increase,23.2,25.6,72.0,51.6,48.8,48.8 (±23.2),25.2 (±23.2),51.6% (±48.8%)
Kyustendil,Female,(65-69),66.4,141,74.6,14.2,5.3,Significant Increase,27.8,38.6,94.2,112.3,62.6,66.4 (±27.8),74.6 (±27.8),112.3% (±62.6%)
Kyustendil,Female,(70-74),128.6,207,78.4,19.5,4.0,Significant Increase,38.3,90.3,166.9,61.0,37.0,128.6 (±38.3),78.4 (±38.3),61.0% (±37.0%)
Kyustendil,Female,(75-79),154.6,263,108.4,22.7,4.8,Significant Increase,44.6,110.0,199.2,70.1,38.1,154.6 (±44.6),108.4 (±44.6),70.1% (±38.1%)
Kyustendil,Female,(80-84),226.6,308,81.4,26.7,3.0,Significant Increase,52.4,174.2,279.0,35.9,25.5,226.6 (±52.4),81.4 (±52.4),35.9% (±25.5%)
Kyustendil,Female,(85-89),264.2,294,29.8,28.6,1.0,Not Significant,56.0,208.2,320.2,11.3,19.5,264.2 (±56.0),29.8 (±56.0),11.3% (±19.5%)
Kyustendil,Female,(90+),149.2,190,40.8,22.5,1.8,Not Significant,44.0,105.2,193.2,27.3,29.0,149.2 (±44.0),40.8 (±44.0),27.3% (±29.0%)
Kyustendil,Male,(0-4),3.2,1,-2.2,3.0,-0.7,Not Significant,5.8,-2.6,9.0,-68.8,20.1,3.2 (±5.8),-2.2 (±5.8),-68.8% (±20.1%)
Kyustendil,Male,(10-14),3.2,0,-3.2,1.5,-2.2,Significant Decrease,2.9,0.3,6.1,-100.0,0.0,3.2 (±2.9),-3.2 (±2.9),-100.0% (±0.0%)
Kyustendil,Male,(15-19),-0.0,0,0.0,3.2,0.0,Not Significant,6.2,-6.2,6.2,-100.0,0.0,-0.0 (±6.2),0.0 (±6.2),-100.0% (±0.0%)
Kyustendil,Male,(20-24),-0.2,0,0.2,2.8,0.1,Not Significant,5.6,-5.8,5.4,-100.0,0.0,-0.2 (±5.6),0.2 (±5.6),-100.0% (±0.0%)
Kyustendil,Male,(25-29),4.2,3,-1.2,3.6,-0.3,Not Significant,7.0,-2.8,11.2,-28.6,44.6,4.2 (±7.0),-1.2 (±7.0),-28.6% (±44.6%)
Kyustendil,Male,(30-34),6.8,5,-1.8,3.7,-0.5,Not Significant,7.3,-0.5,14.1,-26.5,38.0,6.8 (±7.3),-1.8 (±7.3),-26.5% (±38.0%)
Kyustendil,Male,(35-39),13.6,6,-7.6,5.8,-1.3,Not Significant,11.4,2.2,25.0,-55.9,20.1,13.6 (±11.4),-7.6 (±11.4),-55.9% (±20.1%)
Kyustendil,Male,(40-44),22.4,22,-0.4,7.4,-0.1,Not Significant,14.6,7.8,37.0,-1.8,38.7,22.4 (±14.6),-0.4 (±14.6),-1.8% (±38.7%)
Kyustendil,Male,(45-49),36.0,37,1.0,9.4,0.1,Not Significant,18.5,17.5,54.5,2.8,34.9,36.0 (±18.5),1.0 (±18.5),2.8% (±34.9%)
Kyustendil,Male,(5-9),-0.8,0,0.8,1.1,0.8,Not Significant,2.1,-2.9,1.3,-100.0,0.0,-0.8 (±2.1),0.8 (±2.1),-100.0% (±0.0%)
Kyustendil,Male,(50-54),49.8,67,17.2,12.8,1.3,Not Significant,25.0,24.8,74.8,34.5,44.9,49.8 (±25.0),17.2 (±25.0),34.5% (±44.9%)
Kyustendil,Male,(55-59),89.2,106,16.8,15.4,1.1,Not Significant,30.1,59.1,119.3,18.8,29.9,89.2 (±30.1),16.8 (±30.1),18.8% (±29.9%)
Kyustendil,Male,(60-64),150.2,184,33.8,19.5,1.7,Not Significant,38.2,112.0,188.4,22.5,24.8,150.2 (±38.2),33.8 (±38.2),22.5% (±24.8%)
Kyustendil,Male,(65-69),191.6,213,21.4,22.0,1.0,Not Significant,43.2,148.4,234.8,11.2,20.5,191.6 (±43.2),21.4 (±43.2),11.2% (±20.5%)
Kyustendil,Male,(70-74),170.4,283,112.6,23.2,4.9,Significant Increase,45.4,125.0,215.8,66.1,35.0,170.4 (±45.4),112.6 (±45.4),66.1% (±35.0%)
Kyustendil,Male,(75-79),170.0,247,77.0,23.7,3.2,Significant Increase,46.5,123.5,216.5,45.3,31.2,170.0 (±46.5),77.0 (±46.5),45.3% (±31.2%)
Kyustendil,Male,(80-84),173.2,262,88.8,23.6,3.8,Significant Increase,46.3,126.9,219.5,51.3,31.9,173.2 (±46.3),88.8 (±46.3),51.3% (±31.9%)
Kyustendil,Male,(85-89),179.4,190,10.6,21.3,0.5,Not Significant,41.7,137.7,221.1,5.9,20.0,179.4 (±41.7),10.6 (±41.7),5.9% (±20.0%)
Kyustendil,Male,(90+),91.2,99,7.8,14.2,0.5,Not Significant,27.8,63.4,119.0,8.6,25.4,91.2 (±27.8),7.8 (±27.8),8.6% (±25.4%)
Kyustendil,Total,(0-4),3.8,2,-1.8,4.9,-0.4,Not Significant,9.6,-5.8,13.4,-47.4,37.7,3.8 (±9.6),-1.8 (±9.6),-47.4% (±37.7%)
Kyustendil,Total,(10-14),2.8,3,0.2,1.8,0.1,Not Significant,3.6,-0.8,6.4,7.1,60.2,2.8 (±3.6),0.2 (±3.6),7.1% (±60.2%)
Kyustendil,Total,(15-19),1.0,0,-1.0,3.4,-0.3,Not Significant,6.7,-5.7,7.7,-100.0,0.0,1.0 (±6.7),-1.0 (±6.7),-100.0% (±0.0%)
Kyustendil,Total,(20-24),-1.0,2,3.0,3.0,1.0,Not Significant,5.8,-6.8,4.8,-300.0,-241.7,-1.0 (±5.8),3.0 (±5.8),-300.0% (±-241.7%)
Kyustendil,Total,(25-29),5.0,6,1.0,4.1,0.2,Not Significant,8.0,-3.0,13.0,20.0,73.8,5.0 (±8.0),1.0 (±8.0),20.0% (±73.8%)
Kyustendil,Total,(30-34),8.2,7,-1.2,5.3,-0.2,Not Significant,10.4,-2.2,18.6,-14.6,47.8,8.2 (±10.4),-1.2 (±10.4),-14.6% (±47.8%)
Kyustendil,Total,(35-39),19.2,14,-5.2,6.6,-0.8,Not Significant,12.9,6.3,32.1,-27.1,29.3,19.2 (±12.9),-5.2 (±12.9),-27.1% (±29.3%)
Kyustendil,Total,(40-44),32.4,32,-0.4,9.4,-0.0,Not Significant,18.3,14.1,50.7,-1.2,35.7,32.4 (±18.3),-0.4 (±18.3),-1.2% (±35.7%)
Kyustendil,Total,(45-49),42.2,66,23.8,12.0,2.0,Significant Increase,23.5,18.7,65.7,56.4,55.9,42.2 (±23.5),23.8 (±23.5),56.4% (±55.9%)
Kyustendil,Total,(5-9),-0.8,1,1.8,1.1,1.7,Not Significant,2.1,-2.9,1.3,-225.0,-201.9,-0.8 (±2.1),1.8 (±2.1),-225.0% (±-201.9%)
Kyustendil,Total,(50-54),63.2,100,36.8,14.7,2.5,Significant Increase,28.9,34.3,92.1,58.2,49.6,63.2 (±28.9),36.8 (±28.9),58.2% (±49.6%)
Kyustendil,Total,(55-59),127.0,158,31.0,18.3,1.7,Not Significant,35.9,91.1,162.9,24.4,27.4,127.0 (±35.9),31.0 (±35.9),24.4% (±27.4%)
Kyustendil,Total,(60-64),199.0,258,59.0,22.8,2.6,Significant Increase,44.7,154.3,243.7,29.6,23.7,199.0 (±44.7),59.0 (±44.7),29.6% (±23.7%)
Kyustendil,Total,(65-69),258.0,354,96.0,25.0,3.8,Significant Increase,49.1,208.9,307.1,37.2,21.9,258.0 (±49.1),96.0 (±49.1),37.2% (±21.9%)
Kyustendil,Total,(70-74),299.0,490,191.0,29.8,6.4,Significant Increase,58.4,240.6,357.4,63.9,26.8,299.0 (±58.4),191.0 (±58.4),63.9% (±26.8%)
Kyustendil,Total,(75-79),324.6,510,185.4,30.6,6.1,Significant Increase,59.9,264.7,384.5,57.1,24.5,324.6 (±59.9),185.4 (±59.9),57.1% (±24.5%)
Kyustendil,Total,(80-84),399.8,570,170.2,35.3,4.8,Significant Increase,69.2,330.6,469.0,42.6,21.1,399.8 (±69.2),170.2 (±69.2),42.6% (±21.1%)
Kyustendil,Total,(85-89),443.6,484,40.4,36.2,1.1,Not Significant,70.9,372.7,514.5,9.1,15.0,443.6 (±70.9),40.4 (±70.9),9.1% (±15.0%)
Kyustendil,Total,(90+),240.4,289,48.6,25.5,1.9,Not Significant,50.0,190.4,290.4,20.2,20.7,240.4 (±50.0),48.6 (±50.0),20.2% (±20.7%)
Lovech,Female,(0-4),-2.6,3,5.6,3.8,1.5,Not Significant,7.5,-10.1,4.9,-215.4,-176.6,-2.6 (±7.5),5.6 (±7.5),-215.4% (±-176.6%)
Lovech,Female,(10-14),-1.2,0,1.2,1.1,1.1,Not Significant,2.1,-3.3,0.9,-100.0,0.0,-1.2 (±2.1),1.2 (±2.1),-100.0% (±0.0%)
Lovech,Female,(15-19),2.0,2,0.0,1.8,0.0,Not Significant,3.4,-1.4,5.4,0.0,63.0,2.0 (±3.4),0.0 (±3.4),0.0% (±63.0%)
Lovech,Female,(20-24),2.4,1,-1.4,1.5,-0.9,Not Significant,2.9,-0.5,5.3,-58.3,22.8,2.4 (±2.9),-1.4 (±2.9),-58.3% (±22.8%)
Lovech,Female,(25-29),0.8,3,2.2,2.5,0.9,Not Significant,4.9,-4.1,5.7,275.0,322.4,0.8 (±4.9),2.2 (±4.9),275.0% (±322.4%)
Lovech,Female,(30-34),2.6,4,1.4,3.4,0.4,Not Significant,6.6,-4.0,9.2,53.8,110.3,2.6 (±6.6),1.4 (±6.6),53.8% (±110.3%)
Lovech,Female,(35-39),2.6,5,2.4,3.0,0.8,Not Significant,6.0,-3.4,8.6,92.3,134.2,2.6 (±6.0),2.4 (±6.0),92.3% (±134.2%)
Lovech,Female,(40-44),6.8,12,5.2,4.1,1.3,Not Significant,8.0,-1.2,14.8,76.5,95.4,6.8 (±8.0),5.2 (±8.0),76.5% (±95.4%)
Lovech,Female,(45-49),11.4,18,6.6,6.1,1.1,Not Significant,11.9,-0.5,23.3,57.9,80.6,11.4 (±11.9),6.6 (±11.9),57.9% (±80.6%)
Lovech,Female,(5-9),-0.6,0,0.6,1.3,0.5,Not Significant,2.5,-3.1,1.9,-100.0,0.0,-0.6 (±2.5),0.6 (±2.5),-100.0% (±0.0%)
Lovech,Female,(50-54),20.4,35,14.6,7.1,2.1,Significant Increase,13.9,6.5,34.3,71.6,69.6,20.4 (±13.9),14.6 (±13.9),71.6% (±69.6%)
Lovech,Female,(55-59),27.8,41,13.2,9.0,1.5,Not Significant,17.7,10.1,45.5,47.5,57.4,27.8 (±17.7),13.2 (±17.7),47.5% (±57.4%)
Lovech,Female,(60-64),49.4,65,15.6,12.4,1.3,Not Significant,24.4,25.0,73.8,31.6,43.5,49.4 (±24.4),15.6 (±24.4),31.6% (±43.5%)
Lovech,Female,(65-69),87.6,112,24.4,15.5,1.6,Not Significant,30.5,57.1,118.1,27.9,33.1,87.6 (±30.5),24.4 (±30.5),27.9% (±33.1%)
Lovech,Female,(70-74),139.2,207,67.8,19.7,3.4,Significant Increase,38.7,100.5,177.9,48.7,32.3,139.2 (±38.7),67.8 (±38.7),48.7% (±32.3%)
Lovech,Female,(75-79),189.2,256,66.8,23.1,2.9,Significant Increase,45.3,143.9,234.5,35.3,26.1,189.2 (±45.3),66.8 (±45.3),35.3% (±26.1%)
Lovech,Female,(80-84),255.8,277,21.2,29.5,0.7,Not Significant,57.9,197.9,313.7,8.3,20.0,255.8 (±57.9),21.2 (±57.9),8.3% (±20.0%)
Lovech,Female,(85-89),270.6,348,77.4,29.3,2.6,Significant Increase,57.3,213.3,327.9,28.6,22.5,270.6 (±57.3),77.4 (±57.3),28.6% (±22.5%)
Lovech,Female,(90+),172.8,200,27.2,21.9,1.2,Not Significant,42.9,129.9,215.7,15.7,23.0,172.8 (±42.9),27.2 (±42.9),15.7% (±23.0%)
Lovech,Male,(0-4),0.4,4,3.6,4.4,0.8,Not Significant,8.6,-8.2,9.0,900.0,955.6,0.4 (±8.6),3.6 (±8.6),900.0% (±955.6%)
Lovech,Male,(10-14),1.6,3,1.4,1.8,0.8,Not Significant,3.6,-2.0,5.2,87.5,129.8,1.6 (±3.6),1.4 (±3.6),87.5% (±129.8%)
Lovech,Male,(15-19),1.6,3,1.4,3.1,0.5,Not Significant,6.1,-4.5,7.7,87.5,148.5,1.6 (±6.1),1.4 (±6.1),87.5% (±148.5%)
Lovech,Male,(20-24),0.4,11,10.6,3.2,3.3,Significant Increase,6.3,-5.9,6.7,2650.0,2585.8,0.4 (±6.3),10.6 (±6.3),2650.0% (±2585.8%)
Lovech,Male,(25-29),4.8,3,-1.8,3.4,-0.5,Not Significant,6.7,-1.9,11.5,-37.5,36.4,4.8 (±6.7),-1.8 (±6.7),-37.5% (±36.4%)
Lovech,Male,(30-34),9.6,14,4.4,4.4,1.0,Not Significant,8.7,0.9,18.3,45.8,69.3,9.6 (±8.7),4.4 (±8.7),45.8% (±69.3%)
Lovech,Male,(35-39),8.8,12,3.2,5.7,0.6,Not Significant,11.2,-2.4,20.0,36.4,76.4,8.8 (±11.2),3.2 (±11.2),36.4% (±76.4%)
Lovech,Male,(40-44),16.8,21,4.2,6.5,0.6,Not Significant,12.8,4.0,29.6,25.0,54.1,16.8 (±12.8),4.2 (±12.8),25.0% (±54.1%)
Lovech,Male,(45-49),36.8,42,5.2,10.0,0.5,Not Significant,19.7,17.1,56.5,14.1,39.8,36.8 (±19.7),5.2 (±19.7),14.1% (±39.8%)
Lovech,Male,(5-9),-0.4,0,0.4,1.8,0.2,Not Significant,3.6,-4.0,3.2,-100.0,0.0,-0.4 (±3.6),0.4 (±3.6),-100.0% (±0.0%)
Lovech,Male,(50-54),42.4,59,16.6,11.8,1.4,Not Significant,23.2,19.2,65.6,39.2,49.3,42.4 (±23.2),16.6 (±23.2),39.2% (±49.3%)
Lovech,Male,(55-59),64.2,109,44.8,14.5,3.1,Significant Increase,28.5,35.7,92.7,69.8,52.2,64.2 (±28.5),44.8 (±28.5),69.8% (±52.2%)
Lovech,Male,(60-64),111.0,140,29.0,18.5,1.6,Not Significant,36.2,74.8,147.2,26.1,31.0,111.0 (±36.2),29.0 (±36.2),26.1% (±31.0%)
Lovech,Male,(65-69),161.6,199,37.4,21.8,1.7,Not Significant,42.7,118.9,204.3,23.1,25.7,161.6 (±42.7),37.4 (±42.7),23.1% (±25.7%)
Lovech,Male,(70-74),250.2,259,8.8,22.2,0.4,Not Significant,43.5,206.7,293.7,3.5,15.3,250.2 (±43.5),8.8 (±43.5),3.5% (±15.3%)
Lovech,Male,(75-79),186.2,280,93.8,24.4,3.8,Significant Increase,47.8,138.4,234.0,50.4,30.7,186.2 (±47.8),93.8 (±47.8),50.4% (±30.7%)
Lovech,Male,(80-84),255.0,246,-9.0,26.4,-0.3,Not Significant,51.6,203.4,306.6,-3.5,16.3,255.0 (±51.6),-9.0 (±51.6),-3.5% (±16.3%)
Lovech,Male,(85-89),164.2,252,87.8,21.5,4.1,Significant Increase,42.1,122.1,206.3,53.5,31.3,164.2 (±42.1),87.8 (±42.1),53.5% (±31.3%)
Lovech,Male,(90+),82.4,100,17.6,15.2,1.2,Not Significant,29.7,52.7,112.1,21.4,32.2,82.4 (±29.7),17.6 (±29.7),21.4% (±32.2%)
Lovech,Total,(0-4),-2.2,7,9.2,6.1,1.5,Not Significant,12.0,-14.2,9.8,-418.2,-389.6,-2.2 (±12.0),9.2 (±12.0),-418.2% (±-389.6%)
Lovech,Total,(10-14),0.4,3,2.6,2.1,1.2,Not Significant,4.2,-3.8,4.6,650.0,684.8,0.4 (±4.2),2.6 (±4.2),650.0% (±684.8%)
Lovech,Total,(15-19),3.6,5,1.4,3.6,0.4,Not Significant,7.0,-3.4,10.6,38.9,91.7,3.6 (±7.0),1.4 (±7.0),38.9% (±91.7%)
Lovech,Total,(20-24),2.8,12,9.2,3.7,2.5,Significant Increase,7.2,-4.4,10.0,328.6,308.6,2.8 (±7.2),9.2 (±7.2),328.6% (±308.6%)
Lovech,Total,(25-29),5.6,6,0.4,4.5,0.1,Not Significant,8.8,-3.2,14.4,7.1,65.4,5.6 (±8.8),0.4 (±8.8),7.1% (±65.4%)
Lovech,Total,(30-34),12.2,18,5.8,5.4,1.1,Not Significant,10.5,1.7,22.7,47.5,68.2,12.2 (±10.5),5.8 (±10.5),47.5% (±68.2%)
Lovech,Total,(35-39),11.4,17,5.6,6.5,0.9,Not Significant,12.7,-1.3,24.1,49.1,78.6,11.4 (±12.7),5.6 (±12.7),49.1% (±78.6%)
Lovech,Total,(40-44),23.6,33,9.4,7.6,1.2,Not Significant,15.0,8.6,38.6,39.8,54.3,23.6 (±15.0),9.4 (±15.0),39.8% (±54.3%)
Lovech,Total,(45-49),48.2,60,11.8,12.0,1.0,Not Significant,23.5,24.7,71.7,24.5,40.8,48.2 (±23.5),11.8 (±23.5),24.5% (±40.8%)
Lovech,Total,(5-9),-1.0,0,1.0,2.2,0.4,Not Significant,4.4,-5.4,3.4,-100.0,0.0,-1.0 (±4.4),1.0 (±4.4),-100.0% (±0.0%)
Lovech,Total,(50-54),62.8,94,31.2,13.6,2.3,Significant Increase,26.6,36.2,89.4,49.7,44.6,62.8 (±26.6),31.2 (±26.6),49.7% (±44.6%)
Lovech,Total,(55-59),92.0,150,58.0,17.6,3.3,Significant Increase,34.5,57.5,126.5,63.0,44.4,92.0 (±34.5),58.0 (±34.5),63.0% (±44.4%)
Lovech,Total,(60-64),160.4,205,44.6,22.2,2.0,Significant Increase,43.5,116.9,203.9,27.8,27.3,160.4 (±43.5),44.6 (±43.5),27.8% (±27.3%)
Lovech,Total,(65-69),249.2,311,61.8,26.3,2.3,Significant Increase,51.6,197.6,300.8,24.8,21.4,249.2 (±51.6),61.8 (±51.6),24.8% (±21.4%)
Lovech,Total,(70-74),389.4,466,76.6,31.6,2.4,Significant Increase,61.9,327.5,451.3,19.7,16.4,389.4 (±61.9),76.6 (±61.9),19.7% (±16.4%)
Lovech,Total,(75-79),375.4,536,160.6,33.5,4.8,Significant Increase,65.7,309.7,441.1,42.8,21.3,375.4 (±65.7),160.6 (±65.7),42.8% (±21.3%)
Lovech,Total,(80-84),510.8,523,12.2,37.0,0.3,Not Significant,72.5,438.3,583.3,2.4,12.7,510.8 (±72.5),12.2 (±72.5),2.4% (±12.7%)
Lovech,Total,(85-89),434.8,600,165.2,37.3,4.4,Significant Increase,73.1,361.7,507.9,38.0,19.9,434.8 (±73.1),165.2 (±73.1),38.0% (±19.9%)
Lovech,Total,(90+),255.2,300,44.8,26.1,1.7,Not Significant,51.2,204.0,306.4,17.6,19.7,255.2 (±51.2),44.8 (±51.2),17.6% (±19.7%)
Montana,Female,(0-4),5.0,5,-0.0,2.9,-0.0,Not Significant,5.6,-0.6,10.6,-0.0,52.8,5.0 (±5.6),-0.0 (±5.6),-0.0% (±52.8%)
Montana,Female,(10-14),0.0,0,0.0,0.0,,Undetermined,0.0,0.0,0.0,0.0,,0.0 (±0.0),0.0 (±0.0),0.0% (±nan%)
Montana,Female,(15-19),2.4,0,-2.4,1.8,-1.4,Not Significant,3.4,-1.0,5.8,-100.0,0.0,2.4 (±3.4),-2.4 (±3.4),-100.0% (±0.0%)
Montana,Female,(20-24),0.2,1,0.8,2.2,0.4,Not Significant,4.4,-4.2,4.6,400.0,478.3,0.2 (±4.4),0.8 (±4.4),400.0% (±478.3%)
Montana,Female,(25-29),3.8,3,-0.8,2.2,-0.4,Not Significant,4.3,-0.5,8.1,-21.1,41.9,3.8 (±4.3),-0.8 (±4.3),-21.1% (±41.9%)
Montana,Female,(30-34),1.8,6,4.2,2.9,1.5,Not Significant,5.6,-3.8,7.4,233.3,252.2,1.8 (±5.6),4.2 (±5.6),233.3% (±252.2%)
Montana,Female,(35-39),11.4,7,-4.4,4.1,-1.1,Not Significant,8.1,3.3,19.5,-38.6,25.5,11.4 (±8.1),-4.4 (±8.1),-38.6% (±25.5%)
Montana,Female,(40-44),5.2,12,6.8,5.6,1.2,Not Significant,10.9,-5.7,16.1,130.8,156.3,5.2 (±10.9),6.8 (±10.9),130.8% (±156.3%)
Montana,Female,(45-49),23.0,29,6.0,5.8,1.0,Not Significant,11.3,11.7,34.3,26.1,41.6,23.0 (±11.3),6.0 (±11.3),26.1% (±41.6%)
Montana,Female,(5-9),0.2,0,-0.2,1.3,-0.2,Not Significant,2.5,-2.3,2.7,-100.0,0.0,0.2 (±2.5),-0.2 (±2.5),-100.0% (±0.0%)
Montana,Female,(50-54),23.4,33,9.6,9.7,1.0,Not Significant,19.1,4.3,42.5,41.0,63.4,23.4 (±19.1),9.6 (±19.1),41.0% (±63.4%)
Montana,Female,(55-59),44.8,55,10.2,10.6,1.0,Not Significant,20.8,24.0,65.6,22.8,39.0,44.8 (±20.8),10.2 (±20.8),22.8% (±39.0%)
Montana,Female,(60-64),51.0,92,41.0,13.7,3.0,Significant Increase,26.9,24.1,77.9,80.4,62.3,51.0 (±26.9),41.0 (±26.9),80.4% (±62.3%)
Montana,Female,(65-69),113.0,139,26.0,17.0,1.5,Not Significant,33.4,79.6,146.4,23.0,28.1,113.0 (±33.4),26.0 (±33.4),23.0% (±28.1%)
Montana,Female,(70-74),148.8,240,91.2,21.3,4.3,Significant Increase,41.7,107.1,190.5,61.3,35.3,148.8 (±41.7),91.2 (±41.7),61.3% (±35.3%)
Montana,Female,(75-79),188.2,305,116.8,25.2,4.6,Significant Increase,49.3,138.9,237.5,62.1,33.7,188.2 (±49.3),116.8 (±49.3),62.1% (±33.7%)
Montana,Female,(80-84),287.2,369,81.8,29.9,2.7,Significant Increase,58.7,228.5,345.9,28.5,21.8,287.2 (±58.7),81.8 (±58.7),28.5% (±21.8%)
Montana,Female,(85-89),279.8,341,61.2,27.3,2.2,Significant Increase,53.6,226.2,333.4,21.9,19.6,279.8 (±53.6),61.2 (±53.6),21.9% (±19.6%)
Montana,Female,(90+),230.8,208,-22.8,21.8,-1.0,Not Significant,42.8,188.0,273.6,-9.9,14.1,230.8 (±42.8),-22.8 (±42.8),-9.9% (±14.1%)
Montana,Male,(0-4),-2.4,5,7.4,4.3,1.7,Not Significant,8.5,-10.9,6.1,-308.3,-290.3,-2.4 (±8.5),7.4 (±8.5),-308.3% (±-290.3%)
Montana,Male,(10-14),0.2,0,-0.2,1.7,-0.1,Not Significant,3.3,-3.1,3.5,-100.0,0.0,0.2 (±3.3),-0.2 (±3.3),-100.0% (±0.0%)
Montana,Male,(15-19),4.2,0,-4.2,2.6,-1.6,Not Significant,5.2,-1.0,9.4,-100.0,0.0,4.2 (±5.2),-4.2 (±5.2),-100.0% (±0.0%)
Montana,Male,(20-24),0.8,1,0.2,2.4,0.1,Not Significant,4.6,-3.8,5.4,25.0,106.5,0.8 (±4.6),0.2 (±4.6),25.0% (±106.5%)
Montana,Male,(25-29),1.8,4,2.2,3.5,0.6,Not Significant,7.0,-5.2,8.8,122.2,176.7,1.8 (±7.0),2.2 (±7.0),122.2% (±176.7%)
Montana,Male,(30-34),9.0,6,-3.0,4.2,-0.7,Not Significant,8.3,0.7,17.3,-33.3,32.0,9.0 (±8.3),-3.0 (±8.3),-33.3% (±32.0%)
Montana,Male,(35-39),3.8,14,10.2,5.4,1.9,Not Significant,10.6,-6.8,14.4,268.4,271.2,3.8 (±10.6),10.2 (±10.6),268.4% (±271.2%)
Montana,Male,(40-44),24.6,20,-4.6,7.6,-0.6,Not Significant,14.9,9.7,39.5,-18.7,30.7,24.6 (±14.9),-4.6 (±14.9),-18.7% (±30.7%)
Montana,Male,(45-49),51.4,43,-8.4,10.2,-0.8,Not Significant,20.0,31.4,71.4,-16.3,23.5,51.4 (±20.0),-8.4 (±20.0),-16.3% (±23.5%)
Montana,Male,(5-9),0.2,2,1.8,0.8,2.4,Significant Increase,1.5,-1.3,1.7,900.0,882.4,0.2 (±1.5),1.8 (±1.5),900.0% (±882.4%)
Montana,Male,(50-54),44.6,93,48.4,12.3,3.9,Significant Increase,24.1,20.5,68.7,108.5,73.1,44.6 (±24.1),48.4 (±24.1),108.5% (±73.1%)
Montana,Male,(55-59),85.6,116,30.4,16.0,1.9,Not Significant,31.4,54.2,117.0,35.5,36.4,85.6 (±31.4),30.4 (±31.4),35.5% (±36.4%)
Montana,Male,(60-64),112.0,194,82.0,20.2,4.1,Significant Increase,39.6,72.4,151.6,73.2,45.2,112.0 (±39.6),82.0 (±39.6),73.2% (±45.2%)
Montana,Male,(65-69),157.2,261,103.8,23.4,4.4,Significant Increase,45.8,111.4,203.0,66.0,37.4,157.2 (±45.8),103.8 (±45.8),66.0% (±37.4%)
Montana,Male,(70-74),233.6,346,112.4,24.8,4.5,Significant Increase,48.7,184.9,282.3,48.1,25.5,233.6 (±48.7),112.4 (±48.7),48.1% (±25.5%)
Montana,Male,(75-79),174.4,306,131.6,23.1,5.7,Significant Increase,45.3,129.1,219.7,75.5,36.2,174.4 (±45.3),131.6 (±45.3),75.5% (±36.2%)
Montana,Male,(80-84),172.0,287,115.0,29.1,4.0,Significant Increase,57.0,115.0,229.0,66.9,41.6,172.0 (±57.0),115.0 (±57.0),66.9% (±41.6%)
Montana,Male,(85-89),164.2,214,49.8,22.1,2.3,Significant Increase,43.4,120.8,207.6,30.3,27.2,164.2 (±43.4),49.8 (±43.4),30.3% (±27.2%)
Montana,Male,(90+),100.2,104,3.8,15.8,0.2,Not Significant,30.9,69.3,131.1,3.8,24.5,100.2 (±30.9),3.8 (±30.9),3.8% (±24.5%)
Montana,Total,(0-4),2.6,10,7.4,5.0,1.5,Not Significant,9.8,-7.2,12.4,284.6,304.0,2.6 (±9.8),7.4 (±9.8),284.6% (±304.0%)
Montana,Total,(10-14),0.2,0,-0.2,1.7,-0.1,Not Significant,3.3,-3.1,3.5,-100.0,0.0,0.2 (±3.3),-0.2 (±3.3),-100.0% (±0.0%)
Montana,Total,(15-19),6.6,0,-6.6,3.4,-1.9,Not Significant,6.7,-0.1,13.3,-100.0,0.0,6.6 (±6.7),-6.6 (±6.7),-100.0% (±0.0%)
Montana,Total,(20-24),1.0,2,1.0,3.2,0.3,Not Significant,6.3,-5.3,7.3,100.0,172.6,1.0 (±6.3),1.0 (±6.3),100.0% (±172.6%)
Montana,Total,(25-29),5.6,7,1.4,4.0,0.3,Not Significant,7.9,-2.3,13.5,25.0,73.1,5.6 (±7.9),1.4 (±7.9),25.0% (±73.1%)
Montana,Total,(30-34),10.8,12,1.2,5.3,0.2,Not Significant,10.4,0.4,21.2,11.1,54.5,10.8 (±10.4),1.2 (±10.4),11.1% (±54.5%)
Montana,Total,(35-39),15.2,21,5.8,6.7,0.9,Not Significant,13.2,2.0,28.4,38.2,64.3,15.2 (±13.2),5.8 (±13.2),38.2% (±64.3%)
Montana,Total,(40-44),29.8,32,2.2,9.5,0.2,Not Significant,18.6,11.2,48.4,7.4,41.3,29.8 (±18.6),2.2 (±18.6),7.4% (±41.3%)
Montana,Total,(45-49),74.4,72,-2.4,11.7,-0.2,Not Significant,22.8,51.6,97.2,-3.2,22.7,74.4 (±22.8),-2.4 (±22.8),-3.2% (±22.7%)
Montana,Total,(5-9),0.4,2,1.6,1.5,1.1,Not Significant,2.9,-2.5,3.3,400.0,439.4,0.4 (±2.9),1.6 (±2.9),400.0% (±439.4%)
Montana,Total,(50-54),68.0,126,58.0,16.1,3.6,Significant Increase,31.6,36.4,99.6,85.3,58.8,68.0 (±31.6),58.0 (±31.6),85.3% (±58.8%)
Montana,Total,(55-59),130.4,171,40.6,20.1,2.0,Significant Increase,39.4,91.0,169.8,31.1,30.4,130.4 (±39.4),40.6 (±39.4),31.1% (±30.4%)
Montana,Total,(60-64),163.0,286,123.0,23.9,5.2,Significant Increase,46.8,116.2,209.8,75.5,39.2,163.0 (±46.8),123.0 (±46.8),75.5% (±39.2%)
Montana,Total,(65-69),270.2,400,129.8,29.3,4.4,Significant Increase,57.3,212.9,327.5,48.0,25.9,270.2 (±57.3),129.8 (±57.3),48.0% (±25.9%)
Montana,Total,(70-74),382.4,586,203.6,32.8,6.2,Significant Increase,64.2,318.2,446.6,53.2,22.0,382.4 (±64.2),203.6 (±64.2),53.2% (±22.0%)
Montana,Total,(75-79),362.6,611,248.4,35.2,7.1,Significant Increase,68.9,293.7,431.5,68.5,26.9,362.6 (±68.9),248.4 (±68.9),68.5% (±26.9%)
Montana,Total,(80-84),459.2,656,196.8,44.1,4.5,Significant Increase,86.4,372.8,545.6,42.9,22.7,459.2 (±86.4),196.8 (±86.4),42.9% (±22.7%)
Montana,Total,(85-89),444.0,555,111.0,35.9,3.1,Significant Increase,70.4,373.6,514.4,25.0,17.1,444.0 (±70.4),111.0 (±70.4),25.0% (±17.1%)
Montana,Total,(90+),331.0,312,-19.0,27.3,-0.7,Not Significant,53.5,277.5,384.5,-5.7,13.2,331.0 (±53.5),-19.0 (±53.5),-5.7% (±13.2%)
Pazardzhik,Female,(0-4),10.2,5,-5.2,6.0,-0.9,Not Significant,11.8,-1.6,22.0,-51.0,26.3,10.2 (±11.8),-5.2 (±11.8),-51.0% (±26.3%)
Pazardzhik,Female,(10-14),1.6,4,2.4,2.1,1.1,Not Significant,4.2,-2.6,5.8,150.0,181.0,1.6 (±4.2),2.4 (±4.2),150.0% (±181.0%)
Pazardzhik,Female,(15-19),1.8,3,1.2,2.3,0.5,Not Significant,4.4,-2.6,6.2,66.7,118.3,1.8 (±4.4),1.2 (±4.4),66.7% (±118.3%)
Pazardzhik,Female,(20-24),0.8,2,1.2,2.6,0.5,Not Significant,5.1,-4.3,5.9,150.0,216.1,0.8 (±5.1),1.2 (±5.1),150.0% (±216.1%)
Pazardzhik,Female,(25-29),0.4,4,3.6,2.7,1.3,Not Significant,5.3,-4.9,5.7,900.0,929.8,0.4 (±5.3),3.6 (±5.3),900.0% (±929.8%)
Pazardzhik,Female,(30-34),6.2,5,-1.2,3.0,-0.4,Not Significant,5.9,0.3,12.1,-19.4,39.3,6.2 (±5.9),-1.2 (±5.9),-19.4% (±39.3%)
Pazardzhik,Female,(35-39),7.6,12,4.4,4.4,1.0,Not Significant,8.6,-1.0,16.2,57.9,83.8,7.6 (±8.6),4.4 (±8.6),57.9% (±83.8%)
Pazardzhik,Female,(40-44),16.2,18,1.8,6.0,0.3,Not Significant,11.7,4.5,27.9,11.1,46.6,16.2 (±11.7),1.8 (±11.7),11.1% (±46.6%)
Pazardzhik,Female,(45-49),19.8,33,13.2,9.2,1.4,Not Significant,18.0,1.8,37.8,66.7,79.4,19.8 (±18.0),13.2 (±18.0),66.7% (±79.4%)
Pazardzhik,Female,(5-9),2.0,1,-1.0,2.1,-0.5,Not Significant,4.0,-2.0,6.0,-50.0,33.3,2.0 (±4.0),-1.0 (±4.0),-50.0% (±33.3%)
Pazardzhik,Female,(50-54),32.4,71,38.6,10.5,3.7,Significant Increase,20.5,11.9,52.9,119.1,84.9,32.4 (±20.5),38.6 (±20.5),119.1% (±84.9%)
Pazardzhik,Female,(55-59),68.4,100,31.6,13.7,2.3,Significant Increase,26.9,41.5,95.3,46.2,41.3,68.4 (±26.9),31.6 (±26.9),46.2% (±41.3%)
Pazardzhik,Female,(60-64),143.0,140,-3.0,17.2,-0.2,Not Significant,33.8,109.2,176.8,-2.1,18.7,143.0 (±33.8),-3.0 (±33.8),-2.1% (±18.7%)
Pazardzhik,Female,(65-69),134.4,217,82.6,19.3,4.3,Significant Increase,37.9,96.5,172.3,61.5,35.6,134.4 (±37.9),82.6 (±37.9),61.5% (±35.6%)
Pazardzhik,Female,(70-74),225.4,344,118.6,23.9,5.0,Significant Increase,46.8,178.6,272.2,52.6,26.2,225.4 (±46.8),118.6 (±46.8),52.6% (±26.2%)
Pazardzhik,Female,(75-79),259.8,436,176.2,31.1,5.7,Significant Increase,61.1,198.7,320.9,67.8,31.9,259.8 (±61.1),176.2 (±61.1),67.8% (±31.9%)
Pazardzhik,Female,(80-84),330.4,480,149.6,36.3,4.1,Significant Increase,71.1,259.3,401.5,45.3,25.7,330.4 (±71.1),149.6 (±71.1),45.3% (±25.7%)
Pazardzhik,Female,(85-89),389.4,513,123.6,34.5,3.6,Significant Increase,67.6,321.8,457.0,31.7,19.4,389.4 (±67.6),123.6 (±67.6),31.7% (±19.4%)
Pazardzhik,Female,(90+),247.4,283,35.6,26.9,1.3,Not Significant,52.7,194.7,300.1,14.4,20.1,247.4 (±52.7),35.6 (±52.7),14.4% (±20.1%)
Pazardzhik,Male,(0-4),9.4,9,-0.4,6.5,-0.1,Not Significant,12.8,-3.4,22.2,-4.3,55.2,9.4 (±12.8),-0.4 (±12.8),-4.3% (±55.2%)
Pazardzhik,Male,(10-14),0.2,2,1.8,3.2,0.6,Not Significant,6.3,-6.1,6.5,900.0,969.2,0.2 (±6.3),1.8 (±6.3),900.0% (±969.2%)
Pazardzhik,Male,(15-19),5.8,7,1.2,2.8,0.4,Not Significant,5.5,0.3,11.3,20.7,58.8,5.8 (±5.5),1.2 (±5.5),20.7% (±58.8%)
Pazardzhik,Male,(20-24),6.8,3,-3.8,4.6,-0.8,Not Significant,8.9,-2.1,15.7,-55.9,25.0,6.8 (±8.9),-3.8 (±8.9),-55.9% (±25.0%)
Pazardzhik,Male,(25-29),3.8,9,5.2,5.0,1.0,Not Significant,9.7,-5.9,13.5,136.8,170.1,3.8 (±9.7),5.2 (±9.7),136.8% (±170.1%)
Pazardzhik,Male,(30-34),11.8,10,-1.8,5.7,-0.3,Not Significant,11.1,0.7,22.9,-15.3,41.0,11.8 (±11.1),-1.8 (±11.1),-15.3% (±41.0%)
Pazardzhik,Male,(35-39),24.4,28,3.6,7.3,0.5,Not Significant,14.3,10.1,38.7,14.8,42.4,24.4 (±14.3),3.6 (±14.3),14.8% (±42.4%)
Pazardzhik,Male,(40-44),19.0,54,35.0,8.7,4.0,Significant Increase,17.1,1.9,36.1,184.2,134.6,19.0 (±17.1),35.0 (±17.1),184.2% (±134.6%)
Pazardzhik,Male,(45-49),57.0,76,19.0,13.0,1.5,Not Significant,25.4,31.6,82.4,33.3,41.1,57.0 (±25.4),19.0 (±25.4),33.3% (±41.1%)
Pazardzhik,Male,(5-9),-1.8,1,2.8,1.9,1.5,Not Significant,3.7,-5.5,1.9,-155.6,-108.2,-1.8 (±3.7),2.8 (±3.7),-155.6% (±-108.2%)
Pazardzhik,Male,(50-54),73.8,138,64.2,15.6,4.1,Significant Increase,30.5,43.3,104.3,87.0,54.7,73.8 (±30.5),64.2 (±30.5),87.0% (±54.7%)
Pazardzhik,Male,(55-59),159.0,218,59.0,20.2,2.9,Significant Increase,39.6,119.4,198.6,37.1,27.3,159.0 (±39.6),59.0 (±39.6),37.1% (±27.3%)
Pazardzhik,Male,(60-64),219.6,284,64.4,24.7,2.6,Significant Increase,48.5,171.1,268.1,29.3,23.4,219.6 (±48.5),64.4 (±48.5),29.3% (±23.4%)
Pazardzhik,Male,(65-69),241.4,411,169.6,25.9,6.5,Significant Increase,50.8,190.6,292.2,70.3,29.6,241.4 (±50.8),169.6 (±50.8),70.3% (±29.6%)
Pazardzhik,Male,(70-74),336.4,466,129.6,28.4,4.6,Significant Increase,55.6,280.8,392.0,38.5,19.6,336.4 (±55.6),129.6 (±55.6),38.5% (±19.6%)
Pazardzhik,Male,(75-79),295.8,457,161.2,30.7,5.2,Significant Increase,60.2,235.6,356.0,54.5,26.1,295.8 (±60.2),161.2 (±60.2),54.5% (±26.1%)
Pazardzhik,Male,(80-84),305.6,385,79.4,31.4,2.5,Significant Increase,61.5,244.1,367.1,26.0,21.1,305.6 (±61.5),79.4 (±61.5),26.0% (±21.1%)
Pazardzhik,Male,(85-89),225.4,300,74.6,25.1,3.0,Significant Increase,49.2,176.2,274.6,33.1,23.9,225.4 (±49.2),74.6 (±49.2),33.1% (±23.9%)
Pazardzhik,Male,(90+),109.4,150,40.6,17.8,2.3,Significant Increase,34.9,74.5,144.3,37.1,33.1,109.4 (±34.9),40.6 (±34.9),37.1% (±33.1%)
Pazardzhik,Total,(0-4),19.6,14,-5.6,8.6,-0.6,Not Significant,16.9,2.7,36.5,-28.6,33.0,19.6 (±16.9),-5.6 (±16.9),-28.6% (±33.0%)
Pazardzhik,Total,(10-14),1.8,6,4.2,3.7,1.1,Not Significant,7.2,-5.4,9.0,233.3,266.6,1.8 (±7.2),4.2 (±7.2),233.3% (±266.6%)
Pazardzhik,Total,(15-19),7.6,10,2.4,3.6,0.7,Not Significant,7.1,0.5,14.7,31.6,63.6,7.6 (±7.1),2.4 (±7.1),31.6% (±63.6%)
Pazardzhik,Total,(20-24),7.6,5,-2.6,5.0,-0.5,Not Significant,9.9,-2.3,17.5,-34.2,37.2,7.6 (±9.9),-2.6 (±9.9),-34.2% (±37.2%)
Pazardzhik,Total,(25-29),4.2,13,8.8,5.8,1.5,Not Significant,11.3,-7.1,15.5,209.5,225.6,4.2 (±11.3),8.8 (±11.3),209.5% (±225.6%)
Pazardzhik,Total,(30-34),18.0,15,-3.0,6.2,-0.5,Not Significant,12.2,5.8,30.2,-16.7,33.6,18.0 (±12.2),-3.0 (±12.2),-16.7% (±33.6%)
Pazardzhik,Total,(35-39),32.0,40,8.0,8.3,1.0,Not Significant,16.3,15.7,48.3,25.0,42.2,32.0 (±16.3),8.0 (±16.3),25.0% (±42.2%)
Pazardzhik,Total,(40-44),35.2,72,36.8,10.4,3.5,Significant Increase,20.4,14.8,55.6,104.5,75.0,35.2 (±20.4),36.8 (±20.4),104.5% (±75.0%)
Pazardzhik,Total,(45-49),76.8,109,32.2,16.5,1.9,Not Significant,32.4,44.4,109.2,41.9,42.1,76.8 (±32.4),32.2 (±32.4),41.9% (±42.1%)
Pazardzhik,Total,(5-9),0.2,2,1.8,2.9,0.6,Not Significant,5.7,-5.5,5.9,900.0,966.1,0.2 (±5.7),1.8 (±5.7),900.0% (±966.1%)
Pazardzhik,Total,(50-54),106.2,209,102.8,18.4,5.6,Significant Increase,36.2,70.0,142.4,96.8,50.0,106.2 (±36.2),102.8 (±36.2),96.8% (±50.0%)
Pazardzhik,Total,(55-59),227.4,318,90.6,24.4,3.7,Significant Increase,47.9,179.5,275.3,39.8,24.3,227.4 (±47.9),90.6 (±47.9),39.8% (±24.3%)
Pazardzhik,Total,(60-64),362.6,424,61.4,31.5,1.9,Not Significant,61.7,300.9,424.3,16.9,17.0,362.6 (±61.7),61.4 (±61.7),16.9% (±17.0%)
Pazardzhik,Total,(65-69),375.8,628,252.2,33.9,7.4,Significant Increase,66.5,309.3,442.3,67.1,25.1,375.8 (±66.5),252.2 (±66.5),67.1% (±25.1%)
Pazardzhik,Total,(70-74),561.8,810,248.2,36.6,6.8,Significant Increase,71.8,490.0,633.6,44.2,16.4,561.8 (±71.8),248.2 (±71.8),44.2% (±16.4%)
Pazardzhik,Total,(75-79),555.6,893,337.4,45.3,7.4,Significant Increase,88.8,466.8,644.4,60.7,22.1,555.6 (±88.8),337.4 (±88.8),60.7% (±22.1%)
Pazardzhik,Total,(80-84),636.0,865,229.0,49.2,4.7,Significant Increase,96.5,539.5,732.5,36.0,17.9,636.0 (±96.5),229.0 (±96.5),36.0% (±17.9%)
Pazardzhik,Total,(85-89),614.8,813,198.2,44.2,4.5,Significant Increase,86.7,528.1,701.5,32.2,16.3,614.8 (±86.7),198.2 (±86.7),32.2% (±16.3%)
Pazardzhik,Total,(90+),356.8,433,76.2,33.2,2.3,Significant Increase,65.1,291.7,421.9,21.4,18.8,356.8 (±65.1),76.2 (±65.1),21.4% (±18.8%)
Pernik,Female,(0-4),6.0,1,-5.0,2.8,-1.8,Not Significant,5.6,0.4,11.6,-83.3,8.1,6.0 (±5.6),-5.0 (±5.6),-83.3% (±8.1%)
Pernik,Female,(10-14),1.2,0,-1.2,1.1,-1.1,Not Significant,2.1,-0.9,3.3,-100.0,0.0,1.2 (±2.1),-1.2 (±2.1),-100.0% (±0.0%)
Pernik,Female,(15-19),-0.2,0,0.2,1.6,0.1,Not Significant,3.1,-3.3,2.9,-100.0,0.0,-0.2 (±3.1),0.2 (±3.1),-100.0% (±0.0%)
Pernik,Female,(20-24),3.4,3,-0.4,1.6,-0.3,Not Significant,3.1,0.3,6.5,-11.8,42.0,3.4 (±3.1),-0.4 (±3.1),-11.8% (±42.0%)
Pernik,Female,(25-29),-0.4,4,4.4,2.4,1.9,Not Significant,4.6,-5.0,4.2,-1100.0,-1095.2,-0.4 (±4.6),4.4 (±4.6),-1100.0% (±-1095.2%)
Pernik,Female,(30-34),2.8,2,-0.8,2.5,-0.3,Not Significant,5.0,-2.2,7.8,-28.6,45.8,2.8 (±5.0),-0.8 (±5.0),-28.6% (±45.8%)
Pernik,Female,(35-39),-0.4,6,6.4,2.5,2.5,Significant Increase,5.0,-5.4,4.6,-1600.0,-1630.4,-0.4 (±5.0),6.4 (±5.0),-1600.0% (±-1630.4%)
Pernik,Female,(40-44),7.4,11,3.6,4.5,0.8,Not Significant,8.8,-1.4,16.2,48.6,80.7,7.4 (±8.8),3.6 (±8.8),48.6% (±80.7%)
Pernik,Female,(45-49),13.4,16,2.6,6.0,0.4,Not Significant,11.8,1.6,25.2,19.4,55.9,13.4 (±11.8),2.6 (±11.8),19.4% (±55.9%)
Pernik,Female,(5-9),1.0,0,-1.0,0.7,-1.3,Not Significant,1.5,-0.5,2.5,-100.0,0.0,1.0 (±1.5),-1.0 (±1.5),-100.0% (±0.0%)
Pernik,Female,(50-54),16.8,30,13.2,7.8,1.7,Not Significant,15.3,1.5,32.1,78.6,85.1,16.8 (±15.3),13.2 (±15.3),78.6% (±85.1%)
Pernik,Female,(55-59),40.4,45,4.6,9.9,0.5,Not Significant,19.4,21.0,59.8,11.4,36.1,40.4 (±19.4),4.6 (±19.4),11.4% (±36.1%)
Pernik,Female,(60-64),46.4,76,29.6,12.8,2.3,Significant Increase,25.1,21.3,71.5,63.8,57.5,46.4 (±25.1),29.6 (±25.1),63.8% (±57.5%)
Pernik,Female,(65-69),85.0,139,54.0,15.6,3.5,Significant Increase,30.5,54.5,115.5,63.5,43.2,85.0 (±30.5),54.0 (±30.5),63.5% (±43.2%)
Pernik,Female,(70-74),146.0,166,20.0,17.1,1.2,Not Significant,33.6,112.4,179.6,13.7,21.3,146.0 (±33.6),20.0 (±33.6),13.7% (±21.3%)
Pernik,Female,(75-79),169.8,240,70.2,21.4,3.3,Significant Increase,42.0,127.8,211.8,41.3,28.0,169.8 (±42.0),70.2 (±42.0),41.3% (±28.0%)
Pernik,Female,(80-84),213.6,323,109.4,26.8,4.1,Significant Increase,52.5,161.1,266.1,51.2,29.8,213.6 (±52.5),109.4 (±52.5),51.2% (±29.8%)
Pernik,Female,(85-89),257.0,327,70.0,26.8,2.6,Significant Increase,52.4,204.6,309.4,27.2,21.5,257.0 (±52.4),70.0 (±52.4),27.2% (±21.5%)
Pernik,Female,(90+),164.2,230,65.8,21.7,3.0,Significant Increase,42.5,121.7,206.7,40.1,28.8,164.2 (±42.5),65.8 (±42.5),40.1% (±28.8%)
Pernik,Male,(0-4),8.6,2,-6.6,3.6,-1.8,Not Significant,7.1,1.5,15.7,-76.7,10.6,8.6 (±7.1),-6.6 (±7.1),-76.7% (±10.6%)
Pernik,Male,(10-14),3.2,1,-2.2,2.4,-0.9,Not Significant,4.6,-1.4,7.8,-68.7,18.5,3.2 (±4.6),-2.2 (±4.6),-68.7% (±18.5%)
Pernik,Male,(15-19),2.2,2,-0.2,2.2,-0.1,Not Significant,4.3,-2.1,6.5,-9.1,60.1,2.2 (±4.3),-0.2 (±4.3),-9.1% (±60.1%)
Pernik,Male,(20-24),3.0,4,1.0,2.7,0.4,Not Significant,5.2,-2.2,8.2,33.3,84.5,3.0 (±5.2),1.0 (±5.2),33.3% (±84.5%)
Pernik,Male,(25-29),3.0,4,1.0,2.8,0.4,Not Significant,5.5,-2.5,8.5,33.3,86.2,3.0 (±5.5),1.0 (±5.5),33.3% (±86.2%)
Pernik,Male,(30-34),6.2,5,-1.2,4.2,-0.3,Not Significant,8.2,-2.0,14.4,-19.4,45.9,6.2 (±8.2),-1.2 (±8.2),-19.4% (±45.9%)
Pernik,Male,(35-39),17.0,13,-4.0,5.7,-0.7,Not Significant,11.1,5.9,28.1,-23.5,30.2,17.0 (±11.1),-4.0 (±11.1),-23.5% (±30.2%)
Pernik,Male,(40-44),17.2,29,11.8,7.3,1.6,Not Significant,14.3,2.9,31.5,68.6,76.5,17.2 (±14.3),11.8 (±14.3),68.6% (±76.5%)
Pernik,Male,(45-49),49.4,32,-17.4,10.6,-1.6,Not Significant,20.7,28.7,70.1,-35.2,19.2,49.4 (±20.7),-17.4 (±20.7),-35.2% (±19.2%)
Pernik,Male,(5-9),0.6,0,-0.6,1.2,-0.5,Not Significant,2.3,-1.7,2.9,-100.0,0.0,0.6 (±2.3),-0.6 (±2.3),-100.0% (±0.0%)
Pernik,Male,(50-54),45.0,78,33.0,13.2,2.5,Significant Increase,25.9,19.1,70.9,73.3,63.3,45.0 (±25.9),33.0 (±25.9),73.3% (±63.3%)
Pernik,Male,(55-59),80.4,128,47.6,16.1,3.0,Significant Increase,31.5,48.9,111.9,59.2,44.8,80.4 (±31.5),47.6 (±31.5),59.2% (±44.8%)
Pernik,Male,(60-64),129.2,177,47.8,18.0,2.7,Significant Increase,35.3,93.9,164.5,37.0,29.4,129.2 (±35.3),47.8 (±35.3),37.0% (±29.4%)
Pernik,Male,(65-69),152.0,244,92.0,21.2,4.3,Significant Increase,41.5,110.5,193.5,60.5,34.4,152.0 (±41.5),92.0 (±41.5),60.5% (±34.4%)
Pernik,Male,(70-74),167.2,271,103.8,20.4,5.1,Significant Increase,39.9,127.3,207.1,62.1,31.2,167.2 (±39.9),103.8 (±39.9),62.1% (±31.2%)
Pernik,Male,(75-79),174.4,246,71.6,22.1,3.2,Significant Increase,43.2,131.2,217.6,41.1,28.0,174.4 (±43.2),71.6 (±43.2),41.1% (±28.0%)
Pernik,Male,(80-84),152.6,221,68.4,26.4,2.6,Significant Increase,51.8,100.8,204.4,44.8,36.7,152.6 (±51.8),68.4 (±51.8),44.8% (±36.7%)
Pernik,Male,(85-89),177.8,244,66.2,21.6,3.1,Significant Increase,42.4,135.4,220.2,37.2,26.4,177.8 (±42.4),66.2 (±42.4),37.2% (±26.4%)
Pernik,Male,(90+),90.2,119,28.8,15.1,1.9,Not Significant,29.7,60.5,119.9,31.9,32.7,90.2 (±29.7),28.8 (±29.7),31.9% (±32.7%)
Pernik,Total,(0-4),14.6,3,-11.6,4.4,-2.7,Significant Decrease,8.5,6.1,23.1,-79.5,7.5,14.6 (±8.5),-11.6 (±8.5),-79.5% (±7.5%)
Pernik,Total,(10-14),4.4,1,-3.4,2.5,-1.3,Not Significant,5.0,-0.6,9.4,-77.3,12.1,4.4 (±5.0),-3.4 (±5.0),-77.3% (±12.1%)
Pernik,Total,(15-19),2.0,2,-0.0,2.9,-0.0,Not Significant,5.6,-3.6,7.6,-0.0,73.7,2.0 (±5.6),-0.0 (±5.6),-0.0% (±73.7%)
Pernik,Total,(20-24),6.4,7,0.6,3.0,0.2,Not Significant,6.0,0.4,12.4,9.4,52.9,6.4 (±6.0),0.6 (±6.0),9.4% (±52.9%)
Pernik,Total,(25-29),2.6,8,5.4,3.7,1.5,Not Significant,7.2,-4.6,9.8,207.7,226.1,2.6 (±7.2),5.4 (±7.2),207.7% (±226.1%)
Pernik,Total,(30-34),9.0,7,-2.0,5.0,-0.4,Not Significant,9.9,-0.9,18.9,-22.2,40.8,9.0 (±9.9),-2.0 (±9.9),-22.2% (±40.8%)
Pernik,Total,(35-39),16.6,19,2.4,6.2,0.4,Not Significant,12.1,4.5,28.7,14.5,48.3,16.6 (±12.1),2.4 (±12.1),14.5% (±48.3%)
Pernik,Total,(40-44),24.6,40,15.4,9.2,1.7,Not Significant,18.0,6.6,42.6,62.6,68.7,24.6 (±18.0),15.4 (±18.0),62.6% (±68.7%)
Pernik,Total,(45-49),62.8,48,-14.8,12.5,-1.2,Not Significant,24.6,38.2,87.4,-23.6,21.5,62.8 (±24.6),-14.8 (±24.6),-23.6% (±21.5%)
Pernik,Total,(5-9),1.6,0,-1.6,1.4,-1.1,Not Significant,2.7,-1.1,4.3,-100.0,0.0,1.6 (±2.7),-1.6 (±2.7),-100.0% (±0.0%)
Pernik,Total,(50-54),61.8,108,46.2,15.5,3.0,Significant Increase,30.4,31.4,92.2,74.8,57.7,61.8 (±30.4),46.2 (±30.4),74.8% (±57.7%)
Pernik,Total,(55-59),120.8,173,52.2,18.8,2.8,Significant Increase,36.8,84.0,157.6,43.2,33.4,120.8 (±36.8),52.2 (±36.8),43.2% (±33.4%)
Pernik,Total,(60-64),175.6,253,77.4,21.3,3.6,Significant Increase,41.8,133.8,217.4,44.1,27.7,175.6 (±41.8),77.4 (±41.8),44.1% (±27.7%)
Pernik,Total,(65-69),237.0,383,146.0,26.2,5.6,Significant Increase,51.4,185.6,288.4,61.6,28.8,237.0 (±51.4),146.0 (±51.4),61.6% (±28.8%)
Pernik,Total,(70-74),313.2,437,123.8,27.3,4.5,Significant Increase,53.5,259.7,366.7,39.5,20.3,313.2 (±53.5),123.8 (±53.5),39.5% (±20.3%)
Pernik,Total,(75-79),344.2,486,141.8,29.8,4.8,Significant Increase,58.4,285.8,402.6,41.2,20.5,344.2 (±58.4),141.8 (±58.4),41.2% (±20.5%)
Pernik,Total,(80-84),366.2,544,177.8,38.5,4.6,Significant Increase,75.5,290.7,441.7,48.6,25.4,366.2 (±75.5),177.8 (±75.5),48.6% (±25.4%)
Pernik,Total,(85-89),434.8,571,136.2,33.8,4.0,Significant Increase,66.2,368.6,501.0,31.3,17.3,434.8 (±66.2),136.2 (±66.2),31.3% (±17.3%)
Pernik,Total,(90+),254.4,349,94.6,27.0,3.5,Significant Increase,52.9,201.5,307.3,37.2,23.6,254.4 (±52.9),94.6 (±52.9),37.2% (±23.6%)
Pleven,Female,(0-4),7.2,8,0.8,5.8,0.1,Not Significant,11.4,-4.2,18.6,11.1,68.1,7.2 (±11.4),0.8 (±11.4),11.1% (±68.1%)
Pleven,Female,(10-14),3.6,0,-3.6,2.3,-1.6,Not Significant,4.5,-0.9,8.1,-100.0,0.0,3.6 (±4.5),-3.6 (±4.5),-100.0% (±0.0%)
Pleven,Female,(15-19),-2.6,1,3.6,2.4,1.5,Not Significant,4.7,-7.3,2.1,-138.5,-86.1,-2.6 (±4.7),3.6 (±4.7),-138.5% (±-86.1%)
Pleven,Female,(20-24),-1.2,0,1.2,2.6,0.5,Not Significant,5.1,-6.3,3.9,-100.0,0.0,-1.2 (±5.1),1.2 (±5.1),-100.0% (±0.0%)
Pleven,Female,(25-29),1.4,4,2.6,2.9,0.9,Not Significant,5.7,-4.3,7.1,185.7,229.4,1.4 (±5.7),2.6 (±5.7),185.7% (±229.4%)
Pleven,Female,(30-34),4.8,4,-0.8,2.9,-0.3,Not Significant,5.8,-1.0,10.6,-16.7,45.6,4.8 (±5.8),-0.8 (±5.8),-16.7% (±45.6%)
Pleven,Female,(35-39),11.0,11,-0.0,4.1,-0.0,Not Significant,7.9,3.1,18.9,-0.0,41.8,11.0 (±7.9),-0.0 (±7.9),-0.0% (±41.8%)
Pleven,Female,(40-44),13.8,18,4.2,6.2,0.7,Not Significant,12.2,1.6,26.0,30.4,61.2,13.8 (±12.2),4.2 (±12.2),30.4% (±61.2%)
Pleven,Female,(45-49),14.4,35,20.6,8.1,2.5,Significant Increase,15.9,-1.5,30.3,143.1,127.6,14.4 (±15.9),20.6 (±15.9),143.1% (±127.6%)
Pleven,Female,(5-9),0.6,1,0.4,1.3,0.3,Not Significant,2.5,-1.9,3.1,66.7,134.4,0.6 (±2.5),0.4 (±2.5),66.7% (±134.4%)
Pleven,Female,(50-54),35.6,47,11.4,10.2,1.1,Not Significant,20.1,15.5,55.7,32.0,47.6,35.6 (±20.1),11.4 (±20.1),32.0% (±47.6%)
Pleven,Female,(55-59),61.8,81,19.2,12.6,1.5,Not Significant,24.6,37.2,86.4,31.1,37.4,61.8 (±24.6),19.2 (±24.6),31.1% (±37.4%)
Pleven,Female,(60-64),81.2,120,38.8,16.0,2.4,Significant Increase,31.4,49.8,112.6,47.8,41.2,81.2 (±31.4),38.8 (±31.4),47.8% (±41.2%)
Pleven,Female,(65-69),144.0,200,56.0,22.2,2.5,Significant Increase,43.6,100.4,187.6,38.9,32.3,144.0 (±43.6),56.0 (±43.6),38.9% (±32.3%)
Pleven,Female,(70-74),258.2,374,115.8,25.2,4.6,Significant Increase,49.4,208.8,307.6,44.8,23.2,258.2 (±49.4),115.8 (±49.4),44.8% (±23.2%)
Pleven,Female,(75-79),345.0,486,141.0,30.5,4.6,Significant Increase,59.7,285.3,404.7,40.9,20.8,345.0 (±59.7),141.0 (±59.7),40.9% (±20.8%)
Pleven,Female,(80-84),393.4,612,218.6,38.8,5.6,Significant Increase,76.1,317.3,469.5,55.6,25.2,393.4 (±76.1),218.6 (±76.1),55.6% (±25.2%)
Pleven,Female,(85-89),499.4,600,100.6,37.5,2.7,Significant Increase,73.5,425.9,572.9,20.1,15.4,499.4 (±73.5),100.6 (±73.5),20.1% (±15.4%)
Pleven,Female,(90+),332.6,393,60.4,28.1,2.1,Significant Increase,55.1,277.5,387.7,18.2,16.8,332.6 (±55.1),60.4 (±55.1),18.2% (±16.8%)
Pleven,Male,(0-4),17.8,10,-7.8,6.4,-1.2,Not Significant,12.6,5.2,30.4,-43.8,23.3,17.8 (±12.6),-7.8 (±12.6),-43.8% (±23.3%)
Pleven,Male,(10-14),1.8,2,0.2,2.5,0.1,Not Significant,4.9,-3.1,6.7,11.1,81.2,1.8 (±4.9),0.2 (±4.9),11.1% (±81.2%)
Pleven,Male,(15-19),-0.6,4,4.6,4.5,1.0,Not Significant,8.7,-9.3,8.1,-766.7,-716.1,-0.6 (±8.7),4.6 (±8.7),-766.7% (±-716.1%)
Pleven,Male,(20-24),4.0,3,-1.0,4.4,-0.2,Not Significant,8.6,-4.6,12.6,-25.0,51.2,4.0 (±8.6),-1.0 (±8.6),-25.0% (±51.2%)
Pleven,Male,(25-29),6.2,8,1.8,4.8,0.4,Not Significant,9.4,-3.2,15.6,29.0,77.7,6.2 (±9.4),1.8 (±9.4),29.0% (±77.7%)
Pleven,Male,(30-34),1.0,12,11.0,5.4,2.0,Significant Increase,10.6,-9.6,11.6,1100.0,1096.6,1.0 (±10.6),11.0 (±10.6),1100.0% (±1096.6%)
Pleven,Male,(35-39),17.2,22,4.8,6.3,0.8,Not Significant,12.3,4.9,29.5,27.9,53.3,17.2 (±12.3),4.8 (±12.3),27.9% (±53.3%)
Pleven,Male,(40-44),28.4,40,11.6,9.6,1.2,Not Significant,18.8,9.6,47.2,40.8,56.1,28.4 (±18.8),11.6 (±18.8),40.8% (±56.1%)
Pleven,Male,(45-49),62.0,82,20.0,13.1,1.5,Not Significant,25.7,36.3,87.7,32.3,38.8,62.0 (±25.7),20.0 (±25.7),32.3% (±38.8%)
Pleven,Male,(5-9),3.2,2,-1.2,2.1,-0.6,Not Significant,4.1,-0.9,7.3,-37.5,35.1,3.2 (±4.1),-1.2 (±4.1),-37.5% (±35.1%)
Pleven,Male,(50-54),52.0,115,63.0,14.9,4.2,Significant Increase,29.3,22.7,81.3,121.2,79.7,52.0 (±29.3),63.0 (±29.3),121.2% (±79.7%)
Pleven,Male,(55-59),128.4,183,54.6,20.5,2.7,Significant Increase,40.2,88.2,168.6,42.5,34.0,128.4 (±40.2),54.6 (±40.2),42.5% (±34.0%)
Pleven,Male,(60-64),205.0,281,76.0,23.4,3.3,Significant Increase,45.8,159.2,250.8,37.1,25.1,205.0 (±45.8),76.0 (±45.8),37.1% (±25.1%)
Pleven,Male,(65-69),307.0,389,82.0,29.6,2.8,Significant Increase,58.0,249.0,365.0,26.7,20.1,307.0 (±58.0),82.0 (±58.0),26.7% (±20.1%)
Pleven,Male,(70-74),397.4,562,164.6,31.3,5.3,Significant Increase,61.4,336.0,458.8,41.4,18.9,397.4 (±61.4),164.6 (±61.4),41.4% (±18.9%)
Pleven,Male,(75-79),339.6,533,193.4,29.9,6.5,Significant Increase,58.5,281.1,398.1,56.9,23.0,339.6 (±58.5),193.4 (±58.5),56.9% (±23.0%)
Pleven,Male,(80-84),329.2,417,87.8,32.2,2.7,Significant Increase,63.2,266.0,392.4,26.7,20.4,329.2 (±63.2),87.8 (±63.2),26.7% (±20.4%)
Pleven,Male,(85-89),297.4,371,73.6,29.7,2.5,Significant Increase,58.1,239.3,355.5,24.7,20.3,297.4 (±58.1),73.6 (±58.1),24.7% (±20.3%)
Pleven,Male,(90+),199.8,207,7.2,21.0,0.3,Not Significant,41.2,158.6,241.0,3.6,17.7,199.8 (±41.2),7.2 (±41.2),3.6% (±17.7%)
Pleven,Total,(0-4),25.0,18,-7.0,8.8,-0.8,Not Significant,17.2,7.8,42.2,-28.0,29.3,25.0 (±17.2),-7.0 (±17.2),-28.0% (±29.3%)
Pleven,Total,(10-14),5.4,2,-3.4,3.4,-1.0,Not Significant,6.6,-1.2,12.0,-63.0,20.3,5.4 (±6.6),-3.4 (±6.6),-63.0% (±20.3%)
Pleven,Total,(15-19),-3.2,5,8.2,5.4,1.5,Not Significant,10.5,-13.7,7.3,-256.2,-224.7,-3.2 (±10.5),8.2 (±10.5),-256.2% (±-224.7%)
Pleven,Total,(20-24),2.8,3,0.2,5.1,0.0,Not Significant,10.0,-7.2,12.8,7.1,83.7,2.8 (±10.0),0.2 (±10.0),7.1% (±83.7%)
Pleven,Total,(25-29),7.6,12,4.4,5.4,0.8,Not Significant,10.5,-2.9,18.1,57.9,91.6,7.6 (±10.5),4.4 (±10.5),57.9% (±91.6%)
Pleven,Total,(30-34),5.8,16,10.2,6.5,1.6,Not Significant,12.7,-6.9,18.5,175.9,189.4,5.8 (±12.7),10.2 (±12.7),175.9% (±189.4%)
Pleven,Total,(35-39),28.2,33,4.8,7.3,0.7,Not Significant,14.2,14.0,42.4,17.0,39.2,28.2 (±14.2),4.8 (±14.2),17.0% (±39.2%)
Pleven,Total,(40-44),42.2,58,15.8,11.8,1.3,Not Significant,23.1,19.1,65.3,37.4,48.6,42.2 (±23.1),15.8 (±23.1),37.4% (±48.6%)
Pleven,Total,(45-49),76.4,117,40.6,15.6,2.6,Significant Increase,30.5,45.9,106.9,53.1,43.7,76.4 (±30.5),40.6 (±30.5),53.1% (±43.7%)
Pleven,Total,(5-9),3.8,3,-0.8,2.4,-0.3,Not Significant,4.6,-0.8,8.4,-21.1,43.2,3.8 (±4.6),-0.8 (±4.6),-21.1% (±43.2%)
Pleven,Total,(50-54),87.6,162,74.4,17.5,4.2,Significant Increase,34.3,53.3,121.9,84.9,52.0,87.6 (±34.3),74.4 (±34.3),84.9% (±52.0%)
Pleven,Total,(55-59),190.2,264,73.8,24.9,3.0,Significant Increase,48.7,141.5,238.9,38.8,28.3,190.2 (±48.7),73.8 (±48.7),38.8% (±28.3%)
Pleven,Total,(60-64),286.2,401,114.8,29.2,3.9,Significant Increase,57.3,228.9,343.5,40.1,23.4,286.2 (±57.3),114.8 (±57.3),40.1% (±23.4%)
Pleven,Total,(65-69),451.0,589,138.0,36.2,3.8,Significant Increase,71.0,380.0,522.0,30.6,17.8,451.0 (±71.0),138.0 (±71.0),30.6% (±17.8%)
Pleven,Total,(70-74),655.6,936,280.4,39.7,7.1,Significant Increase,77.8,577.8,733.4,42.8,15.2,655.6 (±77.8),280.4 (±77.8),42.8% (±15.2%)
Pleven,Total,(75-79),684.6,1019,334.4,41.7,8.0,Significant Increase,81.8,602.8,766.4,48.8,15.8,684.6 (±81.8),334.4 (±81.8),48.8% (±15.8%)
Pleven,Total,(80-84),722.6,1029,306.4,52.0,5.9,Significant Increase,101.9,620.7,824.5,42.4,17.6,722.6 (±101.9),306.4 (±101.9),42.4% (±17.6%)
Pleven,Total,(85-89),796.8,971,174.2,48.4,3.6,Significant Increase,94.9,701.9,891.7,21.9,13.0,796.8 (±94.9),174.2 (±94.9),21.9% (±13.0%)
Pleven,Total,(90+),532.4,600,67.6,38.0,1.8,Not Significant,74.4,458.0,606.8,12.7,13.8,532.4 (±74.4),67.6 (±74.4),12.7% (±13.8%)
Plovdiv,Female,(0-4),21.4,17,-4.4,8.1,-0.5,Not Significant,15.9,5.5,37.3,-20.6,33.8,21.4 (±15.9),-4.4 (±15.9),-20.6% (±33.8%)
Plovdiv,Female,(10-14),2.2,1,-1.2,2.2,-0.5,Not Significant,4.3,-2.1,6.5,-54.5,30.1,2.2 (±4.3),-1.2 (±4.3),-54.5% (±30.1%)
Plovdiv,Female,(15-19),6.8,3,-3.8,3.4,-1.1,Not Significant,6.6,0.2,13.4,-55.9,21.7,6.8 (±6.6),-3.8 (±6.6),-55.9% (±21.7%)
Plovdiv,Female,(20-24),4.4,14,9.6,3.4,2.8,Significant Increase,6.7,-2.3,11.1,218.2,192.1,4.4 (±6.7),9.6 (±6.7),218.2% (±192.1%)
Plovdiv,Female,(25-29),8.6,14,5.4,5.9,0.9,Not Significant,11.7,-3.1,20.3,62.8,93.8,8.6 (±11.7),5.4 (±11.7),62.8% (±93.8%)
Plovdiv,Female,(30-34),5.4,11,5.6,5.3,1.0,Not Significant,10.5,-5.1,15.9,103.7,134.5,5.4 (±10.5),5.6 (±10.5),103.7% (±134.5%)
Plovdiv,Female,(35-39),16.8,34,17.2,7.0,2.5,Significant Increase,13.7,3.1,30.5,102.4,90.9,16.8 (±13.7),17.2 (±13.7),102.4% (±90.9%)
Plovdiv,Female,(40-44),43.2,54,10.8,10.5,1.0,Not Significant,20.7,22.5,63.9,25.0,40.5,43.2 (±20.7),10.8 (±20.7),25.0% (±40.5%)
Plovdiv,Female,(45-49),43.2,77,33.8,12.4,2.7,Significant Increase,24.4,18.8,67.6,78.2,64.3,43.2 (±24.4),33.8 (±24.4),78.2% (±64.3%)
Plovdiv,Female,(5-9),-1.0,2,3.0,2.4,1.3,Not Significant,4.6,-5.6,3.6,-300.0,-255.6,-1.0 (±4.6),3.0 (±4.6),-300.0% (±-255.6%)
Plovdiv,Female,(50-54),86.0,131,45.0,14.7,3.1,Significant Increase,28.8,57.2,114.8,52.3,38.2,86.0 (±28.8),45.0 (±28.8),52.3% (±38.2%)
Plovdiv,Female,(55-59),145.0,174,29.0,21.4,1.4,Not Significant,42.0,103.0,187.0,20.0,27.0,145.0 (±42.0),29.0 (±42.0),20.0% (±27.0%)
Plovdiv,Female,(60-64),183.8,351,167.2,27.3,6.1,Significant Increase,53.5,130.3,237.3,91.0,43.1,183.8 (±53.5),167.2 (±53.5),91.0% (±43.1%)
Plovdiv,Female,(65-69),323.2,482,158.8,30.9,5.1,Significant Increase,60.5,262.7,383.7,49.1,23.5,323.2 (±60.5),158.8 (±60.5),49.1% (±23.5%)
Plovdiv,Female,(70-74),531.2,824,292.8,37.1,7.9,Significant Increase,72.8,458.4,604.0,55.1,18.7,531.2 (±72.8),292.8 (±72.8),55.1% (±18.7%)
Plovdiv,Female,(75-79),646.4,1017,370.6,40.3,9.2,Significant Increase,79.1,567.3,725.5,57.3,17.1,646.4 (±79.1),370.6 (±79.1),57.3% (±17.1%)
Plovdiv,Female,(80-84),922.0,1289,367.0,61.7,5.9,Significant Increase,121.0,801.0,1043.0,39.8,16.2,922.0 (±121.0),367.0 (±121.0),39.8% (±16.2%)
Plovdiv,Female,(85-89),1059.0,1441,382.0,60.6,6.3,Significant Increase,118.7,940.3,1177.7,36.1,13.7,1059.0 (±118.7),382.0 (±118.7),36.1% (±13.7%)
Plovdiv,Female,(90+),759.4,915,155.6,44.9,3.5,Significant Increase,87.9,671.5,847.3,20.5,12.5,759.4 (±87.9),155.6 (±87.9),20.5% (±12.5%)
Plovdiv,Male,(0-4),17.6,15,-2.6,8.6,-0.3,Not Significant,16.9,0.7,34.5,-14.8,41.7,17.6 (±16.9),-2.6 (±16.9),-14.8% (±41.7%)
Plovdiv,Male,(10-14),-0.2,3,3.2,2.4,1.4,Not Significant,4.6,-4.8,4.4,-1600.0,-1568.2,-0.2 (±4.6),3.2 (±4.6),-1600.0% (±-1568.2%)
Plovdiv,Male,(15-19),13.8,7,-6.8,4.7,-1.4,Not Significant,9.3,4.5,23.1,-49.3,20.4,13.8 (±9.3),-6.8 (±9.3),-49.3% (±20.4%)
Plovdiv,Male,(20-24),4.4,15,10.6,6.8,1.5,Not Significant,13.4,-9.0,17.8,240.9,256.6,4.4 (±13.4),10.6 (±13.4),240.9% (±256.6%)
Plovdiv,Male,(25-29),8.0,19,11.0,8.9,1.2,Not Significant,17.5,-9.5,25.5,137.5,163.0,8.0 (±17.5),11.0 (±17.5),137.5% (±163.0%)
Plovdiv,Male,(30-34),20.6,37,16.4,10.5,1.6,Not Significant,20.7,-0.1,41.3,79.6,90.0,20.6 (±20.7),16.4 (±20.7),79.6% (±90.0%)
Plovdiv,Male,(35-39),59.0,57,-2.0,12.0,-0.2,Not Significant,23.4,35.6,82.4,-3.4,27.4,59.0 (±23.4),-2.0 (±23.4),-3.4% (±27.4%)
Plovdiv,Male,(40-44),67.4,112,44.6,15.7,2.8,Significant Increase,30.8,36.6,98.2,66.2,52.1,67.4 (±30.8),44.6 (±30.8),66.2% (±52.1%)
Plovdiv,Male,(45-49),158.2,178,19.8,20.4,1.0,Not Significant,40.0,118.2,198.2,12.5,22.7,158.2 (±40.0),19.8 (±40.0),12.5% (±22.7%)
Plovdiv,Male,(5-9),-1.2,1,2.2,3.7,0.6,Not Significant,7.2,-8.4,6.0,-183.3,-100.0,-1.2 (±7.2),2.2 (±7.2),-183.3% (±-100.0%)
Plovdiv,Male,(50-54),236.4,256,19.6,24.0,0.8,Not Significant,47.1,189.3,283.5,8.3,18.0,236.4 (±47.1),19.6 (±47.1),8.3% (±18.0%)
Plovdiv,Male,(55-59),296.6,418,121.4,32.8,3.7,Significant Increase,64.4,232.2,361.0,40.9,25.1,296.6 (±64.4),121.4 (±64.4),40.9% (±25.1%)
Plovdiv,Male,(60-64),483.4,647,163.6,39.0,4.2,Significant Increase,76.4,407.0,559.8,33.8,18.2,483.4 (±76.4),163.6 (±76.4),33.8% (±18.2%)
Plovdiv,Male,(65-69),644.2,869,224.8,45.5,4.9,Significant Increase,89.1,555.1,733.3,34.9,16.4,644.2 (±89.1),224.8 (±89.1),34.9% (±16.4%)
Plovdiv,Male,(70-74),716.4,1119,402.6,48.1,8.4,Significant Increase,94.3,622.1,810.7,56.2,18.2,716.4 (±94.3),402.6 (±94.3),56.2% (±18.2%)
Plovdiv,Male,(75-79),686.8,1065,378.2,43.5,8.7,Significant Increase,85.2,601.6,772.0,55.1,17.1,686.8 (±85.2),378.2 (±85.2),55.1% (±17.1%)
Plovdiv,Male,(80-84),680.2,1038,357.8,49.5,7.2,Significant Increase,97.1,583.1,777.3,52.6,19.1,680.2 (±97.1),357.8 (±97.1),52.6% (±19.1%)
Plovdiv,Male,(85-89),643.2,830,186.8,40.9,4.6,Significant Increase,80.1,563.1,723.3,29.0,14.2,643.2 (±80.1),186.8 (±80.1),29.0% (±14.2%)
Plovdiv,Male,(90+),371.0,430,59.0,30.0,2.0,Significant Increase,58.8,312.2,429.8,15.9,15.9,371.0 (±58.8),59.0 (±58.8),15.9% (±15.9%)
Plovdiv,Total,(0-4),39.0,32,-7.0,11.6,-0.6,Not Significant,22.7,16.3,61.7,-17.9,30.2,39.0 (±22.7),-7.0 (±22.7),-17.9% (±30.2%)
Plovdiv,Total,(10-14),2.0,4,2.0,3.4,0.6,Not Significant,6.6,-4.6,8.6,100.0,153.5,2.0 (±6.6),2.0 (±6.6),100.0% (±153.5%)
Plovdiv,Total,(15-19),20.6,10,-10.6,5.8,-1.8,Not Significant,11.4,9.2,32.0,-51.5,17.3,20.6 (±11.4),-10.6 (±11.4),-51.5% (±17.3%)
Plovdiv,Total,(20-24),8.8,29,20.2,7.4,2.7,Significant Increase,14.6,-5.8,23.4,229.5,205.6,8.8 (±14.6),20.2 (±14.6),229.5% (±205.6%)
Plovdiv,Total,(25-29),16.6,33,16.4,10.7,1.5,Not Significant,21.1,-4.5,37.7,98.8,111.3,16.6 (±21.1),16.4 (±21.1),98.8% (±111.3%)
Plovdiv,Total,(30-34),26.0,48,22.0,11.3,1.9,Not Significant,22.1,3.9,48.1,84.6,84.8,26.0 (±22.1),22.0 (±22.1),84.6% (±84.8%)
Plovdiv,Total,(35-39),75.8,91,15.2,13.7,1.1,Not Significant,26.8,49.0,102.6,20.1,31.4,75.8 (±26.8),15.2 (±26.8),20.1% (±31.4%)
Plovdiv,Total,(40-44),110.6,166,55.4,19.8,2.8,Significant Increase,38.8,71.8,149.4,50.1,39.0,110.6 (±38.8),55.4 (±38.8),50.1% (±39.0%)
Plovdiv,Total,(45-49),201.4,255,53.6,23.7,2.3,Significant Increase,46.5,154.9,247.9,26.6,23.7,201.4 (±46.5),53.6 (±46.5),26.6% (±23.7%)
Plovdiv,Total,(5-9),-2.2,3,5.2,4.4,1.2,Not Significant,8.6,-10.8,6.4,-236.4,-183.3,-2.2 (±8.6),5.2 (±8.6),-236.4% (±-183.3%)
Plovdiv,Total,(50-54),322.4,387,64.6,30.0,2.2,Significant Increase,58.8,263.6,381.2,20.0,18.5,322.4 (±58.8),64.6 (±58.8),20.0% (±18.5%)
Plovdiv,Total,(55-59),441.6,592,150.4,40.8,3.7,Significant Increase,80.0,361.6,521.6,34.1,20.6,441.6 (±80.0),150.4 (±80.0),34.1% (±20.6%)
Plovdiv,Total,(60-64),667.2,998,330.8,48.6,6.8,Significant Increase,95.2,572.0,762.4,49.6,18.7,667.2 (±95.2),330.8 (±95.2),49.6% (±18.7%)
Plovdiv,Total,(65-69),967.4,1351,383.6,58.6,6.6,Significant Increase,114.8,852.6,1082.2,39.7,14.9,967.4 (±114.8),383.6 (±114.8),39.7% (±14.9%)
Plovdiv,Total,(70-74),1247.6,1943,695.4,63.3,11.0,Significant Increase,124.0,1123.6,1371.6,55.7,14.0,1247.6 (±124.0),695.4 (±124.0),55.7% (±14.0%)
Plovdiv,Total,(75-79),1333.2,2082,748.8,61.0,12.3,Significant Increase,119.5,1213.7,1452.7,56.2,12.9,1333.2 (±119.5),748.8 (±119.5),56.2% (±12.9%)
Plovdiv,Total,(80-84),1602.2,2327,724.8,84.1,8.6,Significant Increase,164.9,1437.3,1767.1,45.2,13.5,1602.2 (±164.9),724.8 (±164.9),45.2% (±13.5%)
Plovdiv,Total,(85-89),1702.2,2271,568.8,78.0,7.3,Significant Increase,152.8,1549.4,1855.0,33.4,11.0,1702.2 (±152.8),568.8 (±152.8),33.4% (±11.0%)
Plovdiv,Total,(90+),1130.4,1345,214.6,54.8,3.9,Significant Increase,107.4,1023.0,1237.8,19.0,10.3,1130.4 (±107.4),214.6 (±107.4),19.0% (±10.3%)
Razgrad,Female,(0-4),3.6,4,0.4,2.6,0.2,Not Significant,5.1,-1.5,8.7,11.1,65.1,3.6 (±5.1),0.4 (±5.1),11.1% (±65.1%)
Razgrad,Female,(10-14),-0.2,2,2.2,0.7,2.9,Significant Increase,1.5,-1.7,1.3,-1100.0,-1153.8,-0.2 (±1.5),2.2 (±1.5),-1100.0% (±-1153.8%)
Razgrad,Female,(15-19),-0.2,2,2.2,1.7,1.3,Not Significant,3.3,-3.5,3.1,-1100.0,-1064.5,-0.2 (±3.3),2.2 (±3.3),-1100.0% (±-1064.5%)
Razgrad,Female,(20-24),1.2,1,-0.2,2.4,-0.1,Not Significant,4.6,-3.4,5.8,-16.7,66.1,1.2 (±4.6),-0.2 (±4.6),-16.7% (±66.1%)
Razgrad,Female,(25-29),3.4,1,-2.4,2.2,-1.1,Not Significant,4.3,-0.9,7.7,-70.6,16.4,3.4 (±4.3),-2.4 (±4.3),-70.6% (±16.4%)
Razgrad,Female,(30-34),2.4,4,1.6,3.0,0.5,Not Significant,5.8,-3.4,8.2,66.7,117.9,2.4 (±5.8),1.6 (±5.8),66.7% (±117.9%)
Razgrad,Female,(35-39),5.8,4,-1.8,3.4,-0.5,Not Significant,6.6,-0.8,12.4,-31.0,36.7,5.8 (±6.6),-1.8 (±6.6),-31.0% (±36.7%)
Razgrad,Female,(40-44),9.0,11,2.0,4.3,0.5,Not Significant,8.4,0.6,17.4,22.2,59.0,9.0 (±8.4),2.0 (±8.4),22.2% (±59.0%)
Razgrad,Female,(45-49),4.4,10,5.6,5.9,1.0,Not Significant,11.5,-7.1,15.9,127.3,164.4,4.4 (±11.5),5.6 (±11.5),127.3% (±164.4%)
Razgrad,Female,(5-9),1.6,0,-1.6,1.1,-1.5,Not Significant,2.1,-0.5,3.7,-100.0,0.0,1.6 (±2.1),-1.6 (±2.1),-100.0% (±0.0%)
Razgrad,Female,(50-54),11.0,35,24.0,7.0,3.4,Significant Increase,13.7,-2.7,24.7,218.2,176.5,11.0 (±13.7),24.0 (±13.7),218.2% (±176.5%)
Razgrad,Female,(55-59),14.2,51,36.8,9.0,4.1,Significant Increase,17.6,-3.4,31.8,259.2,198.8,14.2 (±17.6),36.8 (±17.6),259.2% (±198.8%)
Razgrad,Female,(60-64),37.4,82,44.6,12.0,3.7,Significant Increase,23.6,13.8,61.0,119.3,84.9,37.4 (±23.6),44.6 (±23.6),119.3% (±84.9%)
Razgrad,Female,(65-69),81.0,125,44.0,16.7,2.6,Significant Increase,32.8,48.2,113.8,54.3,44.5,81.0 (±32.8),44.0 (±32.8),54.3% (±44.5%)
Razgrad,Female,(70-74),107.6,210,102.4,17.9,5.7,Significant Increase,35.0,72.6,142.6,95.2,47.9,107.6 (±35.0),102.4 (±35.0),95.2% (±47.9%)
Razgrad,Female,(75-79),188.2,282,93.8,21.8,4.3,Significant Increase,42.7,145.5,230.9,49.8,27.7,188.2 (±42.7),93.8 (±42.7),49.8% (±27.7%)
Razgrad,Female,(80-84),167.6,215,47.4,23.1,2.1,Significant Increase,45.3,122.3,212.9,28.3,27.3,167.6 (±45.3),47.4 (±45.3),28.3% (±27.3%)
Razgrad,Female,(85-89),169.2,195,25.8,22.2,1.2,Not Significant,43.6,125.6,212.8,15.2,23.6,169.2 (±43.6),25.8 (±43.6),15.2% (±23.6%)
Razgrad,Female,(90+),102.0,80,-22.0,14.3,-1.5,Not Significant,28.1,73.9,130.1,-21.6,16.9,102.0 (±28.1),-22.0 (±28.1),-21.6% (±16.9%)
Razgrad,Male,(0-4),8.0,4,-4.0,4.1,-1.0,Not Significant,8.0,0.0,16.0,-50.0,25.0,8.0 (±8.0),-4.0 (±8.0),-50.0% (±25.0%)
Razgrad,Male,(10-14),0.6,0,-0.6,1.3,-0.5,Not Significant,2.5,-1.9,3.1,-100.0,0.0,0.6 (±2.5),-0.6 (±2.5),-100.0% (±0.0%)
Razgrad,Male,(15-19),4.6,2,-2.6,2.7,-1.0,Not Significant,5.3,-0.7,9.9,-56.5,23.3,4.6 (±5.3),-2.6 (±5.3),-56.5% (±23.3%)
Razgrad,Male,(20-24),0.6,4,3.4,2.9,1.2,Not Significant,5.7,-5.1,6.3,566.7,603.2,0.6 (±5.7),3.4 (±5.7),566.7% (±603.2%)
Razgrad,Male,(25-29),3.6,7,3.4,3.2,1.1,Not Significant,6.3,-2.7,9.9,94.4,123.7,3.6 (±6.3),3.4 (±6.3),94.4% (±123.7%)
Razgrad,Male,(30-34),4.0,8,4.0,3.2,1.2,Not Significant,6.3,-2.3,10.3,100.0,122.3,4.0 (±6.3),4.0 (±6.3),100.0% (±122.3%)
Razgrad,Male,(35-39),10.2,12,1.8,4.9,0.4,Not Significant,9.6,0.6,19.8,17.6,57.0,10.2 (±9.6),1.8 (±9.6),17.6% (±57.0%)
Razgrad,Male,(40-44),11.4,15,3.6,6.7,0.5,Not Significant,13.1,-1.7,24.5,31.6,70.4,11.4 (±13.1),3.6 (±13.1),31.6% (±70.4%)
Razgrad,Male,(45-49),42.2,46,3.8,8.9,0.4,Not Significant,17.5,24.7,59.7,9.0,31.9,42.2 (±17.5),3.8 (±17.5),9.0% (±31.9%)
Razgrad,Male,(5-9),0.6,1,0.4,0.7,0.5,Not Significant,1.5,-0.9,2.1,66.7,119.1,0.6 (±1.5),0.4 (±1.5),66.7% (±119.1%)
Razgrad,Male,(50-54),33.0,60,27.0,11.3,2.4,Significant Increase,22.1,10.9,55.1,81.8,72.9,33.0 (±22.1),27.0 (±22.1),81.8% (±72.9%)
Razgrad,Male,(55-59),59.6,95,35.4,13.4,2.6,Significant Increase,26.3,33.3,85.9,59.4,48.8,59.6 (±26.3),35.4 (±26.3),59.4% (±48.8%)
Razgrad,Male,(60-64),98.8,138,39.2,19.6,2.0,Significant Increase,38.4,60.4,137.2,39.7,39.1,98.8 (±38.4),39.2 (±38.4),39.7% (±39.1%)
Razgrad,Male,(65-69),159.0,181,22.0,20.3,1.1,Not Significant,39.7,119.3,198.7,13.8,22.7,159.0 (±39.7),22.0 (±39.7),13.8% (±22.7%)
Razgrad,Male,(70-74),148.2,237,88.8,22.1,4.0,Significant Increase,43.3,104.9,191.5,59.9,36.1,148.2 (±43.3),88.8 (±43.3),59.9% (±36.1%)
Razgrad,Male,(75-79),160.2,250,89.8,19.7,4.5,Significant Increase,38.7,121.5,198.9,56.1,30.4,160.2 (±38.7),89.8 (±38.7),56.1% (±30.4%)
Razgrad,Male,(80-84),116.0,181,65.0,22.3,2.9,Significant Increase,43.8,72.2,159.8,56.0,42.7,116.0 (±43.8),65.0 (±43.8),56.0% (±42.7%)
Razgrad,Male,(85-89),89.2,132,42.8,14.8,2.9,Significant Increase,29.1,60.1,118.3,48.0,36.4,89.2 (±29.1),42.8 (±29.1),48.0% (±36.4%)
Razgrad,Male,(90+),45.2,48,2.8,12.2,0.2,Not Significant,23.8,21.4,69.0,6.2,36.6,45.2 (±23.8),2.8 (±23.8),6.2% (±36.6%)
Razgrad,Total,(0-4),11.6,8,-3.6,4.8,-0.7,Not Significant,9.5,2.1,21.1,-31.0,31.1,11.6 (±9.5),-3.6 (±9.5),-31.0% (±31.1%)
Razgrad,Total,(10-14),0.4,2,1.6,1.5,1.1,Not Significant,2.9,-2.5,3.3,400.0,439.4,0.4 (±2.9),1.6 (±2.9),400.0% (±439.4%)
Razgrad,Total,(15-19),4.4,4,-0.4,3.1,-0.1,Not Significant,6.1,-1.7,10.5,-9.1,52.8,4.4 (±6.1),-0.4 (±6.1),-9.1% (±52.8%)
Razgrad,Total,(20-24),1.8,5,3.2,4.0,0.8,Not Significant,7.8,-6.0,9.6,177.8,225.7,1.8 (±7.8),3.2 (±7.8),177.8% (±225.7%)
Razgrad,Total,(25-29),7.0,8,1.0,3.8,0.3,Not Significant,7.5,-0.5,14.5,14.3,59.1,7.0 (±7.5),1.0 (±7.5),14.3% (±59.1%)
Razgrad,Total,(30-34),6.4,12,5.6,4.7,1.2,Not Significant,9.2,-2.8,15.6,87.5,110.6,6.4 (±9.2),5.6 (±9.2),87.5% (±110.6%)
Razgrad,Total,(35-39),16.0,16,-0.0,5.8,-0.0,Not Significant,11.3,4.7,27.3,-0.0,41.4,16.0 (±11.3),-0.0 (±11.3),-0.0% (±41.4%)
Razgrad,Total,(40-44),20.4,26,5.6,8.0,0.7,Not Significant,15.6,4.8,36.0,27.5,55.3,20.4 (±15.6),5.6 (±15.6),27.5% (±55.3%)
Razgrad,Total,(45-49),46.6,56,9.4,10.4,0.9,Not Significant,20.4,26.2,67.0,20.2,36.6,46.6 (±20.4),9.4 (±20.4),20.2% (±36.6%)
Razgrad,Total,(5-9),2.2,1,-1.2,1.3,-0.9,Not Significant,2.5,-0.3,4.7,-54.5,24.2,2.2 (±2.5),-1.2 (±2.5),-54.5% (±24.2%)
Razgrad,Total,(50-54),44.0,95,51.0,13.7,3.7,Significant Increase,26.8,17.2,70.8,115.9,81.7,44.0 (±26.8),51.0 (±26.8),115.9% (±81.7%)
Razgrad,Total,(55-59),73.8,146,72.2,15.8,4.6,Significant Increase,31.0,42.8,104.8,97.8,58.5,73.8 (±31.0),72.2 (±31.0),97.8% (±58.5%)
Razgrad,Total,(60-64),136.2,220,83.8,23.0,3.7,Significant Increase,45.0,91.2,181.2,61.5,40.1,136.2 (±45.0),83.8 (±45.0),61.5% (±40.1%)
Razgrad,Total,(65-69),240.0,306,66.0,26.4,2.5,Significant Increase,51.7,188.3,291.7,27.5,22.6,240.0 (±51.7),66.0 (±51.7),27.5% (±22.6%)
Razgrad,Total,(70-74),255.8,447,191.2,28.0,6.8,Significant Increase,55.0,200.8,310.8,74.7,30.9,255.8 (±55.0),191.2 (±55.0),74.7% (±30.9%)
Razgrad,Total,(75-79),348.4,532,183.6,30.2,6.1,Significant Increase,59.3,289.1,407.7,52.7,22.2,348.4 (±59.3),183.6 (±59.3),52.7% (±22.2%)
Razgrad,Total,(80-84),283.6,396,112.4,32.5,3.5,Significant Increase,63.8,219.8,347.4,39.6,25.6,283.6 (±63.8),112.4 (±63.8),39.6% (±25.6%)
Razgrad,Total,(85-89),258.4,327,68.6,27.5,2.5,Significant Increase,53.8,204.6,312.2,26.5,21.8,258.4 (±53.8),68.6 (±53.8),26.5% (±21.8%)
Razgrad,Total,(90+),147.2,128,-19.2,19.2,-1.0,Not Significant,37.7,109.5,184.9,-13.0,17.8,147.2 (±37.7),-19.2 (±37.7),-13.0% (±17.8%)
Ruse,Female,(0-4),4.6,5,0.4,4.1,0.1,Not Significant,8.0,-3.4,12.6,8.7,69.0,4.6 (±8.0),0.4 (±8.0),8.7% (±69.0%)
Ruse,Female,(10-14),3.2,0,-3.2,1.5,-2.2,Significant Decrease,2.9,0.3,6.1,-100.0,0.0,3.2 (±2.9),-3.2 (±2.9),-100.0% (±0.0%)
Ruse,Female,(15-19),-2.0,2,4.0,1.8,2.2,Significant Increase,3.6,-5.6,1.6,-200.0,-225.0,-2.0 (±3.6),4.0 (±3.6),-200.0% (±-225.0%)
Ruse,Female,(20-24),5.2,1,-4.2,2.3,-1.8,Not Significant,4.5,0.7,9.7,-80.8,8.9,5.2 (±4.5),-4.2 (±4.5),-80.8% (±8.9%)
Ruse,Female,(25-29),1.0,2,1.0,2.5,0.4,Not Significant,5.0,-4.0,6.0,100.0,166.7,1.0 (±5.0),1.0 (±5.0),100.0% (±166.7%)
Ruse,Female,(30-34),5.2,3,-2.2,3.4,-0.7,Not Significant,6.6,-1.4,11.8,-42.3,32.3,5.2 (±6.6),-2.2 (±6.6),-42.3% (±32.3%)
Ruse,Female,(35-39),8.8,6,-2.8,4.0,-0.7,Not Significant,7.8,1.0,16.6,-31.8,32.1,8.8 (±7.8),-2.8 (±7.8),-31.8% (±32.1%)
Ruse,Female,(40-44),15.8,18,2.2,6.3,0.4,Not Significant,12.3,3.5,28.1,13.9,49.8,15.8 (±12.3),2.2 (±12.3),13.9% (±49.8%)
Ruse,Female,(45-49),36.8,32,-4.8,8.4,-0.6,Not Significant,16.5,20.3,53.3,-13.0,27.0,36.8 (±16.5),-4.8 (±16.5),-13.0% (±27.0%)
Ruse,Female,(5-9),0.8,0,-0.8,1.8,-0.4,Not Significant,3.6,-2.8,4.4,-100.0,0.0,0.8 (±3.6),-0.8 (±3.6),-100.0% (±0.0%)
Ruse,Female,(50-54),23.4,42,18.6,8.9,2.1,Significant Increase,17.5,5.9,40.9,79.5,76.8,23.4 (±17.5),18.6 (±17.5),79.5% (±76.8%)
Ruse,Female,(55-59),42.0,95,53.0,13.4,4.0,Significant Increase,26.2,15.8,68.2,126.2,86.9,42.0 (±26.2),53.0 (±26.2),126.2% (±86.9%)
Ruse,Female,(60-64),94.4,128,33.6,14.9,2.3,Significant Increase,29.1,65.3,123.5,35.6,32.0,94.4 (±29.1),33.6 (±29.1),35.6% (±32.0%)
Ruse,Female,(65-69),132.4,245,112.6,18.0,6.3,Significant Increase,35.3,97.1,167.7,85.0,38.9,132.4 (±35.3),112.6 (±35.3),85.0% (±38.9%)
Ruse,Female,(70-74),185.4,356,170.6,24.2,7.0,Significant Increase,47.5,137.9,232.9,92.0,39.1,185.4 (±47.5),170.6 (±47.5),92.0% (±39.1%)
Ruse,Female,(75-79),264.0,464,200.0,30.4,6.6,Significant Increase,59.6,204.4,323.6,75.8,32.4,264.0 (±59.6),200.0 (±59.6),75.8% (±32.4%)
Ruse,Female,(80-84),357.2,443,85.8,35.3,2.4,Significant Increase,69.1,288.1,426.3,24.0,20.1,357.2 (±69.1),85.8 (±69.1),24.0% (±20.1%)
Ruse,Female,(85-89),360.2,499,138.8,33.4,4.2,Significant Increase,65.4,294.8,425.6,38.5,21.3,360.2 (±65.4),138.8 (±65.4),38.5% (±21.3%)
Ruse,Female,(90+),241.2,282,40.8,25.2,1.6,Not Significant,49.3,191.9,290.5,16.9,19.8,241.2 (±49.3),40.8 (±49.3),16.9% (±19.8%)
Ruse,Male,(0-4),5.2,4,-1.2,5.4,-0.2,Not Significant,10.5,-5.3,15.7,-23.1,51.4,5.2 (±10.5),-1.2 (±10.5),-23.1% (±51.4%)
Ruse,Male,(10-14),0.4,1,0.6,1.5,0.4,Not Significant,2.9,-2.5,3.3,150.0,219.7,0.4 (±2.9),0.6 (±2.9),150.0% (±219.7%)
Ruse,Male,(15-19),3.6,0,-3.6,2.8,-1.3,Not Significant,5.4,-1.8,9.0,-100.0,0.0,3.6 (±5.4),-3.6 (±5.4),-100.0% (±0.0%)
Ruse,Male,(20-24),0.2,4,3.8,4.1,0.9,Not Significant,7.9,-7.7,8.1,1900.0,1950.6,0.2 (±7.9),3.8 (±7.9),1900.0% (±1950.6%)
Ruse,Male,(25-29),4.0,4,0.0,4.6,0.0,Not Significant,9.0,-5.0,13.0,0.0,69.2,4.0 (±9.0),0.0 (±9.0),0.0% (±69.2%)
Ruse,Male,(30-34),18.4,14,-4.4,6.1,-0.7,Not Significant,12.0,6.4,30.4,-23.9,30.0,18.4 (±12.0),-4.4 (±12.0),-23.9% (±30.0%)
Ruse,Male,(35-39),18.8,19,0.2,6.2,0.0,Not Significant,12.1,6.7,30.9,1.1,39.6,18.8 (±12.1),0.2 (±12.1),1.1% (±39.6%)
Ruse,Male,(40-44),33.4,25,-8.4,8.8,-1.0,Not Significant,17.3,16.1,50.7,-25.1,25.6,33.4 (±17.3),-8.4 (±17.3),-25.1% (±25.6%)
Ruse,Male,(45-49),30.8,65,34.2,10.8,3.2,Significant Increase,21.2,9.6,52.0,111.0,86.0,30.8 (±21.2),34.2 (±21.2),111.0% (±86.0%)
Ruse,Male,(5-9),-0.2,2,2.2,0.7,2.9,Significant Increase,1.5,-1.7,1.3,-1100.0,-1153.8,-0.2 (±1.5),2.2 (±1.5),-1100.0% (±-1153.8%)
Ruse,Male,(50-54),85.2,105,19.8,15.0,1.3,Not Significant,29.3,55.9,114.5,23.2,31.5,85.2 (±29.3),19.8 (±29.3),23.2% (±31.5%)
Ruse,Male,(55-59),116.6,184,67.4,20.1,3.4,Significant Increase,39.3,77.3,155.9,57.8,39.8,116.6 (±39.3),67.4 (±39.3),57.8% (±39.8%)
Ruse,Male,(60-64),188.8,214,25.2,24.2,1.0,Not Significant,47.4,141.4,236.2,13.3,22.7,188.8 (±47.4),25.2 (±47.4),13.3% (±22.7%)
Ruse,Male,(65-69),301.4,368,66.6,25.6,2.6,Significant Increase,50.3,251.1,351.7,22.1,17.5,301.4 (±50.3),66.6 (±50.3),22.1% (±17.5%)
Ruse,Male,(70-74),340.2,492,151.8,29.1,5.2,Significant Increase,57.1,283.1,397.3,44.6,20.8,340.2 (±57.1),151.8 (±57.1),44.6% (±20.8%)
Ruse,Male,(75-79),255.2,445,189.8,29.5,6.4,Significant Increase,57.8,197.4,313.0,74.4,32.2,255.2 (±57.8),189.8 (±57.8),74.4% (±32.2%)
Ruse,Male,(80-84),264.6,364,99.4,30.1,3.3,Significant Increase,59.0,205.6,323.6,37.6,25.1,264.6 (±59.0),99.4 (±59.0),37.6% (±25.1%)
Ruse,Male,(85-89),229.8,279,49.2,24.6,2.0,Significant Increase,48.3,181.5,278.1,21.4,21.1,229.8 (±48.3),49.2 (±48.3),21.4% (±21.1%)
Ruse,Male,(90+),132.0,139,7.0,17.8,0.4,Not Significant,34.9,97.1,166.9,5.3,22.0,132.0 (±34.9),7.0 (±34.9),5.3% (±22.0%)
Ruse,Total,(0-4),9.8,9,-0.8,6.9,-0.1,Not Significant,13.6,-3.8,23.4,-8.2,53.3,9.8 (±13.6),-0.8 (±13.6),-8.2% (±53.3%)
Ruse,Total,(10-14),3.6,1,-2.6,2.0,-1.3,Not Significant,4.0,-0.4,7.6,-72.2,14.6,3.6 (±4.0),-2.6 (±4.0),-72.2% (±14.6%)
Ruse,Total,(15-19),1.6,2,0.4,3.4,0.1,Not Significant,6.7,-5.1,8.3,25.0,100.9,1.6 (±6.7),0.4 (±6.7),25.0% (±100.9%)
Ruse,Total,(20-24),5.4,5,-0.4,5.1,-0.1,Not Significant,10.0,-4.6,15.4,-7.4,60.1,5.4 (±10.0),-0.4 (±10.0),-7.4% (±60.1%)
Ruse,Total,(25-29),5.0,6,1.0,5.5,0.2,Not Significant,10.8,-5.8,15.8,20.0,82.0,5.0 (±10.8),1.0 (±10.8),20.0% (±82.0%)
Ruse,Total,(30-34),23.6,17,-6.6,7.4,-0.9,Not Significant,14.6,9.0,38.2,-28.0,27.5,23.6 (±14.6),-6.6 (±14.6),-28.0% (±27.5%)
Ruse,Total,(35-39),27.6,25,-2.6,7.6,-0.3,Not Significant,14.8,12.8,42.4,-9.4,31.6,27.6 (±14.8),-2.6 (±14.8),-9.4% (±31.6%)
Ruse,Total,(40-44),49.2,43,-6.2,11.2,-0.6,Not Significant,22.0,27.2,71.2,-12.6,27.0,49.2 (±22.0),-6.2 (±22.0),-12.6% (±27.0%)
Ruse,Total,(45-49),67.6,97,29.4,14.1,2.1,Significant Increase,27.6,40.0,95.2,43.5,41.6,67.6 (±27.6),29.4 (±27.6),43.5% (±41.6%)
Ruse,Total,(5-9),0.6,2,1.4,2.0,0.7,Not Significant,3.9,-3.3,4.5,233.3,288.9,0.6 (±3.9),1.4 (±3.9),233.3% (±288.9%)
Ruse,Total,(50-54),108.6,147,38.4,17.9,2.1,Significant Increase,35.1,73.5,143.7,35.4,33.1,108.6 (±35.1),38.4 (±35.1),35.4% (±33.1%)
Ruse,Total,(55-59),158.6,279,120.4,24.7,4.9,Significant Increase,48.3,110.3,206.9,75.9,41.1,158.6 (±48.3),120.4 (±48.3),75.9% (±41.1%)
Ruse,Total,(60-64),283.2,342,58.8,28.8,2.0,Significant Increase,56.4,226.8,339.6,20.8,20.1,283.2 (±56.4),58.8 (±56.4),20.8% (±20.1%)
Ruse,Total,(65-69),433.8,613,179.2,31.3,5.7,Significant Increase,61.3,372.5,495.1,41.3,17.5,433.8 (±61.3),179.2 (±61.3),41.3% (±17.5%)
Ruse,Total,(70-74),525.6,848,322.4,38.9,8.3,Significant Increase,76.2,449.4,601.8,61.3,20.4,525.6 (±76.2),322.4 (±76.2),61.3% (±20.4%)
Ruse,Total,(75-79),519.2,909,389.8,43.2,9.0,Significant Increase,84.7,434.5,603.9,75.1,24.6,519.2 (±84.7),389.8 (±84.7),75.1% (±24.6%)
Ruse,Total,(80-84),621.8,807,185.2,49.5,3.7,Significant Increase,97.1,524.7,718.9,29.8,17.5,621.8 (±97.1),185.2 (±97.1),29.8% (±17.5%)
Ruse,Total,(85-89),590.0,778,188.0,42.7,4.4,Significant Increase,83.8,506.2,673.8,31.9,16.4,590.0 (±83.8),188.0 (±83.8),31.9% (±16.4%)
Ruse,Total,(90+),373.2,421,47.8,31.1,1.5,Not Significant,60.9,312.3,434.1,12.8,15.8,373.2 (±60.9),47.8 (±60.9),12.8% (±15.8%)
Shumen,Female,(0-4),-1.2,6,7.2,3.8,1.9,Not Significant,7.5,-8.7,6.3,-600.0,-595.2,-1.2 (±7.5),7.2 (±7.5),-600.0% (±-595.2%)
Shumen,Female,(10-14),2.4,3,0.6,1.5,0.4,Not Significant,2.9,-0.5,5.3,25.0,68.4,2.4 (±2.9),0.6 (±2.9),25.0% (±68.4%)
Shumen,Female,(15-19),-0.4,3,3.4,2.1,1.6,Not Significant,4.1,-4.5,3.7,-850.0,-831.1,-0.4 (±4.1),3.4 (±4.1),-850.0% (±-831.1%)
Shumen,Female,(20-24),4.0,2,-2.0,2.2,-0.9,Not Significant,4.4,-0.4,8.4,-50.0,26.2,4.0 (±4.4),-2.0 (±4.4),-50.0% (±26.2%)
Shumen,Female,(25-29),4.0,3,-1.0,2.0,-0.5,Not Significant,4.0,0.0,8.0,-25.0,37.5,4.0 (±4.0),-1.0 (±4.0),-25.0% (±37.5%)
Shumen,Female,(30-34),2.6,4,1.4,2.4,0.6,Not Significant,4.6,-2.0,7.2,53.8,98.2,2.6 (±4.6),1.4 (±4.6),53.8% (±98.2%)
Shumen,Female,(35-39),7.4,9,1.6,4.1,0.4,Not Significant,8.0,-0.6,15.4,21.6,63.2,7.4 (±8.0),1.6 (±8.0),21.6% (±63.2%)
Shumen,Female,(40-44),3.0,25,22.0,5.4,4.1,Significant Increase,10.6,-7.6,13.6,733.3,649.5,3.0 (±10.6),22.0 (±10.6),733.3% (±649.5%)
Shumen,Female,(45-49),18.8,28,9.2,7.4,1.2,Not Significant,14.6,4.2,33.4,48.9,65.1,18.8 (±14.6),9.2 (±14.6),48.9% (±65.1%)
Shumen,Female,(5-9),0.8,0,-0.8,1.1,-0.8,Not Significant,2.1,-1.3,2.9,-100.0,0.0,0.8 (±2.1),-0.8 (±2.1),-100.0% (±0.0%)
Shumen,Female,(50-54),24.0,35,11.0,8.9,1.2,Not Significant,17.4,6.6,41.4,45.8,61.3,24.0 (±17.4),11.0 (±17.4),45.8% (±61.3%)
Shumen,Female,(55-59),55.0,72,17.0,12.3,1.4,Not Significant,24.1,30.9,79.1,30.9,39.9,55.0 (±24.1),17.0 (±24.1),30.9% (±39.9%)
Shumen,Female,(60-64),48.6,103,54.4,15.7,3.5,Significant Increase,30.8,17.8,79.4,111.9,82.2,48.6 (±30.8),54.4 (±30.8),111.9% (±82.2%)
Shumen,Female,(65-69),94.0,177,83.0,17.1,4.9,Significant Increase,33.5,60.5,127.5,88.3,49.5,94.0 (±33.5),83.0 (±33.5),88.3% (±49.5%)
Shumen,Female,(70-74),172.8,274,101.2,22.1,4.6,Significant Increase,43.4,129.4,216.2,58.6,31.9,172.8 (±43.4),101.2 (±43.4),58.6% (±31.9%)
Shumen,Female,(75-79),207.2,322,114.8,24.5,4.7,Significant Increase,48.0,159.2,255.2,55.4,29.2,207.2 (±48.0),114.8 (±48.0),55.4% (±29.2%)
Shumen,Female,(80-84),243.4,337,93.6,29.0,3.2,Significant Increase,56.8,186.6,300.2,38.5,26.2,243.4 (±56.8),93.6 (±56.8),38.5% (±26.2%)
Shumen,Female,(85-89),227.8,302,74.2,24.4,3.0,Significant Increase,47.9,179.9,275.7,32.6,23.1,227.8 (±47.9),74.2 (±47.9),32.6% (±23.1%)
Shumen,Female,(90+),164.6,185,20.4,21.6,0.9,Not Significant,42.3,122.3,206.9,12.4,23.0,164.6 (±42.3),20.4 (±42.3),12.4% (±23.0%)
Shumen,Male,(0-4),2.0,4,2.0,3.5,0.6,Not Significant,6.9,-4.9,8.9,100.0,155.1,2.0 (±6.9),2.0 (±6.9),100.0% (±155.1%)
Shumen,Male,(10-14),1.2,0,-1.2,1.5,-0.8,Not Significant,2.9,-1.7,4.1,-100.0,0.0,1.2 (±2.9),-1.2 (±2.9),-100.0% (±0.0%)
Shumen,Male,(15-19),2.0,1,-1.0,2.9,-0.3,Not Significant,5.7,-3.7,7.7,-50.0,37.0,2.0 (±5.7),-1.0 (±5.7),-50.0% (±37.0%)
Shumen,Male,(20-24),4.6,6,1.4,2.8,0.5,Not Significant,5.5,-0.9,10.1,30.4,71.0,4.6 (±5.5),1.4 (±5.5),30.4% (±71.0%)
Shumen,Male,(25-29),0.0,8,8.0,3.6,2.2,Significant Increase,7.1,-7.1,7.1,241092057139648.2,241092057139635.5,0.0 (±7.1),8.0 (±7.1),241092057139648.2% (±241092057139635.5%)
Shumen,Male,(30-34),11.6,9,-2.6,5.4,-0.5,Not Significant,10.6,1.0,22.2,-22.4,37.1,11.6 (±10.6),-2.6 (±10.6),-22.4% (±37.1%)
Shumen,Male,(35-39),9.8,18,8.2,5.3,1.6,Not Significant,10.3,-0.5,20.1,83.7,94.1,9.8 (±10.3),8.2 (±10.3),83.7% (±94.1%)
Shumen,Male,(40-44),14.4,37,22.6,8.3,2.7,Significant Increase,16.3,-1.9,30.7,156.9,136.4,14.4 (±16.3),22.6 (±16.3),156.9% (±136.4%)
Shumen,Male,(45-49),45.8,48,2.2,11.2,0.2,Not Significant,21.9,23.9,67.7,4.8,33.9,45.8 (±21.9),2.2 (±21.9),4.8% (±33.9%)
Shumen,Male,(5-9),1.2,0,-1.2,1.5,-0.8,Not Significant,2.9,-1.7,4.1,-100.0,0.0,1.2 (±2.9),-1.2 (±2.9),-100.0% (±0.0%)
Shumen,Male,(50-54),66.2,103,36.8,13.5,2.7,Significant Increase,26.4,39.8,92.6,55.6,44.4,66.2 (±26.4),36.8 (±26.4),55.6% (±44.4%)
Shumen,Male,(55-59),106.8,139,32.2,17.0,1.9,Not Significant,33.3,73.5,140.1,30.1,30.9,106.8 (±33.3),32.2 (±33.3),30.1% (±30.9%)
Shumen,Male,(60-64),166.6,188,21.4,20.2,1.1,Not Significant,39.6,127.0,206.2,12.8,21.6,166.6 (±39.6),21.4 (±39.6),12.8% (±21.6%)
Shumen,Male,(65-69),217.2,240,22.8,26.3,0.9,Not Significant,51.5,165.7,268.7,10.5,21.2,217.2 (±51.5),22.8 (±51.5),10.5% (±21.2%)
Shumen,Male,(70-74),255.4,341,85.6,22.7,3.8,Significant Increase,44.5,210.9,299.9,33.5,19.8,255.4 (±44.5),85.6 (±44.5),33.5% (±19.8%)
Shumen,Male,(75-79),178.6,331,152.4,24.3,6.3,Significant Increase,47.7,130.9,226.3,85.3,39.0,178.6 (±47.7),152.4 (±47.7),85.3% (±39.0%)
Shumen,Male,(80-84),186.8,231,44.2,25.8,1.7,Not Significant,50.5,136.3,237.3,23.7,26.4,186.8 (±50.5),44.2 (±50.5),23.7% (±26.4%)
Shumen,Male,(85-89),161.0,202,41.0,21.1,1.9,Not Significant,41.3,119.7,202.3,25.5,25.6,161.0 (±41.3),41.0 (±41.3),25.5% (±25.6%)
Shumen,Male,(90+),68.8,79,10.2,12.5,0.8,Not Significant,24.6,44.2,93.4,14.8,30.2,68.8 (±24.6),10.2 (±24.6),14.8% (±30.2%)
Shumen,Total,(0-4),0.8,10,9.2,5.5,1.7,Not Significant,10.8,-10.0,11.6,1150.0,1163.8,0.8 (±10.8),9.2 (±10.8),1150.0% (±1163.8%)
Shumen,Total,(10-14),3.6,3,-0.6,2.1,-0.3,Not Significant,4.1,-0.5,7.7,-16.7,44.3,3.6 (±4.1),-0.6 (±4.1),-16.7% (±44.3%)
Shumen,Total,(15-19),1.6,4,2.4,3.7,0.6,Not Significant,7.3,-5.7,8.9,150.0,205.1,1.6 (±7.3),2.4 (±7.3),150.0% (±205.1%)
Shumen,Total,(20-24),8.6,8,-0.6,3.6,-0.2,Not Significant,7.1,1.5,15.7,-7.0,42.0,8.6 (±7.1),-0.6 (±7.1),-7.0% (±42.0%)
Shumen,Total,(25-29),4.0,11,7.0,4.3,1.6,Not Significant,8.4,-4.4,12.4,175.0,186.3,4.0 (±8.4),7.0 (±8.4),175.0% (±186.3%)
Shumen,Total,(30-34),14.2,13,-1.2,5.8,-0.2,Not Significant,11.3,2.9,25.5,-8.5,40.5,14.2 (±11.3),-1.2 (±11.3),-8.5% (±40.5%)
Shumen,Total,(35-39),17.2,27,9.8,6.6,1.5,Not Significant,12.9,4.3,30.1,57.0,67.3,17.2 (±12.9),9.8 (±12.9),57.0% (±67.3%)
Shumen,Total,(40-44),17.4,62,44.6,9.7,4.6,Significant Increase,19.0,-1.6,36.4,256.3,186.0,17.4 (±19.0),44.6 (±19.0),256.3% (±186.0%)
Shumen,Total,(45-49),64.6,76,11.4,13.6,0.8,Not Significant,26.7,37.9,91.3,17.6,34.4,64.6 (±26.7),11.4 (±26.7),17.6% (±34.4%)
Shumen,Total,(5-9),2.0,0,-2.0,1.8,-1.1,Not Significant,3.6,-1.6,5.6,-100.0,0.0,2.0 (±3.6),-2.0 (±3.6),-100.0% (±0.0%)
Shumen,Total,(50-54),90.2,138,47.8,16.2,2.9,Significant Increase,31.8,58.4,122.0,53.0,39.9,90.2 (±31.8),47.8 (±31.8),53.0% (±39.9%)
Shumen,Total,(55-59),161.8,211,49.2,20.2,2.4,Significant Increase,39.6,122.2,201.4,30.4,25.6,161.8 (±39.6),49.2 (±39.6),30.4% (±25.6%)
Shumen,Total,(60-64),215.2,291,75.8,26.0,2.9,Significant Increase,51.1,164.1,266.3,35.2,25.9,215.2 (±51.1),75.8 (±51.1),35.2% (±25.9%)
Shumen,Total,(65-69),311.2,417,105.8,32.2,3.3,Significant Increase,63.1,248.1,374.3,34.0,22.6,311.2 (±63.1),105.8 (±63.1),34.0% (±22.6%)
Shumen,Total,(70-74),428.2,615,186.8,30.9,6.1,Significant Increase,60.5,367.7,488.7,43.6,17.8,428.2 (±60.5),186.8 (±60.5),43.6% (±17.8%)
Shumen,Total,(75-79),385.8,653,267.2,34.6,7.7,Significant Increase,67.8,318.0,453.6,69.3,25.3,385.8 (±67.8),267.2 (±67.8),69.3% (±25.3%)
Shumen,Total,(80-84),430.2,568,137.8,40.5,3.4,Significant Increase,79.4,350.8,509.6,32.0,20.5,430.2 (±79.4),137.8 (±79.4),32.0% (±20.5%)
Shumen,Total,(85-89),388.8,504,115.2,31.0,3.7,Significant Increase,60.7,328.1,449.5,29.6,17.5,388.8 (±60.7),115.2 (±60.7),29.6% (±17.5%)
Shumen,Total,(90+),233.4,264,30.6,24.1,1.3,Not Significant,47.3,186.1,280.7,13.1,19.0,233.4 (±47.3),30.6 (±47.3),13.1% (±19.0%)
Silistra,Female,(0-4),-0.4,3,3.4,2.3,1.5,Not Significant,4.5,-4.9,4.1,-850.0,-823.2,-0.4 (±4.5),3.4 (±4.5),-850.0% (±-823.2%)
Silistra,Female,(10-14),-1.0,0,1.0,1.3,0.8,Not Significant,2.5,-3.5,1.5,-100.0,0.0,-1.0 (±2.5),1.0 (±2.5),-100.0% (±0.0%)
Silistra,Female,(15-19),4.6,1,-3.6,2.0,-1.8,Not Significant,3.8,0.8,8.4,-78.3,9.8,4.6 (±3.8),-3.6 (±3.8),-78.3% (±9.8%)
Silistra,Female,(20-24),2.2,2,-0.2,1.7,-0.1,Not Significant,3.3,-1.1,5.5,-9.1,54.5,2.2 (±3.3),-0.2 (±3.3),-9.1% (±54.5%)
Silistra,Female,(25-29),0.6,2,1.4,1.7,0.8,Not Significant,3.3,-2.7,3.9,233.3,282.0,0.6 (±3.3),1.4 (±3.3),233.3% (±282.0%)
Silistra,Female,(30-34),0.6,3,2.4,2.4,1.0,Not Significant,4.8,-4.2,5.4,400.0,444.4,0.6 (±4.8),2.4 (±4.8),400.0% (±444.4%)
Silistra,Female,(35-39),3.4,5,1.6,3.1,0.5,Not Significant,6.1,-2.7,9.5,47.1,94.5,3.4 (±6.1),1.6 (±6.1),47.1% (±94.5%)
Silistra,Female,(40-44),1.8,13,11.2,4.5,2.5,Significant Increase,8.8,-7.0,10.6,622.2,599.6,1.8 (±8.8),11.2 (±8.8),622.2% (±599.6%)
Silistra,Female,(45-49),3.0,20,17.0,5.1,3.3,Significant Increase,10.1,-7.1,13.1,566.7,514.0,3.0 (±10.1),17.0 (±10.1),566.7% (±514.0%)
Silistra,Female,(5-9),0.6,2,1.4,0.7,1.9,Not Significant,1.5,-0.9,2.1,233.3,238.1,0.6 (±1.5),1.4 (±1.5),233.3% (±238.1%)
Silistra,Female,(50-54),11.8,29,17.2,6.7,2.6,Significant Increase,13.1,-1.3,24.9,145.8,129.3,11.8 (±13.1),17.2 (±13.1),145.8% (±129.3%)
Silistra,Female,(55-59),23.0,53,30.0,9.2,3.2,Significant Increase,18.1,4.9,41.1,130.4,101.4,23.0 (±18.1),30.0 (±18.1),130.4% (±101.4%)
Silistra,Female,(60-64),48.6,76,27.4,11.2,2.5,Significant Increase,21.9,26.7,70.5,56.4,48.6,48.6 (±21.9),27.4 (±21.9),56.4% (±48.6%)
Silistra,Female,(65-69),70.4,118,47.6,15.0,3.2,Significant Increase,29.4,41.0,99.8,67.6,49.4,70.4 (±29.4),47.6 (±29.4),67.6% (±49.4%)
Silistra,Female,(70-74),115.6,220,104.4,18.4,5.7,Significant Increase,36.0,79.6,151.6,90.3,45.2,115.6 (±36.0),104.4 (±36.0),90.3% (±45.2%)
Silistra,Female,(75-79),164.4,249,84.6,19.3,4.4,Significant Increase,37.9,126.5,202.3,51.5,28.4,164.4 (±37.9),84.6 (±37.9),51.5% (±28.4%)
Silistra,Female,(80-84),185.0,243,58.0,22.8,2.5,Significant Increase,44.6,140.4,229.6,31.4,25.6,185.0 (±44.6),58.0 (±44.6),31.4% (±25.6%)
Silistra,Female,(85-89),165.0,190,25.0,20.1,1.2,Not Significant,39.4,125.6,204.4,15.2,22.2,165.0 (±39.4),25.0 (±39.4),15.2% (±22.2%)
Silistra,Female,(90+),90.8,91,0.2,15.3,0.0,Not Significant,30.0,60.8,120.8,0.2,24.9,90.8 (±30.0),0.2 (±30.0),0.2% (±24.9%)
Silistra,Male,(0-4),2.2,7,4.8,3.6,1.3,Not Significant,7.1,-4.9,9.3,218.2,242.9,2.2 (±7.1),4.8 (±7.1),218.2% (±242.9%)
Silistra,Male,(10-14),1.0,2,1.0,1.6,0.6,Not Significant,3.1,-2.1,4.1,100.0,151.2,1.0 (±3.1),1.0 (±3.1),100.0% (±151.2%)
Silistra,Male,(15-19),1.0,5,4.0,2.1,1.9,Not Significant,4.2,-3.2,5.2,400.0,403.8,1.0 (±4.2),4.0 (±4.2),400.0% (±403.8%)
Silistra,Male,(20-24),6.4,1,-5.4,3.0,-1.8,Not Significant,6.0,0.4,12.4,-84.4,7.5,6.4 (±6.0),-5.4 (±6.0),-84.4% (±7.5%)
Silistra,Male,(25-29),4.4,5,0.6,3.4,0.2,Not Significant,6.7,-2.3,11.1,13.6,68.6,4.4 (±6.7),0.6 (±6.7),13.6% (±68.6%)
Silistra,Male,(30-34),6.0,9,3.0,3.1,1.0,Not Significant,6.0,0.0,12.0,50.0,75.0,6.0 (±6.0),3.0 (±6.0),50.0% (±75.0%)
Silistra,Male,(35-39),6.4,11,4.6,5.2,0.9,Not Significant,10.1,-3.7,16.5,71.9,105.2,6.4 (±10.1),4.6 (±10.1),71.9% (±105.2%)
Silistra,Male,(40-44),10.2,13,2.8,7.3,0.4,Not Significant,14.2,-4.0,24.4,27.5,74.2,10.2 (±14.2),2.8 (±14.2),27.5% (±74.2%)
Silistra,Male,(45-49),13.0,37,24.0,9.5,2.5,Significant Increase,18.5,-5.5,31.5,184.6,167.1,13.0 (±18.5),24.0 (±18.5),184.6% (±167.1%)
Silistra,Male,(5-9),-0.6,0,0.6,0.7,0.8,Not Significant,1.5,-2.1,0.9,-100.0,0.0,-0.6 (±1.5),0.6 (±1.5),-100.0% (±0.0%)
Silistra,Male,(50-54),45.8,83,37.2,11.6,3.2,Significant Increase,22.7,23.1,68.5,81.2,60.0,45.8 (±22.7),37.2 (±22.7),81.2% (±60.0%)
Silistra,Male,(55-59),73.8,120,46.2,14.7,3.1,Significant Increase,28.9,44.9,102.7,62.6,45.8,73.8 (±28.9),46.2 (±28.9),62.6% (±45.8%)
Silistra,Male,(60-64),95.4,130,34.6,18.4,1.9,Not Significant,36.1,59.3,131.5,36.3,37.4,95.4 (±36.1),34.6 (±36.1),36.3% (±37.4%)
Silistra,Male,(65-69),128.8,189,60.2,20.2,3.0,Significant Increase,39.6,89.2,168.4,46.7,34.5,128.8 (±39.6),60.2 (±39.6),46.7% (±34.5%)
Silistra,Male,(70-74),182.4,218,35.6,21.3,1.7,Not Significant,41.7,140.7,224.1,19.5,22.2,182.4 (±41.7),35.6 (±41.7),19.5% (±22.2%)
Silistra,Male,(75-79),236.2,254,17.8,22.1,0.8,Not Significant,43.3,192.9,279.5,7.5,16.6,236.2 (±43.3),17.8 (±43.3),7.5% (±16.6%)
Silistra,Male,(80-84),143.0,181,38.0,20.1,1.9,Not Significant,39.3,103.7,182.3,26.6,27.3,143.0 (±39.3),38.0 (±39.3),26.6% (±27.3%)
Silistra,Male,(85-89),95.8,125,29.2,14.4,2.0,Significant Increase,28.2,67.6,124.0,30.5,29.7,95.8 (±28.2),29.2 (±28.2),30.5% (±29.7%)
Silistra,Male,(90+),33.8,43,9.2,10.8,0.9,Not Significant,21.1,12.7,54.9,27.2,48.9,33.8 (±21.1),9.2 (±21.1),27.2% (±48.9%)
Silistra,Total,(0-4),1.8,10,8.2,4.0,2.1,Significant Increase,7.8,-6.0,9.6,455.6,451.4,1.8 (±7.8),8.2 (±7.8),455.6% (±451.4%)
Silistra,Total,(10-14),0.0,2,2.0,2.0,1.0,Not Significant,4.0,-4.0,4.0,297071215525658.3,297071215525708.3,0.0 (±4.0),2.0 (±4.0),297071215525658.3% (±297071215525708.3%)
Silistra,Total,(15-19),5.6,6,0.4,3.1,0.1,Not Significant,6.0,-0.4,11.6,7.1,55.4,5.6 (±6.0),0.4 (±6.0),7.1% (±55.4%)
Silistra,Total,(20-24),8.6,3,-5.6,3.7,-1.5,Not Significant,7.3,1.3,15.9,-65.1,16.0,8.6 (±7.3),-5.6 (±7.3),-65.1% (±16.0%)
Silistra,Total,(25-29),5.0,7,2.0,3.8,0.5,Not Significant,7.4,-2.4,12.4,40.0,83.5,5.0 (±7.4),2.0 (±7.4),40.0% (±83.5%)
Silistra,Total,(30-34),6.6,12,5.4,3.9,1.4,Not Significant,7.6,-1.0,14.2,81.8,97.3,6.6 (±7.6),5.4 (±7.6),81.8% (±97.3%)
Silistra,Total,(35-39),9.8,16,6.2,6.0,1.0,Not Significant,11.8,-2.0,21.6,63.3,89.2,9.8 (±11.8),6.2 (±11.8),63.3% (±89.2%)
Silistra,Total,(40-44),12.0,26,14.0,8.6,1.6,Not Significant,16.9,-4.9,28.9,116.7,126.7,12.0 (±16.9),14.0 (±16.9),116.7% (±126.7%)
Silistra,Total,(45-49),16.0,57,41.0,11.3,3.6,Significant Increase,22.1,-6.1,38.1,256.3,206.7,16.0 (±22.1),41.0 (±22.1),256.3% (±206.7%)
Silistra,Total,(5-9),-0.0,2,2.0,1.1,1.9,Not Significant,2.1,-2.1,2.1,-477076231713076.2,-477076231713071.4,-0.0 (±2.1),2.0 (±2.1),-477076231713076.2% (±-477076231713071.4%)
Silistra,Total,(50-54),57.6,112,54.4,13.8,3.9,Significant Increase,27.1,30.5,84.7,94.4,62.2,57.6 (±27.1),54.4 (±27.1),94.4% (±62.2%)
Silistra,Total,(55-59),96.8,173,76.2,17.2,4.4,Significant Increase,33.7,63.1,130.5,78.7,46.1,96.8 (±33.7),76.2 (±33.7),78.7% (±46.1%)
Silistra,Total,(60-64),144.0,206,62.0,20.4,3.0,Significant Increase,40.0,104.0,184.0,43.1,31.1,144.0 (±40.0),62.0 (±40.0),43.1% (±31.1%)
Silistra,Total,(65-69),199.2,307,107.8,24.7,4.4,Significant Increase,48.4,150.8,247.6,54.1,30.1,199.2 (±48.4),107.8 (±48.4),54.1% (±30.1%)
Silistra,Total,(70-74),298.0,438,140.0,26.8,5.2,Significant Increase,52.6,245.4,350.6,47.0,22.1,298.0 (±52.6),140.0 (±52.6),47.0% (±22.1%)
Silistra,Total,(75-79),400.6,503,102.4,29.2,3.5,Significant Increase,57.3,343.3,457.9,25.6,15.8,400.6 (±57.3),102.4 (±57.3),25.6% (±15.8%)
Silistra,Total,(80-84),328.0,424,96.0,28.7,3.3,Significant Increase,56.2,271.8,384.2,29.3,18.9,328.0 (±56.2),96.0 (±56.2),29.3% (±18.9%)
Silistra,Total,(85-89),260.8,315,54.2,25.9,2.1,Significant Increase,50.8,210.0,311.6,20.8,19.7,260.8 (±50.8),54.2 (±50.8),20.8% (±19.7%)
Silistra,Total,(90+),124.6,134,9.4,18.8,0.5,Not Significant,36.9,87.7,161.5,7.5,24.5,124.6 (±36.9),9.4 (±36.9),7.5% (±24.5%)
Sliven,Female,(0-4),18.8,15,-3.8,6.1,-0.6,Not Significant,11.9,6.9,30.7,-20.2,30.9,18.8 (±11.9),-3.8 (±11.9),-20.2% (±30.9%)
Sliven,Female,(10-14),1.0,0,-1.0,1.3,-0.8,Not Significant,2.5,-1.5,3.5,-100.0,0.0,1.0 (±2.5),-1.0 (±2.5),-100.0% (±0.0%)
Sliven,Female,(15-19),6.4,3,-3.4,2.5,-1.4,Not Significant,4.9,1.5,11.3,-53.1,20.4,6.4 (±4.9),-3.4 (±4.9),-53.1% (±20.4%)
Sliven,Female,(20-24),3.0,2,-1.0,2.7,-0.4,Not Significant,5.3,-2.3,8.3,-33.3,42.6,3.0 (±5.3),-1.0 (±5.3),-33.3% (±42.6%)
Sliven,Female,(25-29),4.2,6,1.8,3.4,0.5,Not Significant,6.6,-2.4,10.8,42.9,87.3,4.2 (±6.6),1.8 (±6.6),42.9% (±87.3%)
Sliven,Female,(30-34),6.0,10,4.0,3.8,1.0,Not Significant,7.5,-1.5,13.5,66.7,92.6,6.0 (±7.5),4.0 (±7.5),66.7% (±92.6%)
Sliven,Female,(35-39),11.2,10,-1.2,4.8,-0.2,Not Significant,9.5,1.7,20.7,-10.7,41.0,11.2 (±9.5),-1.2 (±9.5),-10.7% (±41.0%)
Sliven,Female,(40-44),9.2,17,7.8,6.3,1.2,Not Significant,12.4,-3.2,21.6,84.8,106.1,9.2 (±12.4),7.8 (±12.4),84.8% (±106.1%)
Sliven,Female,(45-49),25.0,37,12.0,7.2,1.7,Not Significant,14.0,11.0,39.0,48.0,53.1,25.0 (±14.0),12.0 (±14.0),48.0% (±53.1%)
Sliven,Female,(5-9),1.4,2,0.6,1.7,0.4,Not Significant,3.3,-1.9,4.7,42.9,100.3,1.4 (±3.3),0.6 (±3.3),42.9% (±100.3%)
Sliven,Female,(50-54),25.8,43,17.2,9.4,1.8,Not Significant,18.5,7.3,44.3,66.7,69.6,25.8 (±18.5),17.2 (±18.5),66.7% (±69.6%)
Sliven,Female,(55-59),54.2,68,13.8,13.6,1.0,Not Significant,26.6,27.6,80.8,25.5,41.3,54.2 (±26.6),13.8 (±26.6),25.5% (±41.3%)
Sliven,Female,(60-64),72.2,115,42.8,14.4,3.0,Significant Increase,28.3,43.9,100.5,59.3,44.9,72.2 (±28.3),42.8 (±28.3),59.3% (±44.9%)
Sliven,Female,(65-69),108.6,177,68.4,18.3,3.7,Significant Increase,35.9,72.7,144.5,63.0,40.5,108.6 (±35.9),68.4 (±35.9),63.0% (±40.5%)
Sliven,Female,(70-74),169.0,232,63.0,19.7,3.2,Significant Increase,38.7,130.3,207.7,37.3,25.6,169.0 (±38.7),63.0 (±38.7),37.3% (±25.6%)
Sliven,Female,(75-79),160.2,261,100.8,21.7,4.6,Significant Increase,42.6,117.6,202.8,62.9,34.2,160.2 (±42.6),100.8 (±42.6),62.9% (±34.2%)
Sliven,Female,(80-84),262.2,342,79.8,28.9,2.8,Significant Increase,56.7,205.5,318.9,30.4,23.2,262.2 (±56.7),79.8 (±56.7),30.4% (±23.2%)
Sliven,Female,(85-89),251.6,323,71.4,27.7,2.6,Significant Increase,54.3,197.3,305.9,28.4,22.8,251.6 (±54.3),71.4 (±54.3),28.4% (±22.8%)
Sliven,Female,(90+),143.4,161,17.6,20.2,0.9,Not Significant,39.7,103.7,183.1,12.3,24.4,143.4 (±39.7),17.6 (±39.7),12.3% (±24.4%)
Sliven,Male,(0-4),13.4,21,7.6,7.6,1.0,Not Significant,15.0,-1.6,28.4,56.7,82.8,13.4 (±15.0),7.6 (±15.0),56.7% (±82.8%)
Sliven,Male,(10-14),2.0,0,-2.0,2.4,-0.8,Not Significant,4.6,-2.6,6.6,-100.0,0.0,2.0 (±4.6),-2.0 (±4.6),-100.0% (±0.0%)
Sliven,Male,(15-19),4.4,2,-2.4,3.6,-0.7,Not Significant,7.1,-2.7,11.5,-54.5,28.1,4.4 (±7.1),-2.4 (±7.1),-54.5% (±28.1%)
Sliven,Male,(20-24),3.8,4,0.2,3.7,0.1,Not Significant,7.2,-3.4,11.0,5.3,68.9,3.8 (±7.2),0.2 (±7.2),5.3% (±68.9%)
Sliven,Male,(25-29),3.8,11,7.2,4.4,1.6,Not Significant,8.7,-4.9,12.5,189.5,201.5,3.8 (±8.7),7.2 (±8.7),189.5% (±201.5%)
Sliven,Male,(30-34),9.6,16,6.4,5.6,1.1,Not Significant,11.0,-1.4,20.6,66.7,89.0,9.6 (±11.0),6.4 (±11.0),66.7% (±89.0%)
Sliven,Male,(35-39),24.0,20,-4.0,7.0,-0.6,Not Significant,13.7,10.3,37.7,-16.7,30.2,24.0 (±13.7),-4.0 (±13.7),-16.7% (±30.2%)
Sliven,Male,(40-44),35.8,36,0.2,9.3,0.0,Not Significant,18.3,17.5,54.1,0.6,34.1,35.8 (±18.3),0.2 (±18.3),0.6% (±34.1%)
Sliven,Male,(45-49),54.0,50,-4.0,10.6,-0.4,Not Significant,20.8,33.2,74.8,-7.4,25.8,54.0 (±20.8),-4.0 (±20.8),-7.4% (±25.8%)
Sliven,Male,(5-9),1.4,2,0.6,2.3,0.3,Not Significant,4.4,-3.0,5.8,42.9,108.4,1.4 (±4.4),0.6 (±4.4),42.9% (±108.4%)
Sliven,Male,(50-54),68.8,79,10.2,13.9,0.7,Not Significant,27.3,41.5,96.1,14.8,32.6,68.8 (±27.3),10.2 (±27.3),14.8% (±32.6%)
Sliven,Male,(55-59),104.6,123,18.4,17.4,1.1,Not Significant,34.1,70.5,138.7,17.6,28.9,104.6 (±34.1),18.4 (±34.1),17.6% (±28.9%)
Sliven,Male,(60-64),176.4,205,28.6,22.8,1.3,Not Significant,44.6,131.8,221.0,16.2,23.4,176.4 (±44.6),28.6 (±44.6),16.2% (±23.4%)
Sliven,Male,(65-69),189.8,267,77.2,24.2,3.2,Significant Increase,47.4,142.4,237.2,40.7,28.1,189.8 (±47.4),77.2 (±47.4),40.7% (±28.1%)
Sliven,Male,(70-74),245.6,328,82.4,24.3,3.4,Significant Increase,47.6,198.0,293.2,33.6,21.7,245.6 (±47.6),82.4 (±47.6),33.6% (±21.7%)
Sliven,Male,(75-79),190.0,277,87.0,23.5,3.7,Significant Increase,46.1,143.9,236.1,45.8,28.5,190.0 (±46.1),87.0 (±46.1),45.8% (±28.5%)
Sliven,Male,(80-84),184.0,236,52.0,24.3,2.1,Significant Increase,47.7,136.3,231.7,28.3,26.4,184.0 (±47.7),52.0 (±47.7),28.3% (±26.4%)
Sliven,Male,(85-89),166.2,205,38.8,20.1,1.9,Not Significant,39.4,126.8,205.6,23.3,23.6,166.2 (±39.4),38.8 (±39.4),23.3% (±23.6%)
Sliven,Male,(90+),81.4,117,35.6,14.3,2.5,Significant Increase,28.0,53.4,109.4,43.7,36.8,81.4 (±28.0),35.6 (±28.0),43.7% (±36.8%)
Sliven,Total,(0-4),32.2,36,3.8,9.9,0.4,Not Significant,19.5,12.7,51.7,11.8,42.2,32.2 (±19.5),3.8 (±19.5),11.8% (±42.2%)
Sliven,Total,(10-14),3.0,0,-3.0,2.7,-1.1,Not Significant,5.2,-2.2,8.2,-100.0,0.0,3.0 (±5.2),-3.0 (±5.2),-100.0% (±0.0%)
Sliven,Total,(15-19),10.8,5,-5.8,4.5,-1.3,Not Significant,8.9,1.9,19.7,-53.7,20.9,10.8 (±8.9),-5.8 (±8.9),-53.7% (±20.9%)
Sliven,Total,(20-24),6.8,6,-0.8,4.4,-0.2,Not Significant,8.6,-1.8,15.4,-11.8,49.2,6.8 (±8.6),-0.8 (±8.6),-11.8% (±49.2%)
Sliven,Total,(25-29),8.0,17,9.0,5.5,1.6,Not Significant,10.7,-2.7,18.7,112.5,121.6,8.0 (±10.7),9.0 (±10.7),112.5% (±121.6%)
Sliven,Total,(30-34),15.6,26,10.4,6.9,1.5,Not Significant,13.6,2.0,29.2,66.7,77.7,15.6 (±13.6),10.4 (±13.6),66.7% (±77.7%)
Sliven,Total,(35-39),35.2,30,-5.2,8.3,-0.6,Not Significant,16.3,18.9,51.5,-14.8,26.9,35.2 (±16.3),-5.2 (±16.3),-14.8% (±26.9%)
Sliven,Total,(40-44),45.0,53,8.0,11.0,0.7,Not Significant,21.5,23.5,66.5,17.8,38.1,45.0 (±21.5),8.0 (±21.5),17.8% (±38.1%)
Sliven,Total,(45-49),79.0,87,8.0,13.1,0.6,Not Significant,25.6,53.4,104.6,10.1,26.9,79.0 (±25.6),8.0 (±25.6),10.1% (±26.9%)
Sliven,Total,(5-9),2.8,4,1.2,3.0,0.4,Not Significant,5.8,-3.0,8.6,42.9,96.4,2.8 (±5.8),1.2 (±5.8),42.9% (±96.4%)
Sliven,Total,(50-54),94.6,122,27.4,16.1,1.7,Not Significant,31.5,63.1,126.1,29.0,32.3,94.6 (±31.5),27.4 (±31.5),29.0% (±32.3%)
Sliven,Total,(55-59),158.8,191,32.2,21.6,1.5,Not Significant,42.3,116.5,201.1,20.3,25.3,158.8 (±42.3),32.2 (±42.3),20.3% (±25.3%)
Sliven,Total,(60-64),248.6,320,71.4,27.0,2.6,Significant Increase,52.8,195.8,301.4,28.7,22.5,248.6 (±52.8),71.4 (±52.8),28.7% (±22.5%)
Sliven,Total,(65-69),298.4,444,145.6,31.0,4.7,Significant Increase,60.7,237.7,359.1,48.8,25.2,298.4 (±60.7),145.6 (±60.7),48.8% (±25.2%)
Sliven,Total,(70-74),414.6,560,145.4,31.0,4.7,Significant Increase,60.7,353.9,475.3,35.1,17.3,414.6 (±60.7),145.4 (±60.7),35.1% (±17.3%)
Sliven,Total,(75-79),350.2,538,187.8,33.0,5.7,Significant Increase,64.6,285.6,414.8,53.6,23.9,350.2 (±64.6),187.8 (±64.6),53.6% (±23.9%)
Sliven,Total,(80-84),446.2,578,131.8,37.5,3.5,Significant Increase,73.5,372.7,519.7,29.5,18.3,446.2 (±73.5),131.8 (±73.5),29.5% (±18.3%)
Sliven,Total,(85-89),417.8,528,110.2,34.5,3.2,Significant Increase,67.6,350.2,485.4,26.4,17.6,417.8 (±67.6),110.2 (±67.6),26.4% (±17.6%)
Sliven,Total,(90+),224.8,278,53.2,25.6,2.1,Significant Increase,50.2,174.6,275.0,23.7,22.6,224.8 (±50.2),53.2 (±50.2),23.7% (±22.6%)
Smolyan,Female,(0-4),-1.4,4,5.4,2.0,2.7,Significant Increase,3.9,-5.3,2.5,-385.7,-445.7,-1.4 (±3.9),5.4 (±3.9),-385.7% (±-445.7%)
Smolyan,Female,(10-14),0.4,0,-0.4,1.1,-0.4,Not Significant,2.1,-1.7,2.5,-100.0,0.0,0.4 (±2.1),-0.4 (±2.1),-100.0% (±0.0%)
Smolyan,Female,(15-19),-0.4,0,0.4,1.1,0.4,Not Significant,2.1,-2.5,1.7,-100.0,0.0,-0.4 (±2.1),0.4 (±2.1),-100.0% (±0.0%)
Smolyan,Female,(20-24),-1.6,1,2.6,1.5,1.8,Not Significant,2.9,-4.5,1.3,-162.5,-139.4,-1.6 (±2.9),2.6 (±2.9),-162.5% (±-139.4%)
Smolyan,Female,(25-29),-0.2,1,1.2,1.6,0.8,Not Significant,3.1,-3.3,2.9,-600.0,-534.5,-0.2 (±3.1),1.2 (±3.1),-600.0% (±-534.5%)
Smolyan,Female,(30-34),2.8,3,0.2,2.3,0.1,Not Significant,4.5,-1.7,7.3,7.1,66.0,2.8 (±4.5),0.2 (±4.5),7.1% (±66.0%)
Smolyan,Female,(35-39),3.4,2,-1.4,3.7,-0.4,Not Significant,7.3,-3.9,10.7,-41.2,40.1,3.4 (±7.3),-1.4 (±7.3),-41.2% (±40.1%)
Smolyan,Female,(40-44),4.2,6,1.8,3.6,0.5,Not Significant,7.1,-2.9,11.3,42.9,89.8,4.2 (±7.1),1.8 (±7.1),42.9% (±89.8%)
Smolyan,Female,(45-49),9.0,17,8.0,5.3,1.5,Not Significant,10.4,-1.4,19.4,88.9,101.3,9.0 (±10.4),8.0 (±10.4),88.9% (±101.3%)
Smolyan,Female,(5-9),1.0,0,-1.0,0.7,-1.3,Not Significant,1.5,-0.5,2.5,-100.0,0.0,1.0 (±1.5),-1.0 (±1.5),-100.0% (±0.0%)
Smolyan,Female,(50-54),22.4,22,-0.4,6.6,-0.1,Not Significant,13.0,9.4,35.4,-1.8,36.1,22.4 (±13.0),-0.4 (±13.0),-1.8% (±36.1%)
Smolyan,Female,(55-59),14.0,30,16.0,8.5,1.9,Not Significant,16.7,-2.7,30.7,114.3,116.6,14.0 (±16.7),16.0 (±16.7),114.3% (±116.6%)
Smolyan,Female,(60-64),42.0,42,-0.0,10.3,-0.0,Not Significant,20.2,21.8,62.2,-0.0,32.5,42.0 (±20.2),-0.0 (±20.2),-0.0% (±32.5%)
Smolyan,Female,(65-69),51.6,105,53.4,11.8,4.5,Significant Increase,23.1,28.5,74.7,103.5,62.9,51.6 (±23.1),53.4 (±23.1),103.5% (±62.9%)
Smolyan,Female,(70-74),85.0,154,69.0,15.4,4.5,Significant Increase,30.2,54.8,115.2,81.2,47.5,85.0 (±30.2),69.0 (±30.2),81.2% (±47.5%)
Smolyan,Female,(75-79),108.8,174,65.2,19.1,3.4,Significant Increase,37.5,71.3,146.3,59.9,41.0,108.8 (±37.5),65.2 (±37.5),59.9% (±41.0%)
Smolyan,Female,(80-84),165.2,235,69.8,22.0,3.2,Significant Increase,43.1,122.1,208.3,42.3,29.5,165.2 (±43.1),69.8 (±43.1),42.3% (±29.5%)
Smolyan,Female,(85-89),164.2,200,35.8,21.1,1.7,Not Significant,41.3,122.9,205.5,21.8,24.5,164.2 (±41.3),35.8 (±41.3),21.8% (±24.5%)
Smolyan,Female,(90+),101.2,133,31.8,17.6,1.8,Not Significant,34.4,66.8,135.6,31.4,33.3,101.2 (±34.4),31.8 (±34.4),31.4% (±33.3%)
Smolyan,Male,(0-4),0.8,2,1.2,2.5,0.5,Not Significant,5.0,-4.2,5.8,150.0,215.5,0.8 (±5.0),1.2 (±5.0),150.0% (±215.5%)
Smolyan,Male,(10-14),1.8,0,-1.8,1.7,-1.1,Not Significant,3.3,-1.5,5.1,-100.0,0.0,1.8 (±3.3),-1.8 (±3.3),-100.0% (±0.0%)
Smolyan,Male,(15-19),1.0,0,-1.0,1.6,-0.6,Not Significant,3.1,-2.1,4.1,-100.0,0.0,1.0 (±3.1),-1.0 (±3.1),-100.0% (±0.0%)
Smolyan,Male,(20-24),1.8,3,1.2,2.0,0.6,Not Significant,3.9,-2.1,5.7,66.7,114.1,1.8 (±3.9),1.2 (±3.9),66.7% (±114.1%)
Smolyan,Male,(25-29),6.8,1,-5.8,3.7,-1.6,Not Significant,7.2,-0.4,14.0,-85.3,7.6,6.8 (±7.2),-5.8 (±7.2),-85.3% (±7.6%)
Smolyan,Male,(30-34),0.8,6,5.2,3.5,1.5,Not Significant,6.8,-6.0,7.6,650.0,671.1,0.8 (±6.8),5.2 (±6.8),650.0% (±671.1%)
Smolyan,Male,(35-39),5.6,7,1.4,4.7,0.3,Not Significant,9.2,-3.6,14.8,25.0,77.7,5.6 (±9.2),1.4 (±9.2),25.0% (±77.7%)
Smolyan,Male,(40-44),7.6,14,6.4,5.9,1.1,Not Significant,11.5,-3.9,19.1,84.2,110.9,7.6 (±11.5),6.4 (±11.5),84.2% (±110.9%)
Smolyan,Male,(45-49),27.8,27,-0.8,8.0,-0.1,Not Significant,15.7,12.1,43.5,-2.9,35.0,27.8 (±15.7),-0.8 (±15.7),-2.9% (±35.0%)
Smolyan,Male,(5-9),0.0,0,0.0,0.0,,Undetermined,0.0,0.0,0.0,0.0,,0.0 (±0.0),0.0 (±0.0),0.0% (±nan%)
Smolyan,Male,(50-54),34.8,54,19.2,10.6,1.8,Not Significant,20.7,14.1,55.5,55.2,57.9,34.8 (±20.7),19.2 (±20.7),55.2% (±57.9%)
Smolyan,Male,(55-59),78.4,73,-5.4,13.5,-0.4,Not Significant,26.5,51.9,104.9,-6.9,23.5,78.4 (±26.5),-5.4 (±26.5),-6.9% (±23.5%)
Smolyan,Male,(60-64),98.8,132,33.2,16.9,2.0,Significant Increase,33.1,65.7,131.9,33.6,33.5,98.8 (±33.1),33.2 (±33.1),33.6% (±33.5%)
Smolyan,Male,(65-69),133.0,144,11.0,18.8,0.6,Not Significant,36.9,96.1,169.9,8.3,23.5,133.0 (±36.9),11.0 (±36.9),8.3% (±23.5%)
Smolyan,Male,(70-74),149.4,218,68.6,16.6,4.1,Significant Increase,32.4,117.0,181.8,45.9,26.0,149.4 (±32.4),68.6 (±32.4),45.9% (±26.0%)
Smolyan,Male,(75-79),131.0,195,64.0,21.2,3.0,Significant Increase,41.5,89.5,172.5,48.9,35.9,131.0 (±41.5),64.0 (±41.5),48.9% (±35.9%)
Smolyan,Male,(80-84),118.4,149,30.6,18.5,1.7,Not Significant,36.2,82.2,154.6,25.8,29.4,118.4 (±36.2),30.6 (±36.2),25.8% (±29.4%)
Smolyan,Male,(85-89),101.8,124,22.2,16.5,1.3,Not Significant,32.3,69.5,134.1,21.8,29.3,101.8 (±32.3),22.2 (±32.3),21.8% (±29.3%)
Smolyan,Male,(90+),47.8,52,4.2,10.4,0.4,Not Significant,20.3,27.5,68.1,8.8,32.4,47.8 (±20.3),4.2 (±20.3),8.8% (±32.4%)
Smolyan,Total,(0-4),-0.6,6,6.6,3.2,2.1,Significant Increase,6.3,-6.9,5.7,-1100.0,-1105.3,-0.6 (±6.3),6.6 (±6.3),-1100.0% (±-1105.3%)
Smolyan,Total,(10-14),2.2,0,-2.2,2.0,-1.1,Not Significant,3.9,-1.7,6.1,-100.0,0.0,2.2 (±3.9),-2.2 (±3.9),-100.0% (±0.0%)
Smolyan,Total,(15-19),0.6,0,-0.6,1.9,-0.3,Not Significant,3.7,-3.1,4.3,-100.0,0.0,0.6 (±3.7),-0.6 (±3.7),-100.0% (±0.0%)
Smolyan,Total,(20-24),0.2,4,3.8,2.5,1.5,Not Significant,4.9,-4.7,5.1,1900.0,1921.6,0.2 (±4.9),3.8 (±4.9),1900.0% (±1921.6%)
Smolyan,Total,(25-29),6.6,2,-4.6,3.9,-1.2,Not Significant,7.7,-1.1,14.3,-69.7,16.3,6.6 (±7.7),-4.6 (±7.7),-69.7% (±16.3%)
Smolyan,Total,(30-34),3.6,9,5.4,4.2,1.3,Not Significant,8.2,-4.6,11.8,150.0,173.7,3.6 (±8.2),5.4 (±8.2),150.0% (±173.7%)
Smolyan,Total,(35-39),9.0,9,0.0,5.9,0.0,Not Significant,11.7,-2.7,20.7,0.0,56.5,9.0 (±11.7),0.0 (±11.7),0.0% (±56.5%)
Smolyan,Total,(40-44),11.8,20,8.2,6.9,1.2,Not Significant,13.4,-1.6,25.2,69.5,90.1,11.8 (±13.4),8.2 (±13.4),69.5% (±90.1%)
Smolyan,Total,(45-49),36.8,44,7.2,9.7,0.7,Not Significant,19.1,17.7,55.9,19.6,40.9,36.8 (±19.1),7.2 (±19.1),19.6% (±40.9%)
Smolyan,Total,(5-9),1.0,0,-1.0,0.7,-1.3,Not Significant,1.5,-0.5,2.5,-100.0,0.0,1.0 (±1.5),-1.0 (±1.5),-100.0% (±0.0%)
Smolyan,Total,(50-54),57.2,76,18.8,12.9,1.5,Not Significant,25.3,31.9,82.5,32.9,40.8,57.2 (±25.3),18.8 (±25.3),32.9% (±40.8%)
Smolyan,Total,(55-59),92.4,103,10.6,15.6,0.7,Not Significant,30.6,61.8,123.0,11.5,27.8,92.4 (±30.6),10.6 (±30.6),11.5% (±27.8%)
Smolyan,Total,(60-64),140.8,174,33.2,20.3,1.6,Not Significant,39.8,101.0,180.6,23.6,27.3,140.8 (±39.8),33.2 (±39.8),23.6% (±27.3%)
Smolyan,Total,(65-69),184.6,249,64.4,22.5,2.9,Significant Increase,44.1,140.5,228.7,34.9,26.0,184.6 (±44.1),64.4 (±44.1),34.9% (±26.0%)
Smolyan,Total,(70-74),234.4,372,137.6,23.1,6.0,Significant Increase,45.3,189.1,279.7,58.7,25.7,234.4 (±45.3),137.6 (±45.3),58.7% (±25.7%)
Smolyan,Total,(75-79),239.8,369,129.2,29.0,4.5,Significant Increase,56.8,183.0,296.6,53.9,29.5,239.8 (±56.8),129.2 (±56.8),53.9% (±29.5%)
Smolyan,Total,(80-84),283.6,384,100.4,27.1,3.7,Significant Increase,53.1,230.5,336.7,35.4,21.4,283.6 (±53.1),100.4 (±53.1),35.4% (±21.4%)
Smolyan,Total,(85-89),266.0,324,58.0,28.5,2.0,Significant Increase,55.9,210.1,321.9,21.8,21.1,266.0 (±55.9),58.0 (±55.9),21.8% (±21.1%)
Smolyan,Total,(90+),149.0,185,36.0,21.0,1.7,Not Significant,41.1,107.9,190.1,24.2,26.9,149.0 (±41.1),36.0 (±41.1),24.2% (±26.9%)
Sofia,Female,(0-4),6.8,8,1.2,4.7,0.3,Not Significant,9.2,-2.4,16.0,17.6,67.6,6.8 (±9.2),1.2 (±9.2),17.6% (±67.6%)
Sofia,Female,(10-14),3.6,0,-3.6,2.1,-1.7,Not Significant,4.1,-0.5,7.7,-100.0,0.0,3.6 (±4.1),-3.6 (±4.1),-100.0% (±0.0%)
Sofia,Female,(15-19),2.6,3,0.4,1.7,0.2,Not Significant,3.3,-0.7,5.9,15.4,64.6,2.6 (±3.3),0.4 (±3.3),15.4% (±64.6%)
Sofia,Female,(20-24),-2.0,1,3.0,1.8,1.7,Not Significant,3.6,-5.6,1.6,-150.0,-112.5,-2.0 (±3.6),3.0 (±3.6),-150.0% (±-112.5%)
Sofia,Female,(25-29),2.4,5,2.6,2.1,1.3,Not Significant,4.0,-1.6,6.4,108.3,130.2,2.4 (±4.0),2.6 (±4.0),108.3% (±130.2%)
Sofia,Female,(30-34),2.0,7,5.0,3.8,1.3,Not Significant,7.5,-5.5,9.5,250.0,276.3,2.0 (±7.5),5.0 (±7.5),250.0% (±276.3%)
Sofia,Female,(35-39),7.0,11,4.0,4.9,0.8,Not Significant,9.6,-2.6,16.6,57.1,90.8,7.0 (±9.6),4.0 (±9.6),57.1% (±90.8%)
Sofia,Female,(40-44),16.6,20,3.4,6.3,0.5,Not Significant,12.4,4.2,29.0,20.5,51.5,16.6 (±12.4),3.4 (±12.4),20.5% (±51.5%)
Sofia,Female,(45-49),24.2,36,11.8,8.9,1.3,Not Significant,17.5,6.7,41.7,48.8,62.5,24.2 (±17.5),11.8 (±17.5),48.8% (±62.5%)
Sofia,Female,(5-9),-0.0,1,1.0,1.1,0.9,Not Significant,2.1,-2.1,2.1,-83092244047526.1,-83092244047473.7,-0.0 (±2.1),1.0 (±2.1),-83092244047526.1% (±-83092244047473.7%)
Sofia,Female,(50-54),30.6,71,40.4,10.4,3.9,Significant Increase,20.4,10.2,51.0,132.0,92.8,30.6 (±20.4),40.4 (±20.4),132.0% (±92.8%)
Sofia,Female,(55-59),72.0,74,2.0,15.1,0.1,Not Significant,29.7,42.3,101.7,2.8,30.0,72.0 (±29.7),2.0 (±29.7),2.8% (±30.0%)
Sofia,Female,(60-64),87.6,150,62.4,15.2,4.1,Significant Increase,29.7,57.9,117.3,71.2,43.3,87.6 (±29.7),62.4 (±29.7),71.2% (±43.3%)
Sofia,Female,(65-69),139.4,224,84.6,20.5,4.1,Significant Increase,40.2,99.2,179.6,60.7,36.0,139.4 (±40.2),84.6 (±40.2),60.7% (±36.0%)
Sofia,Female,(70-74),250.8,380,129.2,24.7,5.2,Significant Increase,48.4,202.4,299.2,51.5,24.5,250.8 (±48.4),129.2 (±48.4),51.5% (±24.5%)
Sofia,Female,(75-79),253.6,414,160.4,30.1,5.3,Significant Increase,59.0,194.6,312.6,63.2,30.8,253.6 (±59.0),160.4 (±59.0),63.2% (±30.8%)
Sofia,Female,(80-84),359.8,507,147.2,33.8,4.4,Significant Increase,66.3,293.5,426.1,40.9,21.9,359.8 (±66.3),147.2 (±66.3),40.9% (±21.9%)
Sofia,Female,(85-89),439.4,513,73.6,37.1,2.0,Significant Increase,72.7,366.7,512.1,16.8,16.6,439.4 (±72.7),73.6 (±72.7),16.8% (±16.6%)
Sofia,Female,(90+),263.6,341,77.4,25.8,3.0,Significant Increase,50.7,212.9,314.3,29.4,20.9,263.6 (±50.7),77.4 (±50.7),29.4% (±20.9%)
Sofia,Male,(0-4),4.2,6,1.8,5.2,0.3,Not Significant,10.3,-6.1,14.5,42.9,101.5,4.2 (±10.3),1.8 (±10.3),42.9% (±101.5%)
Sofia,Male,(10-14),2.2,1,-1.2,1.7,-0.7,Not Significant,3.3,-1.1,5.5,-54.5,27.3,2.2 (±3.3),-1.2 (±3.3),-54.5% (±27.3%)
Sofia,Male,(15-19),3.0,4,1.0,3.9,0.3,Not Significant,7.6,-4.6,10.6,33.3,95.6,3.0 (±7.6),1.0 (±7.6),33.3% (±95.6%)
Sofia,Male,(20-24),12.0,7,-5.0,3.3,-1.5,Not Significant,6.5,5.5,18.5,-41.7,20.5,12.0 (±6.5),-5.0 (±6.5),-41.7% (±20.5%)
Sofia,Male,(25-29),11.2,9,-2.2,5.6,-0.4,Not Significant,10.9,0.3,22.1,-19.6,39.7,11.2 (±10.9),-2.2 (±10.9),-19.6% (±39.7%)
Sofia,Male,(30-34),8.6,14,5.4,6.5,0.8,Not Significant,12.7,-4.1,21.3,62.8,97.1,8.6 (±12.7),5.4 (±12.7),62.8% (±97.1%)
Sofia,Male,(35-39),20.4,23,2.6,7.5,0.3,Not Significant,14.7,5.7,35.1,12.7,47.2,20.4 (±14.7),2.6 (±14.7),12.7% (±47.2%)
Sofia,Male,(40-44),38.0,56,18.0,10.5,1.7,Not Significant,20.5,17.5,58.5,47.4,51.7,38.0 (±20.5),18.0 (±20.5),47.4% (±51.7%)
Sofia,Male,(45-49),56.8,78,21.2,12.1,1.7,Not Significant,23.8,33.0,80.6,37.3,40.5,56.8 (±23.8),21.2 (±23.8),37.3% (±40.5%)
Sofia,Male,(5-9),-1.0,1,2.0,1.7,1.2,Not Significant,3.3,-4.3,2.3,-200.0,-143.5,-1.0 (±3.3),2.0 (±3.3),-200.0% (±-143.5%)
Sofia,Male,(50-54),90.6,125,34.4,16.6,2.1,Significant Increase,32.5,58.1,123.1,38.0,36.5,90.6 (±32.5),34.4 (±32.5),38.0% (±36.5%)
Sofia,Male,(55-59),123.6,195,71.4,19.9,3.6,Significant Increase,38.9,84.7,162.5,57.8,37.8,123.6 (±38.9),71.4 (±38.9),57.8% (±37.8%)
Sofia,Male,(60-64),228.2,287,58.8,25.6,2.3,Significant Increase,50.2,178.0,278.4,25.8,22.7,228.2 (±50.2),58.8 (±50.2),25.8% (±22.7%)
Sofia,Male,(65-69),278.4,388,109.6,28.3,3.9,Significant Increase,55.5,222.9,333.9,39.4,23.2,278.4 (±55.5),109.6 (±55.5),39.4% (±23.2%)
Sofia,Male,(70-74),410.8,544,133.2,29.9,4.5,Significant Increase,58.6,352.2,469.4,32.4,16.5,410.8 (±58.6),133.2 (±58.6),32.4% (±16.5%)
Sofia,Male,(75-79),268.8,458,189.2,30.4,6.2,Significant Increase,59.5,209.3,328.3,70.4,30.9,268.8 (±59.5),189.2 (±59.5),70.4% (±30.9%)
Sofia,Male,(80-84),303.6,431,127.4,30.5,4.2,Significant Increase,59.8,243.8,363.4,42.0,23.4,303.6 (±59.8),127.4 (±59.8),42.0% (±23.4%)
Sofia,Male,(85-89),286.4,356,69.6,26.4,2.6,Significant Increase,51.7,234.7,338.1,24.3,19.0,286.4 (±51.7),69.6 (±51.7),24.3% (±19.0%)
Sofia,Male,(90+),136.2,157,20.8,18.8,1.1,Not Significant,36.9,99.3,173.1,15.3,24.6,136.2 (±36.9),20.8 (±36.9),15.3% (±24.6%)
Sofia,Total,(0-4),11.0,14,3.0,7.1,0.4,Not Significant,14.0,-3.0,25.0,27.3,71.3,11.0 (±14.0),3.0 (±14.0),27.3% (±71.3%)
Sofia,Total,(10-14),5.8,1,-4.8,2.6,-1.9,Not Significant,5.1,0.7,10.9,-82.8,8.0,5.8 (±5.1),-4.8 (±5.1),-82.8% (±8.0%)
Sofia,Total,(15-19),5.6,7,1.4,4.1,0.3,Not Significant,8.1,-2.5,13.7,25.0,73.9,5.6 (±8.1),1.4 (±8.1),25.0% (±73.9%)
Sofia,Total,(20-24),10.0,8,-2.0,3.9,-0.5,Not Significant,7.6,2.4,17.6,-20.0,34.5,10.0 (±7.6),-2.0 (±7.6),-20.0% (±34.5%)
Sofia,Total,(25-29),13.6,14,0.4,5.8,0.1,Not Significant,11.3,2.3,24.9,2.9,46.7,13.6 (±11.3),0.4 (±11.3),2.9% (±46.7%)
Sofia,Total,(30-34),10.6,21,10.4,7.6,1.4,Not Significant,14.9,-4.3,25.5,98.1,115.7,10.6 (±14.9),10.4 (±14.9),98.1% (±115.7%)
Sofia,Total,(35-39),27.4,34,6.6,8.9,0.7,Not Significant,17.4,10.0,44.8,24.1,48.2,27.4 (±17.4),6.6 (±17.4),24.1% (±48.2%)
Sofia,Total,(40-44),54.6,76,21.4,12.5,1.7,Not Significant,24.5,30.1,79.1,39.2,43.1,54.6 (±24.5),21.4 (±24.5),39.2% (±43.1%)
Sofia,Total,(45-49),81.0,114,33.0,15.1,2.2,Significant Increase,29.6,51.4,110.6,40.7,37.6,81.0 (±29.6),33.0 (±29.6),40.7% (±37.6%)
Sofia,Total,(5-9),-1.0,2,3.0,2.0,1.5,Not Significant,3.9,-4.9,2.9,-300.0,-269.0,-1.0 (±3.9),3.0 (±3.9),-300.0% (±-269.0%)
Sofia,Total,(50-54),121.2,196,74.8,18.8,4.0,Significant Increase,36.9,84.3,158.1,61.7,37.7,121.2 (±36.9),74.8 (±36.9),61.7% (±37.7%)
Sofia,Total,(55-59),195.6,269,73.4,24.0,3.1,Significant Increase,47.0,148.6,242.6,37.5,26.6,195.6 (±47.0),73.4 (±47.0),37.5% (±26.6%)
Sofia,Total,(60-64),315.8,437,121.2,29.4,4.1,Significant Increase,57.7,258.1,373.5,38.4,21.4,315.8 (±57.7),121.2 (±57.7),38.4% (±21.4%)
Sofia,Total,(65-69),417.8,612,194.2,33.7,5.8,Significant Increase,66.1,351.7,483.9,46.5,20.0,417.8 (±66.1),194.2 (±66.1),46.5% (±20.0%)
Sofia,Total,(70-74),661.6,924,262.4,40.2,6.5,Significant Increase,78.8,582.8,740.4,39.7,14.9,661.6 (±78.8),262.4 (±78.8),39.7% (±14.9%)
Sofia,Total,(75-79),522.4,872,349.6,43.5,8.0,Significant Increase,85.2,437.2,607.6,66.9,23.4,522.4 (±85.2),349.6 (±85.2),66.9% (±23.4%)
Sofia,Total,(80-84),663.4,938,274.6,48.1,5.7,Significant Increase,94.3,569.1,757.7,41.4,17.6,663.4 (±94.3),274.6 (±94.3),41.4% (±17.6%)
Sofia,Total,(85-89),725.8,869,143.2,44.0,3.3,Significant Increase,86.3,639.5,812.1,19.7,12.7,725.8 (±86.3),143.2 (±86.3),19.7% (±12.7%)
Sofia,Total,(90+),399.8,498,98.2,32.2,3.0,Significant Increase,63.2,336.6,463.0,24.6,17.0,399.8 (±63.2),98.2 (±63.2),24.6% (±17.0%)
Sofia (stolitsa),Female,(0-4),16.8,23,6.2,7.8,0.8,Not Significant,15.3,1.5,32.1,36.9,65.2,16.8 (±15.3),6.2 (±15.3),36.9% (±65.2%)
Sofia (stolitsa),Female,(10-14),5.0,8,3.0,2.9,1.0,Not Significant,5.7,-0.7,10.7,60.0,85.2,5.0 (±5.7),3.0 (±5.7),60.0% (±85.2%)
Sofia (stolitsa),Female,(15-19),3.4,3,-0.4,3.9,-0.1,Not Significant,7.7,-4.3,11.1,-11.8,61.2,3.4 (±7.7),-0.4 (±7.7),-11.8% (±61.2%)
Sofia (stolitsa),Female,(20-24),11.4,7,-4.4,5.4,-0.8,Not Significant,10.5,0.9,21.9,-38.6,29.4,11.4 (±10.5),-4.4 (±10.5),-38.6% (±29.4%)
Sofia (stolitsa),Female,(25-29),3.0,13,10.0,6.5,1.5,Not Significant,12.8,-9.8,15.8,333.3,351.0,3.0 (±12.8),10.0 (±12.8),333.3% (±351.0%)
Sofia (stolitsa),Female,(30-34),19.6,28,8.4,8.7,1.0,Not Significant,17.1,2.5,36.7,42.9,66.6,19.6 (±17.1),8.4 (±17.1),42.9% (±66.6%)
Sofia (stolitsa),Female,(35-39),47.4,59,11.6,12.6,0.9,Not Significant,24.7,22.7,72.1,24.5,42.7,47.4 (±24.7),11.6 (±24.7),24.5% (±42.7%)
Sofia (stolitsa),Female,(40-44),85.2,95,9.8,15.3,0.6,Not Significant,30.0,55.2,115.2,11.5,29.0,85.2 (±30.0),9.8 (±30.0),11.5% (±29.0%)
Sofia (stolitsa),Female,(45-49),116.2,155,38.8,18.8,2.1,Significant Increase,36.8,79.4,153.0,33.4,32.1,116.2 (±36.8),38.8 (±36.8),33.4% (±32.1%)
Sofia (stolitsa),Female,(5-9),6.8,5,-1.8,3.4,-0.5,Not Significant,6.7,0.1,13.5,-26.5,36.5,6.8 (±6.7),-1.8 (±6.7),-26.5% (±36.5%)
Sofia (stolitsa),Female,(50-54),125.4,202,76.6,20.5,3.7,Significant Increase,40.2,85.2,165.6,61.1,39.1,125.4 (±40.2),76.6 (±40.2),61.1% (±39.1%)
Sofia (stolitsa),Female,(55-59),224.4,324,99.6,26.6,3.7,Significant Increase,52.1,172.3,276.5,44.4,27.2,224.4 (±52.1),99.6 (±52.1),44.4% (±27.2%)
Sofia (stolitsa),Female,(60-64),415.6,571,155.4,31.6,4.9,Significant Increase,62.0,353.6,477.6,37.4,17.8,415.6 (±62.0),155.4 (±62.0),37.4% (±17.8%)
Sofia (stolitsa),Female,(65-69),688.4,945,256.6,40.9,6.3,Significant Increase,80.1,608.3,768.5,37.3,14.3,688.4 (±80.1),256.6 (±80.1),37.3% (±14.3%)
Sofia (stolitsa),Female,(70-74),966.6,1399,432.4,48.4,8.9,Significant Increase,94.8,871.8,1061.4,44.7,12.9,966.6 (±94.8),432.4 (±94.8),44.7% (±12.9%)
Sofia (stolitsa),Female,(75-79),1006.0,1554,548.0,56.3,9.7,Significant Increase,110.4,895.6,1116.4,54.5,15.3,1006.0 (±110.4),548.0 (±110.4),54.5% (±15.3%)
Sofia (stolitsa),Female,(80-84),1292.2,1826,533.8,73.3,7.3,Significant Increase,143.6,1148.6,1435.8,41.3,14.1,1292.2 (±143.6),533.8 (±143.6),41.3% (±14.1%)
Sofia (stolitsa),Female,(85-89),1559.8,2009,449.2,72.5,6.2,Significant Increase,142.1,1417.7,1701.9,28.8,10.8,1559.8 (±142.1),449.2 (±142.1),28.8% (±10.8%)
Sofia (stolitsa),Female,(90+),1431.0,1736,305.0,65.4,4.7,Significant Increase,128.3,1302.7,1559.3,21.3,10.0,1431.0 (±128.3),305.0 (±128.3),21.3% (±10.0%)
Sofia (stolitsa),Male,(0-4),30.8,30,-0.8,8.3,-0.1,Not Significant,16.2,14.6,47.0,-2.6,33.6,30.8 (±16.2),-0.8 (±16.2),-2.6% (±33.6%)
Sofia (stolitsa),Male,(10-14),4.6,4,-0.6,3.4,-0.2,Not Significant,6.7,-2.1,11.3,-13.0,51.6,4.6 (±6.7),-0.6 (±6.7),-13.0% (±51.6%)
Sofia (stolitsa),Male,(15-19),8.6,15,6.4,5.6,1.1,Not Significant,11.0,-2.4,19.6,74.4,97.9,8.6 (±11.0),6.4 (±11.0),74.4% (±97.9%)
Sofia (stolitsa),Male,(20-24),11.4,34,22.6,7.5,3.0,Significant Increase,14.7,-3.3,26.1,198.2,167.9,11.4 (±14.7),22.6 (±14.7),198.2% (±167.9%)
Sofia (stolitsa),Male,(25-29),33.8,38,4.2,10.6,0.4,Not Significant,20.8,13.0,54.6,12.4,42.8,33.8 (±20.8),4.2 (±20.8),12.4% (±42.8%)
Sofia (stolitsa),Male,(30-34),74.2,75,0.8,13.0,0.1,Not Significant,25.6,48.6,99.8,1.1,25.9,74.2 (±25.6),0.8 (±25.6),1.1% (±25.9%)
Sofia (stolitsa),Male,(35-39),98.2,133,34.8,18.4,1.9,Not Significant,36.0,62.2,134.2,35.4,36.3,98.2 (±36.0),34.8 (±36.0),35.4% (±36.3%)
Sofia (stolitsa),Male,(40-44),187.6,210,22.4,21.8,1.0,Not Significant,42.7,144.9,230.3,11.9,20.7,187.6 (±42.7),22.4 (±42.7),11.9% (±20.7%)
Sofia (stolitsa),Male,(45-49),283.4,371,87.6,25.7,3.4,Significant Increase,50.5,232.9,333.9,30.9,19.8,283.4 (±50.5),87.6 (±50.5),30.9% (±19.8%)
Sofia (stolitsa),Male,(5-9),4.0,3,-1.0,2.9,-0.3,Not Significant,5.7,-1.7,9.7,-25.0,44.1,4.0 (±5.7),-1.0 (±5.7),-25.0% (±44.1%)
Sofia (stolitsa),Male,(50-54),260.4,542,281.6,32.3,8.7,Significant Increase,63.3,197.1,323.7,108.1,40.7,260.4 (±63.3),281.6 (±63.3),108.1% (±40.7%)
Sofia (stolitsa),Male,(55-59),469.2,640,170.8,37.4,4.6,Significant Increase,73.4,395.8,542.6,36.4,18.4,469.2 (±73.4),170.8 (±73.4),36.4% (±18.4%)
Sofia (stolitsa),Male,(60-64),704.0,1013,309.0,47.3,6.5,Significant Increase,92.7,611.3,796.7,43.9,16.8,704.0 (±92.7),309.0 (±92.7),43.9% (±16.8%)
Sofia (stolitsa),Male,(65-69),937.4,1294,356.6,48.8,7.3,Significant Increase,95.7,841.7,1033.1,38.0,12.7,937.4 (±95.7),356.6 (±95.7),38.0% (±12.7%)
Sofia (stolitsa),Male,(70-74),1152.8,1776,623.2,55.7,11.2,Significant Increase,109.1,1043.7,1261.9,54.1,13.4,1152.8 (±109.1),623.2 (±109.1),54.1% (±13.4%)
Sofia (stolitsa),Male,(75-79),984.4,1622,637.6,53.6,11.9,Significant Increase,105.1,879.3,1089.5,64.8,15.9,984.4 (±105.1),637.6 (±105.1),64.8% (±15.9%)
Sofia (stolitsa),Male,(80-84),944.0,1444,500.0,54.0,9.3,Significant Increase,105.8,838.2,1049.8,53.0,15.4,944.0 (±105.8),500.0 (±105.8),53.0% (±15.4%)
Sofia (stolitsa),Male,(85-89),884.6,1218,333.4,54.4,6.1,Significant Increase,106.6,778.0,991.2,37.7,14.8,884.6 (±106.6),333.4 (±106.6),37.7% (±14.8%)
Sofia (stolitsa),Male,(90+),666.0,896,230.0,47.6,4.8,Significant Increase,93.3,572.7,759.3,34.5,16.5,666.0 (±93.3),230.0 (±93.3),34.5% (±16.5%)
Sofia (stolitsa),Total,(0-4),47.6,53,5.4,11.6,0.5,Not Significant,22.7,24.9,70.3,11.3,35.9,47.6 (±22.7),5.4 (±22.7),11.3% (±35.9%)
Sofia (stolitsa),Total,(10-14),9.6,12,2.4,4.3,0.6,Not Significant,8.4,1.2,18.0,25.0,58.3,9.6 (±8.4),2.4 (±8.4),25.0% (±58.3%)
Sofia (stolitsa),Total,(15-19),12.0,18,6.0,7.1,0.8,Not Significant,14.0,-2.0,26.0,50.0,80.8,12.0 (±14.0),6.0 (±14.0),50.0% (±80.8%)
Sofia (stolitsa),Total,(20-24),22.8,41,18.2,10.3,1.8,Not Significant,20.2,2.6,43.0,79.8,84.5,22.8 (±20.2),18.2 (±20.2),79.8% (±84.5%)
Sofia (stolitsa),Total,(25-29),36.8,51,14.2,11.9,1.2,Not Significant,23.4,13.4,60.2,38.6,53.9,36.8 (±23.4),14.2 (±23.4),38.6% (±53.9%)
Sofia (stolitsa),Total,(30-34),93.8,103,9.2,15.9,0.6,Not Significant,31.2,62.6,125.0,9.8,27.4,93.8 (±31.2),9.2 (±31.2),9.8% (±27.4%)
Sofia (stolitsa),Total,(35-39),145.6,192,46.4,23.0,2.0,Significant Increase,45.2,100.4,190.8,31.9,31.3,145.6 (±45.2),46.4 (±45.2),31.9% (±31.3%)
Sofia (stolitsa),Total,(40-44),272.8,305,32.2,27.7,1.2,Not Significant,54.3,218.5,327.1,11.8,18.6,272.8 (±54.3),32.2 (±54.3),11.8% (±18.6%)
Sofia (stolitsa),Total,(45-49),399.6,526,126.4,33.4,3.8,Significant Increase,65.5,334.1,465.1,31.6,18.5,399.6 (±65.5),126.4 (±65.5),31.6% (±18.5%)
Sofia (stolitsa),Total,(5-9),10.8,8,-2.8,4.4,-0.6,Not Significant,8.6,2.2,19.4,-25.9,32.9,10.8 (±8.6),-2.8 (±8.6),-25.9% (±32.9%)
Sofia (stolitsa),Total,(50-54),385.8,744,358.2,37.6,9.5,Significant Increase,73.6,312.2,459.4,92.8,30.8,385.8 (±73.6),358.2 (±73.6),92.8% (±30.8%)
Sofia (stolitsa),Total,(55-59),693.6,964,270.4,46.2,5.8,Significant Increase,90.6,603.0,784.2,39.0,16.1,693.6 (±90.6),270.4 (±90.6),39.0% (±16.1%)
Sofia (stolitsa),Total,(60-64),1119.6,1584,464.4,58.3,8.0,Significant Increase,114.2,1005.4,1233.8,41.5,13.1,1119.6 (±114.2),464.4 (±114.2),41.5% (±13.1%)
Sofia (stolitsa),Total,(65-69),1625.8,2239,613.2,66.0,9.3,Significant Increase,129.4,1496.4,1755.2,37.7,10.1,1625.8 (±129.4),613.2 (±129.4),37.7% (±10.1%)
Sofia (stolitsa),Total,(70-74),2119.4,3175,1055.6,76.4,13.8,Significant Increase,149.7,1969.7,2269.1,49.8,9.9,2119.4 (±149.7),1055.6 (±149.7),49.8% (±9.9%)
Sofia (stolitsa),Total,(75-79),1990.4,3176,1185.6,80.8,14.7,Significant Increase,158.4,1832.0,2148.8,59.6,11.8,1990.4 (±158.4),1185.6 (±158.4),59.6% (±11.8%)
Sofia (stolitsa),Total,(80-84),2236.2,3270,1033.8,96.7,10.7,Significant Increase,189.6,2046.6,2425.8,46.2,11.4,2236.2 (±189.6),1033.8 (±189.6),46.2% (±11.4%)
Sofia (stolitsa),Total,(85-89),2444.4,3227,782.6,95.1,8.2,Significant Increase,186.4,2258.0,2630.8,32.0,9.3,2444.4 (±186.4),782.6 (±186.4),32.0% (±9.3%)
Sofia (stolitsa),Total,(90+),2097.0,2632,535.0,82.5,6.5,Significant Increase,161.7,1935.3,2258.7,25.5,9.0,2097.0 (±161.7),535.0 (±161.7),25.5% (±9.0%)
Stara Zagora,Female,(0-4),16.4,18,1.6,6.8,0.2,Not Significant,13.3,3.1,29.7,9.8,49.2,16.4 (±13.3),1.6 (±13.3),9.8% (±49.2%)
Stara Zagora,Female,(10-14),1.2,1,-0.2,1.1,-0.2,Not Significant,2.1,-0.9,3.3,-16.7,53.0,1.2 (±2.1),-0.2 (±2.1),-16.7% (±53.0%)
Stara Zagora,Female,(15-19),3.4,3,-0.4,2.4,-0.2,Not Significant,4.8,-1.4,8.2,-11.8,51.6,3.4 (±4.8),-0.4 (±4.8),-11.8% (±51.6%)
Stara Zagora,Female,(20-24),5.4,2,-3.4,2.9,-1.2,Not Significant,5.8,-0.4,11.2,-63.0,19.1,5.4 (±5.8),-3.4 (±5.8),-63.0% (±19.1%)
Stara Zagora,Female,(25-29),3.6,10,6.4,3.3,2.0,Not Significant,6.4,-2.8,10.0,177.8,177.8,3.6 (±6.4),6.4 (±6.4),177.8% (±177.8%)
Stara Zagora,Female,(30-34),10.0,10,0.0,4.4,0.0,Not Significant,8.6,1.4,18.6,0.0,46.2,10.0 (±8.6),0.0 (±8.6),0.0% (±46.2%)
Stara Zagora,Female,(35-39),5.2,17,11.8,5.5,2.1,Significant Increase,10.8,-5.6,16.0,226.9,220.6,5.2 (±10.8),11.8 (±10.8),226.9% (±220.6%)
Stara Zagora,Female,(40-44),22.0,27,5.0,7.2,0.7,Not Significant,14.0,8.0,36.0,22.7,47.7,22.0 (±14.0),5.0 (±14.0),22.7% (±47.7%)
Stara Zagora,Female,(45-49),19.8,40,20.2,9.5,2.1,Significant Increase,18.6,1.2,38.4,102.0,97.8,19.8 (±18.6),20.2 (±18.6),102.0% (±97.8%)
Stara Zagora,Female,(5-9),1.6,2,0.4,1.4,0.3,Not Significant,2.7,-1.1,4.3,25.0,78.5,1.6 (±2.7),0.4 (±2.7),25.0% (±78.5%)
Stara Zagora,Female,(50-54),52.2,64,11.8,11.8,1.0,Not Significant,23.2,29.0,75.4,22.6,37.7,52.2 (±23.2),11.8 (±23.2),22.6% (±37.7%)
Stara Zagora,Female,(55-59),56.2,114,57.8,14.1,4.1,Significant Increase,27.7,28.5,83.9,102.8,66.9,56.2 (±27.7),57.8 (±27.7),102.8% (±66.9%)
Stara Zagora,Female,(60-64),117.0,212,95.0,20.0,4.8,Significant Increase,39.1,77.9,156.1,81.2,45.4,117.0 (±39.1),95.0 (±39.1),81.2% (±45.4%)
Stara Zagora,Female,(65-69),211.8,271,59.2,23.0,2.6,Significant Increase,45.1,166.7,256.9,28.0,22.5,211.8 (±45.1),59.2 (±45.1),28.0% (±22.5%)
Stara Zagora,Female,(70-74),269.0,431,162.0,26.1,6.2,Significant Increase,51.2,217.8,320.2,60.2,25.6,269.0 (±51.2),162.0 (±51.2),60.2% (±25.6%)
Stara Zagora,Female,(75-79),337.8,542,204.2,33.9,6.0,Significant Increase,66.4,271.4,404.2,60.4,26.3,337.8 (±66.4),204.2 (±66.4),60.4% (±26.3%)
Stara Zagora,Female,(80-84),494.2,644,149.8,41.8,3.6,Significant Increase,81.9,412.3,576.1,30.3,18.5,494.2 (±81.9),149.8 (±81.9),30.3% (±18.5%)
Stara Zagora,Female,(85-89),547.2,699,151.8,38.5,3.9,Significant Increase,75.4,471.8,622.6,27.7,15.4,547.2 (±75.4),151.8 (±75.4),27.7% (±15.4%)
Stara Zagora,Female,(90+),366.8,426,59.2,30.2,2.0,Not Significant,59.2,307.6,426.0,16.1,16.1,366.8 (±59.2),59.2 (±59.2),16.1% (±16.1%)
Stara Zagora,Male,(0-4),11.6,14,2.4,6.3,0.4,Not Significant,12.4,-0.8,24.0,20.7,62.4,11.6 (±12.4),2.4 (±12.4),20.7% (±62.4%)
Stara Zagora,Male,(10-14),6.2,4,-2.2,3.4,-0.6,Not Significant,6.7,-0.5,12.9,-35.5,33.5,6.2 (±6.7),-2.2 (±6.7),-35.5% (±33.5%)
Stara Zagora,Male,(15-19),15.6,8,-7.6,5.0,-1.5,Not Significant,9.7,5.9,25.3,-48.7,19.7,15.6 (±9.7),-7.6 (±9.7),-48.7% (±19.7%)
Stara Zagora,Male,(20-24),6.4,9,2.6,4.8,0.5,Not Significant,9.4,-3.0,15.8,40.6,83.6,6.4 (±9.4),2.6 (±9.4),40.6% (±83.6%)
Stara Zagora,Male,(25-29),13.8,14,0.2,6.4,0.0,Not Significant,12.5,1.3,26.3,1.4,48.2,13.8 (±12.5),0.2 (±12.5),1.4% (±48.2%)
Stara Zagora,Male,(30-34),12.0,18,6.0,6.1,1.0,Not Significant,11.9,0.1,23.9,50.0,74.7,12.0 (±11.9),6.0 (±11.9),50.0% (±74.7%)
Stara Zagora,Male,(35-39),25.8,39,13.2,8.7,1.5,Not Significant,17.1,8.7,42.9,51.2,60.3,25.8 (±17.1),13.2 (±17.1),51.2% (±60.3%)
Stara Zagora,Male,(40-44),30.4,50,19.6,10.4,1.9,Not Significant,20.5,9.9,50.9,64.5,66.3,30.4 (±20.5),19.6 (±20.5),64.5% (±66.3%)
Stara Zagora,Male,(45-49),89.0,77,-12.0,14.2,-0.8,Not Significant,27.7,61.3,116.7,-13.5,20.5,89.0 (±27.7),-12.0 (±27.7),-13.5% (±20.5%)
Stara Zagora,Male,(5-9),-1.0,4,5.0,2.6,1.9,Not Significant,5.1,-6.1,4.1,-500.0,-497.6,-1.0 (±5.1),5.0 (±5.1),-500.0% (±-497.6%)
Stara Zagora,Male,(50-54),100.6,147,46.4,19.3,2.4,Significant Increase,37.8,62.8,138.4,46.1,39.9,100.6 (±37.8),46.4 (±37.8),46.1% (±39.9%)
Stara Zagora,Male,(55-59),163.4,223,59.6,22.6,2.6,Significant Increase,44.2,119.2,207.6,36.5,29.1,163.4 (±44.2),59.6 (±44.2),36.5% (±29.1%)
Stara Zagora,Male,(60-64),240.4,329,88.6,27.3,3.2,Significant Increase,53.5,186.9,293.9,36.9,25.0,240.4 (±53.5),88.6 (±53.5),36.9% (±25.0%)
Stara Zagora,Male,(65-69),349.0,443,94.0,33.3,2.8,Significant Increase,65.2,283.8,414.2,26.9,19.9,349.0 (±65.2),94.0 (±65.2),26.9% (±19.9%)
Stara Zagora,Male,(70-74),389.8,579,189.2,34.4,5.5,Significant Increase,67.5,322.3,457.3,48.5,21.9,389.8 (±67.5),189.2 (±67.5),48.5% (±21.9%)
Stara Zagora,Male,(75-79),333.2,569,235.8,30.7,7.7,Significant Increase,60.1,273.1,393.3,70.8,26.1,333.2 (±60.1),235.8 (±60.1),70.8% (±26.1%)
Stara Zagora,Male,(80-84),415.8,505,89.2,39.0,2.3,Significant Increase,76.5,339.3,492.3,21.5,18.9,415.8 (±76.5),89.2 (±76.5),21.5% (±18.9%)
Stara Zagora,Male,(85-89),369.0,412,43.0,31.6,1.4,Not Significant,61.9,307.1,430.9,11.7,16.1,369.0 (±61.9),43.0 (±61.9),11.7% (±16.1%)
Stara Zagora,Male,(90+),159.8,223,63.2,21.6,2.9,Significant Increase,42.3,117.5,202.1,39.5,29.2,159.8 (±42.3),63.2 (±42.3),39.5% (±29.2%)
Stara Zagora,Total,(0-4),28.0,32,4.0,8.9,0.4,Not Significant,17.5,10.5,45.5,14.3,44.0,28.0 (±17.5),4.0 (±17.5),14.3% (±44.0%)
Stara Zagora,Total,(10-14),7.4,5,-2.4,3.6,-0.7,Not Significant,7.0,0.4,14.4,-32.4,32.9,7.4 (±7.0),-2.4 (±7.0),-32.4% (±32.9%)
Stara Zagora,Total,(15-19),19.0,11,-8.0,5.4,-1.5,Not Significant,10.5,8.5,29.5,-42.1,20.6,19.0 (±10.5),-8.0 (±10.5),-42.1% (±20.6%)
Stara Zagora,Total,(20-24),11.8,11,-0.8,5.8,-0.1,Not Significant,11.3,0.5,23.1,-6.8,45.6,11.8 (±11.3),-0.8 (±11.3),-6.8% (±45.6%)
Stara Zagora,Total,(25-29),17.4,24,6.6,7.1,0.9,Not Significant,13.9,3.5,31.3,37.9,61.2,17.4 (±13.9),6.6 (±13.9),37.9% (±61.2%)
Stara Zagora,Total,(30-34),22.0,28,6.0,7.5,0.8,Not Significant,14.8,7.2,36.8,27.3,51.2,22.0 (±14.8),6.0 (±14.8),27.3% (±51.2%)
Stara Zagora,Total,(35-39),31.0,56,25.0,9.8,2.6,Significant Increase,19.1,11.9,50.1,80.6,68.8,31.0 (±19.1),25.0 (±19.1),80.6% (±68.8%)
Stara Zagora,Total,(40-44),52.4,77,24.6,12.9,1.9,Not Significant,25.2,27.2,77.6,46.9,47.7,52.4 (±25.2),24.6 (±25.2),46.9% (±47.7%)
Stara Zagora,Total,(45-49),108.8,117,8.2,17.1,0.5,Not Significant,33.5,75.3,142.3,7.5,25.3,108.8 (±33.5),8.2 (±33.5),7.5% (±25.3%)
Stara Zagora,Total,(5-9),0.6,6,5.4,2.8,1.9,Not Significant,5.6,-5.0,6.2,900.0,903.2,0.6 (±5.6),5.4 (±5.6),900.0% (±903.2%)
Stara Zagora,Total,(50-54),152.8,211,58.2,23.2,2.5,Significant Increase,45.4,107.4,198.2,38.1,31.6,152.8 (±45.4),58.2 (±45.4),38.1% (±31.6%)
Stara Zagora,Total,(55-59),219.6,337,117.4,27.0,4.4,Significant Increase,52.8,166.8,272.4,53.5,29.8,219.6 (±52.8),117.4 (±52.8),53.5% (±29.8%)
Stara Zagora,Total,(60-64),357.4,541,183.6,33.9,5.4,Significant Increase,66.5,290.9,423.9,51.4,23.8,357.4 (±66.5),183.6 (±66.5),51.4% (±23.8%)
Stara Zagora,Total,(65-69),560.8,714,153.2,41.6,3.7,Significant Increase,81.5,479.3,642.3,27.3,16.1,560.8 (±81.5),153.2 (±81.5),27.3% (±16.1%)
Stara Zagora,Total,(70-74),658.8,1010,351.2,44.1,8.0,Significant Increase,86.5,572.3,745.3,53.3,17.8,658.8 (±86.5),351.2 (±86.5),53.3% (±17.8%)
Stara Zagora,Total,(75-79),671.0,1111,440.0,44.4,9.9,Significant Increase,87.0,584.0,758.0,65.6,19.0,671.0 (±87.0),440.0 (±87.0),65.6% (±19.0%)
Stara Zagora,Total,(80-84),910.0,1149,239.0,57.8,4.1,Significant Increase,113.2,796.8,1023.2,26.3,14.0,910.0 (±113.2),239.0 (±113.2),26.3% (±14.0%)
Stara Zagora,Total,(85-89),916.2,1111,194.8,48.9,4.0,Significant Increase,95.9,820.3,1012.1,21.3,11.5,916.2 (±95.9),194.8 (±95.9),21.3% (±11.5%)
Stara Zagora,Total,(90+),526.6,649,122.4,38.4,3.2,Significant Increase,75.3,451.3,601.9,23.2,15.4,526.6 (±75.3),122.4 (±75.3),23.2% (±15.4%)
Targovishte,Female,(0-4),3.2,4,0.8,3.0,0.3,Not Significant,5.8,-2.6,9.0,25.0,80.6,3.2 (±5.8),0.8 (±5.8),25.0% (±80.6%)
Targovishte,Female,(10-14),1.0,0,-1.0,0.7,-1.3,Not Significant,1.5,-0.5,2.5,-100.0,0.0,1.0 (±1.5),-1.0 (±1.5),-100.0% (±0.0%)
Targovishte,Female,(15-19),0.4,0,-0.4,1.8,-0.2,Not Significant,3.6,-3.2,4.0,-100.0,0.0,0.4 (±3.6),-0.4 (±3.6),-100.0% (±0.0%)
Targovishte,Female,(20-24),0.2,1,0.8,2.0,0.4,Not Significant,3.9,-3.7,4.1,400.0,475.6,0.2 (±3.9),0.8 (±3.9),400.0% (±475.6%)
Targovishte,Female,(25-29),-1.4,3,4.4,1.9,2.3,Significant Increase,3.7,-5.1,2.3,-314.3,-344.7,-1.4 (±3.7),4.4 (±3.7),-314.3% (±-344.7%)
Targovishte,Female,(30-34),4.2,3,-1.2,2.6,-0.5,Not Significant,5.2,-1.0,9.4,-28.6,39.5,4.2 (±5.2),-1.2 (±5.2),-28.6% (±39.5%)
Targovishte,Female,(35-39),5.0,5,-0.0,4.2,-0.0,Not Significant,8.3,-3.3,13.3,-0.0,62.4,5.0 (±8.3),-0.0 (±8.3),-0.0% (±62.4%)
Targovishte,Female,(40-44),10.4,9,-1.4,4.7,-0.3,Not Significant,9.3,1.1,19.7,-13.5,40.8,10.4 (±9.3),-1.4 (±9.3),-13.5% (±40.8%)
Targovishte,Female,(45-49),15.2,12,-3.2,6.6,-0.5,Not Significant,12.9,2.3,28.1,-21.1,36.2,15.2 (±12.9),-3.2 (±12.9),-21.1% (±36.2%)
Targovishte,Female,(5-9),-0.2,1,1.2,1.7,0.7,Not Significant,3.3,-3.5,3.1,-600.0,-532.3,-0.2 (±3.3),1.2 (±3.3),-600.0% (±-532.3%)
Targovishte,Female,(50-54),20.4,31,10.6,6.9,1.5,Not Significant,13.5,6.9,33.9,52.0,60.6,20.4 (±13.5),10.6 (±13.5),52.0% (±60.6%)
Targovishte,Female,(55-59),42.4,49,6.6,9.2,0.7,Not Significant,18.1,24.3,60.5,15.6,34.6,42.4 (±18.1),6.6 (±18.1),15.6% (±34.6%)
Targovishte,Female,(60-64),42.8,88,45.2,10.8,4.2,Significant Increase,21.2,21.6,64.0,105.6,68.1,42.8 (±21.2),45.2 (±21.2),105.6% (±68.1%)
Targovishte,Female,(65-69),90.4,106,15.6,15.3,1.0,Not Significant,30.0,60.4,120.4,17.3,29.3,90.4 (±30.0),15.6 (±30.0),17.3% (±29.3%)
Targovishte,Female,(70-74),118.2,191,72.8,15.6,4.7,Significant Increase,30.6,87.6,148.8,61.6,33.2,118.2 (±30.6),72.8 (±30.6),61.6% (±33.2%)
Targovishte,Female,(75-79),162.0,205,43.0,19.7,2.2,Significant Increase,38.7,123.3,200.7,26.5,24.4,162.0 (±38.7),43.0 (±38.7),26.5% (±24.4%)
Targovishte,Female,(80-84),164.8,258,93.2,24.7,3.8,Significant Increase,48.5,116.3,213.3,56.6,35.6,164.8 (±48.5),93.2 (±48.5),56.6% (±35.6%)
Targovishte,Female,(85-89),190.0,196,6.0,20.6,0.3,Not Significant,40.4,149.6,230.4,3.2,18.1,190.0 (±40.4),6.0 (±40.4),3.2% (±18.1%)
Targovishte,Female,(90+),98.8,116,17.2,16.9,1.0,Not Significant,33.2,65.6,132.0,17.4,29.5,98.8 (±33.2),17.2 (±33.2),17.4% (±29.5%)
Targovishte,Male,(0-4),8.4,3,-5.4,3.8,-1.4,Not Significant,7.5,0.9,15.9,-64.3,16.8,8.4 (±7.5),-5.4 (±7.5),-64.3% (±16.8%)
Targovishte,Male,(10-14),0.4,1,0.6,1.1,0.6,Not Significant,2.1,-1.7,2.5,150.0,210.0,0.4 (±2.1),0.6 (±2.1),150.0% (±210.0%)
Targovishte,Male,(15-19),3.8,1,-2.8,2.0,-1.4,Not Significant,3.9,-0.1,7.7,-73.7,13.3,3.8 (±3.9),-2.8 (±3.9),-73.7% (±13.3%)
Targovishte,Male,(20-24),1.0,0,-1.0,2.5,-0.4,Not Significant,4.9,-3.9,5.9,-100.0,0.0,1.0 (±4.9),-1.0 (±4.9),-100.0% (±0.0%)
Targovishte,Male,(25-29),4.6,2,-2.6,3.2,-0.8,Not Significant,6.2,-1.6,10.8,-56.5,25.0,4.6 (±6.2),-2.6 (±6.2),-56.5% (±25.0%)
Targovishte,Male,(30-34),2.8,7,4.2,3.2,1.3,Not Significant,6.3,-3.5,9.1,150.0,173.1,2.8 (±6.3),4.2 (±6.3),150.0% (±173.1%)
Targovishte,Male,(35-39),9.6,8,-1.6,5.3,-0.3,Not Significant,10.4,-0.8,20.0,-16.7,43.3,9.6 (±10.4),-1.6 (±10.4),-16.7% (±43.3%)
Targovishte,Male,(40-44),20.4,18,-2.4,6.2,-0.4,Not Significant,12.1,8.3,32.5,-11.8,32.8,20.4 (±12.1),-2.4 (±12.1),-11.8% (±32.8%)
Targovishte,Male,(45-49),23.0,30,7.0,7.4,0.9,Not Significant,14.6,8.4,37.6,30.4,50.6,23.0 (±14.6),7.0 (±14.6),30.4% (±50.6%)
Targovishte,Male,(5-9),3.6,1,-2.6,2.1,-1.2,Not Significant,4.1,-0.5,7.7,-72.2,14.8,3.6 (±4.1),-2.6 (±4.1),-72.2% (±14.8%)
Targovishte,Male,(50-54),47.4,66,18.6,10.7,1.7,Not Significant,21.0,26.4,68.4,39.2,42.7,47.4 (±21.0),18.6 (±21.0),39.2% (±42.7%)
Targovishte,Male,(55-59),67.6,92,24.4,13.9,1.8,Not Significant,27.3,40.3,94.9,36.1,39.2,67.6 (±27.3),24.4 (±27.3),36.1% (±39.2%)
Targovishte,Male,(60-64),87.4,142,54.6,17.6,3.1,Significant Increase,34.5,52.9,121.9,62.5,46.0,87.4 (±34.5),54.6 (±34.5),62.5% (±46.0%)
Targovishte,Male,(65-69),83.2,194,110.8,19.6,5.7,Significant Increase,38.4,44.8,121.6,133.2,73.7,83.2 (±38.4),110.8 (±38.4),133.2% (±73.7%)
Targovishte,Male,(70-74),142.6,230,87.4,18.7,4.7,Significant Increase,36.6,106.0,179.2,61.3,33.0,142.6 (±36.6),87.4 (±36.6),61.3% (±33.0%)
Targovishte,Male,(75-79),117.6,222,104.4,20.4,5.1,Significant Increase,40.0,77.6,157.6,88.8,47.9,117.6 (±40.0),104.4 (±40.0),88.8% (±47.9%)
Targovishte,Male,(80-84),150.0,184,34.0,20.0,1.7,Not Significant,39.3,110.7,189.3,22.7,25.5,150.0 (±39.3),34.0 (±39.3),22.7% (±25.5%)
Targovishte,Male,(85-89),113.0,140,27.0,17.6,1.5,Not Significant,34.4,78.6,147.4,23.9,28.9,113.0 (±34.4),27.0 (±34.4),23.9% (±28.9%)
Targovishte,Male,(90+),33.8,58,24.2,12.7,1.9,Not Significant,24.8,9.0,58.6,71.6,72.6,33.8 (±24.8),24.2 (±24.8),71.6% (±72.6%)
Targovishte,Total,(0-4),11.6,7,-4.6,4.9,-0.9,Not Significant,9.6,2.0,21.2,-39.7,27.3,11.6 (±9.6),-4.6 (±9.6),-39.7% (±27.3%)
Targovishte,Total,(10-14),1.4,1,-0.4,1.3,-0.3,Not Significant,2.5,-1.1,3.9,-28.6,45.8,1.4 (±2.5),-0.4 (±2.5),-28.6% (±45.8%)
Targovishte,Total,(15-19),4.2,1,-3.2,2.7,-1.2,Not Significant,5.3,-1.1,9.5,-76.2,13.3,4.2 (±5.3),-3.2 (±5.3),-76.2% (±13.3%)
Targovishte,Total,(20-24),1.2,1,-0.2,3.3,-0.1,Not Significant,6.5,-5.3,7.7,-16.7,70.3,1.2 (±6.5),-0.2 (±6.5),-16.7% (±70.3%)
Targovishte,Total,(25-29),3.2,5,1.8,3.6,0.5,Not Significant,7.0,-3.8,10.2,56.3,107.3,3.2 (±7.0),1.8 (±7.0),56.3% (±107.3%)
Targovishte,Total,(30-34),7.0,10,3.0,4.4,0.7,Not Significant,8.6,-1.6,15.6,42.9,78.8,7.0 (±8.6),3.0 (±8.6),42.9% (±78.8%)
Targovishte,Total,(35-39),14.6,13,-1.6,7.0,-0.2,Not Significant,13.8,0.8,28.4,-11.0,43.2,14.6 (±13.8),-1.6 (±13.8),-11.0% (±43.2%)
Targovishte,Total,(40-44),30.8,27,-3.8,7.4,-0.5,Not Significant,14.5,16.3,45.3,-12.3,28.1,30.8 (±14.5),-3.8 (±14.5),-12.3% (±28.1%)
Targovishte,Total,(45-49),38.2,42,3.8,10.1,0.4,Not Significant,19.8,18.4,58.0,9.9,37.5,38.2 (±19.8),3.8 (±19.8),9.9% (±37.5%)
Targovishte,Total,(5-9),3.4,2,-1.4,2.7,-0.5,Not Significant,5.3,-1.9,8.7,-41.2,35.8,3.4 (±5.3),-1.4 (±5.3),-41.2% (±35.8%)
Targovishte,Total,(50-54),67.8,97,29.2,13.3,2.2,Significant Increase,26.0,41.8,93.8,43.1,39.7,67.8 (±26.0),29.2 (±26.0),43.1% (±39.7%)
Targovishte,Total,(55-59),110.0,141,31.0,16.7,1.9,Not Significant,32.7,77.3,142.7,28.2,29.4,110.0 (±32.7),31.0 (±32.7),28.2% (±29.4%)
Targovishte,Total,(60-64),130.2,230,99.8,20.8,4.8,Significant Increase,40.7,89.5,170.9,76.7,42.1,130.2 (±40.7),99.8 (±40.7),76.7% (±42.1%)
Targovishte,Total,(65-69),173.6,300,126.4,24.9,5.1,Significant Increase,48.8,124.8,222.4,72.8,37.9,173.6 (±48.8),126.4 (±48.8),72.8% (±37.9%)
Targovishte,Total,(70-74),260.8,421,160.2,23.1,6.9,Significant Increase,45.3,215.5,306.1,61.4,23.9,260.8 (±45.3),160.2 (±45.3),61.4% (±23.9%)
Targovishte,Total,(75-79),279.6,427,147.4,28.4,5.2,Significant Increase,55.7,223.9,335.3,52.7,25.4,279.6 (±55.7),147.4 (±55.7),52.7% (±25.4%)
Targovishte,Total,(80-84),314.8,442,127.2,30.6,4.2,Significant Increase,60.0,254.8,374.8,40.4,22.5,314.8 (±60.0),127.2 (±60.0),40.4% (±22.5%)
Targovishte,Total,(85-89),303.0,336,33.0,28.5,1.2,Not Significant,55.9,247.1,358.9,10.9,17.3,303.0 (±55.9),33.0 (±55.9),10.9% (±17.3%)
Targovishte,Total,(90+),132.6,174,41.4,22.0,1.9,Not Significant,43.1,89.5,175.7,31.2,32.2,132.6 (±43.1),41.4 (±43.1),31.2% (±32.2%)
Varna,Female,(0-4),16.4,11,-5.4,7.1,-0.8,Not Significant,13.9,2.5,30.3,-32.9,30.8,16.4 (±13.9),-5.4 (±13.9),-32.9% (±30.8%)
Varna,Female,(10-14),0.2,1,0.8,2.0,0.4,Not Significant,3.9,-3.7,4.1,400.0,475.6,0.2 (±3.9),0.8 (±3.9),400.0% (±475.6%)
Varna,Female,(15-19),1.0,1,-0.0,2.1,-0.0,Not Significant,4.2,-3.2,5.2,-0.0,80.8,1.0 (±4.2),-0.0 (±4.2),-0.0% (±80.8%)
Varna,Female,(20-24),3.0,2,-1.0,3.4,-0.3,Not Significant,6.6,-3.6,9.6,-33.3,45.9,3.0 (±6.6),-1.0 (±6.6),-33.3% (±45.9%)
Varna,Female,(25-29),3.0,5,2.0,3.3,0.6,Not Significant,6.5,-3.5,9.5,66.7,114.1,3.0 (±6.5),2.0 (±6.5),66.7% (±114.1%)
Varna,Female,(30-34),4.0,11,7.0,4.3,1.6,Not Significant,8.5,-4.5,12.5,175.0,187.0,4.0 (±8.5),7.0 (±8.5),175.0% (±187.0%)
Varna,Female,(35-39),12.2,17,4.8,6.4,0.7,Not Significant,12.6,-0.4,24.8,39.3,70.8,12.2 (±12.6),4.8 (±12.6),39.3% (±70.8%)
Varna,Female,(40-44),37.2,38,0.8,8.7,0.1,Not Significant,17.0,20.2,54.2,2.2,32.1,37.2 (±17.0),0.8 (±17.0),2.2% (±32.1%)
Varna,Female,(45-49),28.8,56,27.2,11.2,2.4,Significant Increase,21.9,6.9,50.7,94.4,83.9,28.8 (±21.9),27.2 (±21.9),94.4% (±83.9%)
Varna,Female,(5-9),5.2,2,-3.2,2.6,-1.2,Not Significant,5.1,0.1,10.3,-61.5,19.1,5.2 (±5.1),-3.2 (±5.1),-61.5% (±19.1%)
Varna,Female,(50-54),55.6,89,33.4,12.5,2.7,Significant Increase,24.5,31.1,80.1,60.1,49.0,55.6 (±24.5),33.4 (±24.5),60.1% (±49.0%)
Varna,Female,(55-59),93.0,152,59.0,15.6,3.8,Significant Increase,30.7,62.3,123.7,63.4,40.5,93.0 (±30.7),59.0 (±30.7),63.4% (±40.5%)
Varna,Female,(60-64),162.0,250,88.0,22.2,4.0,Significant Increase,43.5,118.5,205.5,54.3,32.6,162.0 (±43.5),88.0 (±43.5),54.3% (±32.6%)
Varna,Female,(65-69),249.0,359,110.0,25.1,4.4,Significant Increase,49.2,199.8,298.2,44.2,23.8,249.0 (±49.2),110.0 (±49.2),44.2% (±23.8%)
Varna,Female,(70-74),300.8,534,233.2,29.3,7.9,Significant Increase,57.5,243.3,358.3,77.5,28.5,300.8 (±57.5),233.2 (±57.5),77.5% (±28.5%)
Varna,Female,(75-79),369.4,649,279.6,34.2,8.2,Significant Increase,66.9,302.5,436.3,75.7,26.9,369.4 (±66.9),279.6 (±66.9),75.7% (±26.9%)
Varna,Female,(80-84),534.0,713,179.0,43.7,4.1,Significant Increase,85.6,448.4,619.6,33.5,18.4,534.0 (±85.6),179.0 (±85.6),33.5% (±18.4%)
Varna,Female,(85-89),668.6,846,177.4,42.4,4.2,Significant Increase,83.1,585.5,751.7,26.5,14.0,668.6 (±83.1),177.4 (±83.1),26.5% (±14.0%)
Varna,Female,(90+),411.2,471,59.8,31.8,1.9,Not Significant,62.3,348.9,473.5,14.5,15.0,411.2 (±62.3),59.8 (±62.3),14.5% (±15.0%)
Varna,Male,(0-4),12.8,12,-0.8,6.0,-0.1,Not Significant,11.8,1.0,24.6,-6.2,45.0,12.8 (±11.8),-0.8 (±11.8),-6.2% (±45.0%)
Varna,Male,(10-14),3.6,2,-1.6,3.0,-0.5,Not Significant,5.8,-2.2,9.4,-44.4,34.3,3.6 (±5.8),-1.6 (±5.8),-44.4% (±34.3%)
Varna,Male,(15-19),4.4,8,3.6,4.1,0.9,Not Significant,8.0,-3.6,12.4,81.8,117.3,4.4 (±8.0),3.6 (±8.0),81.8% (±117.3%)
Varna,Male,(20-24),7.0,10,3.0,4.8,0.6,Not Significant,9.3,-2.3,16.3,42.9,81.6,7.0 (±9.3),3.0 (±9.3),42.9% (±81.6%)
Varna,Male,(25-29),9.8,17,7.2,6.6,1.1,Not Significant,12.9,-3.1,22.7,73.5,98.6,9.8 (±12.9),7.2 (±12.9),73.5% (±98.6%)
Varna,Male,(30-34),21.0,42,21.0,8.0,2.6,Significant Increase,15.8,5.2,36.8,100.0,85.9,21.0 (±15.8),21.0 (±15.8),100.0% (±85.9%)
Varna,Male,(35-39),33.4,51,17.6,10.5,1.7,Not Significant,20.5,12.9,53.9,52.7,58.1,33.4 (±20.5),17.6 (±20.5),52.7% (±58.1%)
Varna,Male,(40-44),39.0,57,18.0,12.3,1.5,Not Significant,24.1,14.9,63.1,46.2,55.9,39.0 (±24.1),18.0 (±24.1),46.2% (±55.9%)
Varna,Male,(45-49),87.2,150,62.8,16.4,3.8,Significant Increase,32.1,55.1,119.3,72.0,46.3,87.2 (±32.1),62.8 (±32.1),72.0% (±46.3%)
Varna,Male,(5-9),-0.4,1,1.4,2.5,0.6,Not Significant,5.0,-5.4,4.6,-350.0,-271.7,-0.4 (±5.0),1.4 (±5.0),-350.0% (±-271.7%)
Varna,Male,(50-54),139.6,230,90.4,19.3,4.7,Significant Increase,37.8,101.8,177.4,64.8,35.1,139.6 (±37.8),90.4 (±37.8),64.8% (±35.1%)
Varna,Male,(55-59),222.0,263,41.0,26.2,1.6,Not Significant,51.4,170.6,273.4,18.5,22.3,222.0 (±51.4),41.0 (±51.4),18.5% (±22.3%)
Varna,Male,(60-64),295.0,412,117.0,28.9,4.1,Significant Increase,56.6,238.4,351.6,39.7,22.5,295.0 (±56.6),117.0 (±56.6),39.7% (±22.5%)
Varna,Male,(65-69),416.8,536,119.2,34.3,3.5,Significant Increase,67.2,349.6,484.0,28.6,17.9,416.8 (±67.2),119.2 (±67.2),28.6% (±17.9%)
Varna,Male,(70-74),537.0,681,144.0,37.9,3.8,Significant Increase,74.3,462.7,611.3,26.8,15.4,537.0 (±74.3),144.0 (±74.3),26.8% (±15.4%)
Varna,Male,(75-79),398.8,688,289.2,36.1,8.0,Significant Increase,70.8,328.0,469.6,72.5,26.0,398.8 (±70.8),289.2 (±70.8),72.5% (±26.0%)
Varna,Male,(80-84),409.2,600,190.8,34.8,5.5,Significant Increase,68.2,341.0,477.4,46.6,20.9,409.2 (±68.2),190.8 (±68.2),46.6% (±20.9%)
Varna,Male,(85-89),395.0,427,32.0,34.5,0.9,Not Significant,67.7,327.3,462.7,8.1,15.8,395.0 (±67.7),32.0 (±67.7),8.1% (±15.8%)
Varna,Male,(90+),194.4,258,63.6,22.1,2.9,Significant Increase,43.4,151.0,237.8,32.7,24.2,194.4 (±43.4),63.6 (±43.4),32.7% (±24.2%)
Varna,Total,(0-4),29.2,23,-6.2,9.1,-0.7,Not Significant,17.8,11.4,47.0,-21.2,29.9,29.2 (±17.8),-6.2 (±17.8),-21.2% (±29.9%)
Varna,Total,(10-14),3.8,3,-0.8,3.5,-0.2,Not Significant,6.8,-3.0,10.6,-21.1,50.6,3.8 (±6.8),-0.8 (±6.8),-21.1% (±50.6%)
Varna,Total,(15-19),5.4,9,3.6,4.6,0.8,Not Significant,9.0,-3.6,14.4,66.7,104.2,5.4 (±9.0),3.6 (±9.0),66.7% (±104.2%)
Varna,Total,(20-24),10.0,12,2.0,6.0,0.3,Not Significant,11.8,-1.8,21.8,20.0,65.0,10.0 (±11.8),2.0 (±11.8),20.0% (±65.0%)
Varna,Total,(25-29),12.8,22,9.2,7.4,1.2,Not Significant,14.6,-1.8,27.4,71.9,91.6,12.8 (±14.6),9.2 (±14.6),71.9% (±91.6%)
Varna,Total,(30-34),25.0,53,28.0,9.4,3.0,Significant Increase,18.3,6.7,43.3,112.0,89.6,25.0 (±18.3),28.0 (±18.3),112.0% (±89.6%)
Varna,Total,(35-39),45.6,68,22.4,12.1,1.9,Not Significant,23.6,22.0,69.2,49.1,50.8,45.6 (±23.6),22.4 (±23.6),49.1% (±50.8%)
Varna,Total,(40-44),76.2,95,18.8,15.1,1.2,Not Significant,29.7,46.5,105.9,24.7,35.0,76.2 (±29.7),18.8 (±29.7),24.7% (±35.0%)
Varna,Total,(45-49),116.0,206,90.0,19.3,4.7,Significant Increase,37.8,78.2,153.8,77.6,43.7,116.0 (±37.8),90.0 (±37.8),77.6% (±43.7%)
Varna,Total,(5-9),4.8,3,-1.8,3.9,-0.5,Not Significant,7.6,-2.8,12.4,-37.5,38.3,4.8 (±7.6),-1.8 (±7.6),-37.5% (±38.3%)
Varna,Total,(50-54),195.2,319,123.8,22.0,5.6,Significant Increase,43.1,152.1,238.3,63.4,29.5,195.2 (±43.1),123.8 (±43.1),63.4% (±29.5%)
Varna,Total,(55-59),315.0,415,100.0,29.8,3.4,Significant Increase,58.5,256.5,373.5,31.7,20.6,315.0 (±58.5),100.0 (±58.5),31.7% (±20.6%)
Varna,Total,(60-64),457.0,662,205.0,38.9,5.3,Significant Increase,76.2,380.8,533.2,44.9,20.7,457.0 (±76.2),205.0 (±76.2),44.9% (±20.7%)
Varna,Total,(65-69),665.8,895,229.2,43.6,5.3,Significant Increase,85.5,580.3,751.3,34.4,15.3,665.8 (±85.5),229.2 (±85.5),34.4% (±15.3%)
Varna,Total,(70-74),837.8,1215,377.2,49.1,7.7,Significant Increase,96.2,741.6,934.0,45.0,14.9,837.8 (±96.2),377.2 (±96.2),45.0% (±14.9%)
Varna,Total,(75-79),768.2,1337,568.8,48.8,11.7,Significant Increase,95.7,672.5,863.9,74.0,19.2,768.2 (±95.7),568.8 (±95.7),74.0% (±19.2%)
Varna,Total,(80-84),943.2,1313,369.8,56.3,6.6,Significant Increase,110.4,832.8,1053.6,39.2,14.6,943.2 (±110.4),369.8 (±110.4),39.2% (±14.6%)
Varna,Total,(85-89),1063.6,1273,209.4,52.9,4.0,Significant Increase,103.7,959.9,1167.3,19.7,10.6,1063.6 (±103.7),209.4 (±103.7),19.7% (±10.6%)
Varna,Total,(90+),605.6,729,123.4,41.3,3.0,Significant Increase,81.0,524.6,686.6,20.4,14.2,605.6 (±81.0),123.4 (±81.0),20.4% (±14.2%)
Veliko Tarnovo,Female,(0-4),7.8,2,-5.8,4.4,-1.3,Not Significant,8.6,-0.8,16.4,-74.4,13.4,7.8 (±8.6),-5.8 (±8.6),-74.4% (±13.4%)
Veliko Tarnovo,Female,(10-14),-1.4,0,1.4,1.7,0.8,Not Significant,3.3,-4.7,1.9,-100.0,0.0,-1.4 (±3.3),1.4 (±3.3),-100.0% (±0.0%)
Veliko Tarnovo,Female,(15-19),2.6,2,-0.6,1.7,-0.4,Not Significant,3.3,-0.7,5.9,-23.1,43.0,2.6 (±3.3),-0.6 (±3.3),-23.1% (±43.0%)
Veliko Tarnovo,Female,(20-24),-1.8,4,5.8,2.7,2.2,Significant Increase,5.2,-7.0,3.4,-322.2,-339.8,-1.8 (±5.2),5.8 (±5.2),-322.2% (±-339.8%)
Veliko Tarnovo,Female,(25-29),2.0,4,2.0,3.9,0.5,Not Significant,7.6,-5.6,9.6,100.0,158.3,2.0 (±7.6),2.0 (±7.6),100.0% (±158.3%)
Veliko Tarnovo,Female,(30-34),-0.6,12,12.6,3.6,3.5,Significant Increase,7.1,-7.7,6.5,-2100.0,-2184.6,-0.6 (±7.1),12.6 (±7.1),-2100.0% (±-2184.6%)
Veliko Tarnovo,Female,(35-39),9.6,10,0.4,5.0,0.1,Not Significant,9.7,-0.1,19.3,4.2,52.4,9.6 (±9.7),0.4 (±9.7),4.2% (±52.4%)
Veliko Tarnovo,Female,(40-44),13.6,19,5.4,6.9,0.8,Not Significant,13.4,0.2,27.0,39.7,69.3,13.6 (±13.4),5.4 (±13.4),39.7% (±69.3%)
Veliko Tarnovo,Female,(45-49),26.8,33,6.2,8.1,0.8,Not Significant,16.0,10.8,42.8,23.1,46.0,26.8 (±16.0),6.2 (±16.0),23.1% (±46.0%)
Veliko Tarnovo,Female,(5-9),1.2,1,-0.2,1.1,-0.2,Not Significant,2.1,-0.9,3.3,-16.7,53.0,1.2 (±2.1),-0.2 (±2.1),-16.7% (±53.0%)
Veliko Tarnovo,Female,(50-54),37.4,59,21.6,10.5,2.1,Significant Increase,20.5,16.9,57.9,57.8,55.9,37.4 (±20.5),21.6 (±20.5),57.8% (±55.9%)
Veliko Tarnovo,Female,(55-59),56.0,73,17.0,13.4,1.3,Not Significant,26.3,29.7,82.3,30.4,41.7,56.0 (±26.3),17.0 (±26.3),30.4% (±41.7%)
Veliko Tarnovo,Female,(60-64),96.4,132,35.6,16.0,2.2,Significant Increase,31.3,65.1,127.7,36.9,33.5,96.4 (±31.3),35.6 (±31.3),36.9% (±33.5%)
Veliko Tarnovo,Female,(65-69),174.6,242,67.4,21.1,3.2,Significant Increase,41.4,133.2,216.0,38.6,26.6,174.6 (±41.4),67.4 (±41.4),38.6% (±26.6%)
Veliko Tarnovo,Female,(70-74),236.6,372,135.4,25.3,5.4,Significant Increase,49.5,187.1,286.1,57.2,27.2,236.6 (±49.5),135.4 (±49.5),57.2% (±27.2%)
Veliko Tarnovo,Female,(75-79),297.4,474,176.6,27.5,6.4,Significant Increase,53.9,243.5,351.3,59.4,24.5,297.4 (±53.9),176.6 (±53.9),59.4% (±24.5%)
Veliko Tarnovo,Female,(80-84),375.0,511,136.0,37.1,3.7,Significant Increase,72.8,302.2,447.8,36.3,22.2,375.0 (±72.8),136.0 (±72.8),36.3% (±22.2%)
Veliko Tarnovo,Female,(85-89),492.2,531,38.8,34.9,1.1,Not Significant,68.4,423.8,560.6,7.9,13.2,492.2 (±68.4),38.8 (±68.4),7.9% (±13.2%)
Veliko Tarnovo,Female,(90+),269.0,296,27.0,26.4,1.0,Not Significant,51.8,217.2,320.8,10.0,17.7,269.0 (±51.8),27.0 (±51.8),10.0% (±17.7%)
Veliko Tarnovo,Male,(0-4),-1.6,8,9.6,5.4,1.8,Not Significant,10.7,-12.3,9.1,-600.0,-587.9,-1.6 (±10.7),9.6 (±10.7),-600.0% (±-587.9%)
Veliko Tarnovo,Male,(10-14),2.0,2,-0.0,2.1,-0.0,Not Significant,4.2,-2.2,6.2,-0.0,67.7,2.0 (±4.2),-0.0 (±4.2),-0.0% (±67.7%)
Veliko Tarnovo,Male,(15-19),2.4,5,2.6,3.1,0.8,Not Significant,6.1,-3.7,8.5,108.3,149.5,2.4 (±6.1),2.6 (±6.1),108.3% (±149.5%)
Veliko Tarnovo,Male,(20-24),2.8,7,4.2,3.6,1.2,Not Significant,7.0,-4.2,9.8,150.0,178.6,2.8 (±7.0),4.2 (±7.0),150.0% (±178.6%)
Veliko Tarnovo,Male,(25-29),7.2,16,8.8,4.5,1.9,Not Significant,8.9,-1.7,16.1,122.2,122.8,7.2 (±8.9),8.8 (±8.9),122.2% (±122.8%)
Veliko Tarnovo,Male,(30-34),9.2,14,4.8,4.6,1.0,Not Significant,9.0,0.2,18.2,52.2,75.3,9.2 (±9.0),4.8 (±9.0),52.2% (±75.3%)
Veliko Tarnovo,Male,(35-39),6.8,25,18.2,6.9,2.6,Significant Increase,13.5,-6.7,20.3,267.6,244.4,6.8 (±13.5),18.2 (±13.5),267.6% (±244.4%)
Veliko Tarnovo,Male,(40-44),26.6,35,8.4,8.6,1.0,Not Significant,16.8,9.8,43.4,31.6,51.0,26.6 (±16.8),8.4 (±16.8),31.6% (±51.0%)
Veliko Tarnovo,Male,(45-49),53.0,66,13.0,11.9,1.1,Not Significant,23.3,29.7,76.3,24.5,38.0,53.0 (±23.3),13.0 (±23.3),24.5% (±38.0%)
Veliko Tarnovo,Male,(5-9),1.4,0,-1.4,1.3,-1.1,Not Significant,2.5,-1.1,3.9,-100.0,0.0,1.4 (±2.5),-1.4 (±2.5),-100.0% (±0.0%)
Veliko Tarnovo,Male,(50-54),67.6,102,34.4,14.3,2.4,Significant Increase,28.1,39.5,95.7,50.9,44.3,67.6 (±28.1),34.4 (±28.1),50.9% (±44.3%)
Veliko Tarnovo,Male,(55-59),138.2,142,3.8,20.0,0.2,Not Significant,39.2,99.0,177.4,2.7,22.7,138.2 (±39.2),3.8 (±39.2),2.7% (±22.7%)
Veliko Tarnovo,Male,(60-64),179.4,292,112.6,24.1,4.7,Significant Increase,47.2,132.2,226.6,62.8,33.9,179.4 (±47.2),112.6 (±47.2),62.8% (±33.9%)
Veliko Tarnovo,Male,(65-69),269.8,392,122.2,29.7,4.1,Significant Increase,58.2,211.6,328.0,45.3,25.8,269.8 (±58.2),122.2 (±58.2),45.3% (±25.8%)
Veliko Tarnovo,Male,(70-74),380.2,503,122.8,30.1,4.1,Significant Increase,59.0,321.2,439.2,32.3,17.8,380.2 (±59.0),122.8 (±59.0),32.3% (±17.8%)
Veliko Tarnovo,Male,(75-79),302.0,479,177.0,29.9,5.9,Significant Increase,58.7,243.3,360.7,58.6,25.8,302.0 (±58.7),177.0 (±58.7),58.6% (±25.8%)
Veliko Tarnovo,Male,(80-84),225.2,384,158.8,27.7,5.7,Significant Increase,54.3,170.9,279.5,70.5,33.1,225.2 (±54.3),158.8 (±54.3),70.5% (±33.1%)
Veliko Tarnovo,Male,(85-89),285.6,334,48.4,26.5,1.8,Not Significant,52.0,233.6,337.6,16.9,18.0,285.6 (±52.0),48.4 (±52.0),16.9% (±18.0%)
Veliko Tarnovo,Male,(90+),126.0,160,34.0,19.4,1.8,Not Significant,38.0,88.0,164.0,27.0,29.4,126.0 (±38.0),34.0 (±38.0),27.0% (±29.4%)
Veliko Tarnovo,Total,(0-4),6.2,10,3.8,7.0,0.5,Not Significant,13.7,-7.5,19.9,61.3,111.0,6.2 (±13.7),3.8 (±13.7),61.3% (±111.0%)
Veliko Tarnovo,Total,(10-14),0.6,2,1.4,2.9,0.5,Not Significant,5.7,-5.1,6.3,233.3,301.6,0.6 (±5.7),1.4 (±5.7),233.3% (±301.6%)
Veliko Tarnovo,Total,(15-19),5.0,7,2.0,3.4,0.6,Not Significant,6.7,-1.7,11.7,40.0,80.2,5.0 (±6.7),2.0 (±6.7),40.0% (±80.2%)
Veliko Tarnovo,Total,(20-24),1.0,11,10.0,4.4,2.3,Significant Increase,8.7,-7.7,9.7,1000.0,986.6,1.0 (±8.7),10.0 (±8.7),1000.0% (±986.6%)
Veliko Tarnovo,Total,(25-29),9.2,20,10.8,6.1,1.8,Not Significant,12.0,-2.8,21.2,117.4,123.1,9.2 (±12.0),10.8 (±12.0),117.4% (±123.1%)
Veliko Tarnovo,Total,(30-34),8.6,26,17.4,5.9,3.0,Significant Increase,11.5,-2.9,20.1,202.3,172.9,8.6 (±11.5),17.4 (±11.5),202.3% (±172.9%)
Veliko Tarnovo,Total,(35-39),16.4,35,18.6,8.6,2.2,Significant Increase,16.9,-0.5,33.3,113.4,108.3,16.4 (±16.9),18.6 (±16.9),113.4% (±108.3%)
Veliko Tarnovo,Total,(40-44),40.2,54,13.8,10.7,1.3,Not Significant,21.1,19.1,61.3,34.3,46.2,40.2 (±21.1),13.8 (±21.1),34.3% (±46.2%)
Veliko Tarnovo,Total,(45-49),79.8,99,19.2,14.8,1.3,Not Significant,28.9,50.9,108.7,24.1,33.0,79.8 (±28.9),19.2 (±28.9),24.1% (±33.0%)
Veliko Tarnovo,Total,(5-9),2.6,1,-1.6,1.7,-1.0,Not Significant,3.3,-0.7,5.9,-61.5,21.6,2.6 (±3.3),-1.6 (±3.3),-61.5% (±21.6%)
Veliko Tarnovo,Total,(50-54),105.0,161,56.0,18.6,3.0,Significant Increase,36.5,68.5,141.5,53.3,39.5,105.0 (±36.5),56.0 (±36.5),53.3% (±39.5%)
Veliko Tarnovo,Total,(55-59),194.2,215,20.8,23.6,0.9,Not Significant,46.3,147.9,240.5,10.7,21.3,194.2 (±46.3),20.8 (±46.3),10.7% (±21.3%)
Veliko Tarnovo,Total,(60-64),275.8,424,148.2,29.4,5.0,Significant Increase,57.6,218.2,333.4,53.7,26.5,275.8 (±57.6),148.2 (±57.6),53.7% (±26.5%)
Veliko Tarnovo,Total,(65-69),444.4,634,189.6,35.9,5.3,Significant Increase,70.3,374.1,514.7,42.7,19.5,444.4 (±70.3),189.6 (±70.3),42.7% (±19.5%)
Veliko Tarnovo,Total,(70-74),616.8,875,258.2,38.1,6.8,Significant Increase,74.6,542.2,691.4,41.9,15.3,616.8 (±74.6),258.2 (±74.6),41.9% (±15.3%)
Veliko Tarnovo,Total,(75-79),599.4,953,353.6,40.1,8.8,Significant Increase,78.6,520.8,678.0,59.0,18.4,599.4 (±78.6),353.6 (±78.6),59.0% (±18.4%)
Veliko Tarnovo,Total,(80-84),600.2,895,294.8,46.2,6.4,Significant Increase,90.6,509.6,690.8,49.1,19.5,600.2 (±90.6),294.8 (±90.6),49.1% (±19.5%)
Veliko Tarnovo,Total,(85-89),777.8,865,87.2,43.0,2.0,Significant Increase,84.3,693.5,862.1,11.2,10.9,777.8 (±84.3),87.2 (±84.3),11.2% (±10.9%)
Veliko Tarnovo,Total,(90+),395.0,456,61.0,34.3,1.8,Not Significant,67.1,327.9,462.1,15.4,16.7,395.0 (±67.1),61.0 (±67.1),15.4% (±16.7%)
Vidin,Female,(0-4),2.8,4,1.2,2.7,0.5,Not Significant,5.2,-2.4,8.0,42.9,92.9,2.8 (±5.2),1.2 (±5.2),42.9% (±92.9%)
Vidin,Female,(10-14),-0.2,1,1.2,0.7,1.6,Not Significant,1.5,-1.7,1.3,-600.0,-576.9,-0.2 (±1.5),1.2 (±1.5),-600.0% (±-576.9%)
Vidin,Female,(15-19),-0.2,1,1.2,0.7,1.6,Not Significant,1.5,-1.7,1.3,-600.0,-576.9,-0.2 (±1.5),1.2 (±1.5),-600.0% (±-576.9%)
Vidin,Female,(20-24),1.0,1,-0.0,1.7,-0.0,Not Significant,3.3,-2.3,4.3,-0.0,76.7,1.0 (±3.3),-0.0 (±3.3),-0.0% (±76.7%)
Vidin,Female,(25-29),1.0,1,0.0,2.5,0.0,Not Significant,4.9,-3.9,5.9,0.0,83.1,1.0 (±4.9),0.0 (±4.9),0.0% (±83.1%)
Vidin,Female,(30-34),0.2,1,0.8,2.2,0.4,Not Significant,4.4,-4.2,4.6,400.0,478.3,0.2 (±4.4),0.8 (±4.4),400.0% (±478.3%)
Vidin,Female,(35-39),4.2,2,-2.2,3.4,-0.6,Not Significant,6.7,-2.5,10.9,-52.4,29.3,4.2 (±6.7),-2.2 (±6.7),-52.4% (±29.3%)
Vidin,Female,(40-44),9.4,5,-4.4,3.9,-1.1,Not Significant,7.6,1.8,17.0,-46.8,23.8,9.4 (±7.6),-4.4 (±7.6),-46.8% (±23.8%)
Vidin,Female,(45-49),16.8,14,-2.8,5.5,-0.5,Not Significant,10.8,6.0,27.6,-16.7,32.6,16.8 (±10.8),-2.8 (±10.8),-16.7% (±32.6%)
Vidin,Female,(5-9),0.8,0,-0.8,1.1,-0.8,Not Significant,2.1,-1.3,2.9,-100.0,0.0,0.8 (±2.1),-0.8 (±2.1),-100.0% (±0.0%)
Vidin,Female,(50-54),2.8,24,21.2,5.4,3.9,Significant Increase,10.5,-7.7,13.3,757.1,676.6,2.8 (±10.5),21.2 (±10.5),757.1% (±676.6%)
Vidin,Female,(55-59),24.2,27,2.8,8.1,0.3,Not Significant,15.8,8.4,40.0,11.6,44.1,24.2 (±15.8),2.8 (±15.8),11.6% (±44.1%)
Vidin,Female,(60-64),40.6,57,16.4,10.3,1.6,Not Significant,20.2,20.4,60.8,40.4,46.6,40.6 (±20.2),16.4 (±20.2),40.4% (±46.6%)
Vidin,Female,(65-69),48.4,100,51.6,12.9,4.0,Significant Increase,25.3,23.1,73.7,106.6,70.9,48.4 (±25.3),51.6 (±25.3),106.6% (±70.9%)
Vidin,Female,(70-74),129.4,193,63.6,17.7,3.6,Significant Increase,34.7,94.7,164.1,49.1,31.5,129.4 (±34.7),63.6 (±34.7),49.1% (±31.5%)
Vidin,Female,(75-79),121.8,214,92.2,22.1,4.2,Significant Increase,43.4,78.4,165.2,75.7,46.2,121.8 (±43.4),92.2 (±43.4),75.7% (±46.2%)
Vidin,Female,(80-84),186.4,231,44.6,25.6,1.7,Not Significant,50.2,136.2,236.6,23.9,26.3,186.4 (±50.2),44.6 (±50.2),23.9% (±26.3%)
Vidin,Female,(85-89),163.6,215,51.4,24.0,2.1,Significant Increase,47.0,116.6,210.6,31.4,29.3,163.6 (±47.0),51.4 (±47.0),31.4% (±29.3%)
Vidin,Female,(90+),160.6,135,-25.6,19.0,-1.4,Not Significant,37.2,123.4,197.8,-15.9,15.8,160.6 (±37.2),-25.6 (±37.2),-15.9% (±15.8%)
Vidin,Male,(0-4),3.8,3,-0.8,2.7,-0.3,Not Significant,5.3,-1.5,9.1,-21.1,45.9,3.8 (±5.3),-0.8 (±5.3),-21.1% (±45.9%)
Vidin,Male,(10-14),0.0,0,0.0,0.0,,Undetermined,0.0,0.0,0.0,0.0,,0.0 (±0.0),0.0 (±0.0),0.0% (±nan%)
Vidin,Male,(15-19),1.6,1,-0.6,1.8,-0.3,Not Significant,3.4,-1.8,5.0,-37.5,42.5,1.6 (±3.4),-0.6 (±3.4),-37.5% (±42.5%)
Vidin,Male,(20-24),-0.2,2,2.2,2.2,1.0,Not Significant,4.3,-4.5,4.1,-1100.0,-1048.8,-0.2 (±4.3),2.2 (±4.3),-1100.0% (±-1048.8%)
Vidin,Male,(25-29),6.0,5,-1.0,2.7,-0.4,Not Significant,5.3,0.7,11.3,-16.7,39.1,6.0 (±5.3),-1.0 (±5.3),-16.7% (±39.1%)
Vidin,Male,(30-34),1.8,5,3.2,4.1,0.8,Not Significant,7.9,-6.1,9.7,177.8,226.3,1.8 (±7.9),3.2 (±7.9),177.8% (±226.3%)
Vidin,Male,(35-39),3.6,10,6.4,4.2,1.5,Not Significant,8.2,-4.6,11.8,177.8,193.1,3.6 (±8.2),6.4 (±8.2),177.8% (±193.1%)
Vidin,Male,(40-44),12.0,19,7.0,6.5,1.1,Not Significant,12.7,-0.7,24.7,58.3,81.4,12.0 (±12.7),7.0 (±12.7),58.3% (±81.4%)
Vidin,Male,(45-49),23.4,40,16.6,8.5,2.0,Significant Increase,16.6,6.8,40.0,70.9,70.9,23.4 (±16.6),16.6 (±16.6),70.9% (±70.9%)
Vidin,Male,(5-9),0.2,0,-0.2,0.8,-0.3,Not Significant,1.5,-1.3,1.7,-100.0,0.0,0.2 (±1.5),-0.2 (±1.5),-100.0% (±0.0%)
Vidin,Male,(50-54),48.2,54,5.8,10.2,0.6,Not Significant,19.9,28.3,68.1,12.0,32.7,48.2 (±19.9),5.8 (±19.9),12.0% (±32.7%)
Vidin,Male,(55-59),58.0,62,4.0,12.3,0.3,Not Significant,24.2,33.8,82.2,6.9,31.5,58.0 (±24.2),4.0 (±24.2),6.9% (±31.5%)
Vidin,Male,(60-64),83.6,97,13.4,15.0,0.9,Not Significant,29.5,54.1,113.1,16.0,30.2,83.6 (±29.5),13.4 (±29.5),16.0% (±30.2%)
Vidin,Male,(65-69),88.8,192,103.2,19.6,5.3,Significant Increase,38.5,50.3,127.3,116.2,65.4,88.8 (±38.5),103.2 (±38.5),116.2% (±65.4%)
Vidin,Male,(70-74),173.6,241,67.4,21.5,3.1,Significant Increase,42.2,131.4,215.8,38.8,27.1,173.6 (±42.2),67.4 (±42.2),38.8% (±27.1%)
Vidin,Male,(75-79),150.2,245,94.8,21.7,4.4,Significant Increase,42.5,107.7,192.7,63.1,36.0,150.2 (±42.5),94.8 (±42.5),63.1% (±36.0%)
Vidin,Male,(80-84),103.0,203,100.0,23.8,4.2,Significant Increase,46.7,56.3,149.7,97.1,61.5,103.0 (±46.7),100.0 (±46.7),97.1% (±61.5%)
Vidin,Male,(85-89),125.6,155,29.4,19.9,1.5,Not Significant,39.0,86.6,164.6,23.4,29.2,125.6 (±39.0),29.4 (±39.0),23.4% (±29.2%)
Vidin,Male,(90+),63.4,82,18.6,12.4,1.5,Not Significant,24.3,39.1,87.7,29.3,35.8,63.4 (±24.3),18.6 (±24.3),29.3% (±35.8%)
Vidin,Total,(0-4),6.6,7,0.4,3.7,0.1,Not Significant,7.2,-0.6,13.8,6.1,55.4,6.6 (±7.2),0.4 (±7.2),6.1% (±55.4%)
Vidin,Total,(10-14),-0.2,1,1.2,0.7,1.6,Not Significant,1.5,-1.7,1.3,-600.0,-576.9,-0.2 (±1.5),1.2 (±1.5),-600.0% (±-576.9%)
Vidin,Total,(15-19),1.4,2,0.6,1.9,0.3,Not Significant,3.7,-2.3,5.1,42.9,103.7,1.4 (±3.7),0.6 (±3.7),42.9% (±103.7%)
Vidin,Total,(20-24),0.8,3,2.2,2.6,0.8,Not Significant,5.2,-4.4,6.0,275.0,325.0,0.8 (±5.2),2.2 (±5.2),275.0% (±325.0%)
Vidin,Total,(25-29),7.0,6,-1.0,4.0,-0.2,Not Significant,7.9,-0.9,14.9,-14.3,45.4,7.0 (±7.9),-1.0 (±7.9),-14.3% (±45.4%)
Vidin,Total,(30-34),2.0,6,4.0,4.6,0.9,Not Significant,9.1,-7.1,11.1,200.0,245.9,2.0 (±9.1),4.0 (±9.1),200.0% (±245.9%)
Vidin,Total,(35-39),7.8,12,4.2,5.6,0.8,Not Significant,10.9,-3.1,18.7,53.8,89.6,7.8 (±10.9),4.2 (±10.9),53.8% (±89.6%)
Vidin,Total,(40-44),21.4,24,2.6,7.4,0.4,Not Significant,14.6,6.8,36.0,12.1,45.4,21.4 (±14.6),2.6 (±14.6),12.1% (±45.4%)
Vidin,Total,(45-49),40.2,54,13.8,10.2,1.4,Not Significant,20.0,20.2,60.2,34.3,44.6,40.2 (±20.0),13.8 (±20.0),34.3% (±44.6%)
Vidin,Total,(5-9),1.0,0,-1.0,1.3,-0.8,Not Significant,2.5,-1.5,3.5,-100.0,0.0,1.0 (±2.5),-1.0 (±2.5),-100.0% (±0.0%)
Vidin,Total,(50-54),51.0,78,27.0,11.5,2.3,Significant Increase,22.6,28.4,73.6,52.9,46.9,51.0 (±22.6),27.0 (±22.6),52.9% (±46.9%)
Vidin,Total,(55-59),82.2,89,6.8,14.5,0.5,Not Significant,28.3,53.9,110.5,8.3,27.8,82.2 (±28.3),6.8 (±28.3),8.3% (±27.8%)
Vidin,Total,(60-64),124.2,154,29.8,18.5,1.6,Not Significant,36.3,87.9,160.5,24.0,28.0,124.2 (±36.3),29.8 (±36.3),24.0% (±28.0%)
Vidin,Total,(65-69),137.2,292,154.8,24.6,6.3,Significant Increase,48.3,88.9,185.5,112.8,55.4,137.2 (±48.3),154.8 (±48.3),112.8% (±55.4%)
Vidin,Total,(70-74),303.0,434,131.0,28.2,4.6,Significant Increase,55.3,247.7,358.3,43.2,22.1,303.0 (±55.3),131.0 (±55.3),43.2% (±22.1%)
Vidin,Total,(75-79),272.0,459,187.0,32.2,5.8,Significant Increase,63.1,208.9,335.1,68.8,31.8,272.0 (±63.1),187.0 (±63.1),68.8% (±31.8%)
Vidin,Total,(80-84),289.4,434,144.6,36.5,4.0,Significant Increase,71.5,217.9,360.9,50.0,29.7,289.4 (±71.5),144.6 (±71.5),50.0% (±29.7%)
Vidin,Total,(85-89),289.2,370,80.8,29.8,2.7,Significant Increase,58.4,230.8,347.6,27.9,21.5,289.2 (±58.4),80.8 (±58.4),27.9% (±21.5%)
Vidin,Total,(90+),224.0,217,-7.0,22.2,-0.3,Not Significant,43.6,180.4,267.6,-3.1,15.8,224.0 (±43.6),-7.0 (±43.6),-3.1% (±15.8%)
Vratsa,Female,(0-4),7.6,3,-4.6,3.7,-1.2,Not Significant,7.3,0.3,14.9,-60.5,19.4,7.6 (±7.3),-4.6 (±7.3),-60.5% (±19.4%)
Vratsa,Female,(10-14),4.2,0,-4.2,2.5,-1.7,Not Significant,4.9,-0.7,9.1,-100.0,0.0,4.2 (±4.9),-4.2 (±4.9),-100.0% (±0.0%)
Vratsa,Female,(15-19),1.0,2,1.0,1.3,0.8,Not Significant,2.5,-1.5,3.5,100.0,142.9,1.0 (±2.5),1.0 (±2.5),100.0% (±142.9%)
Vratsa,Female,(20-24),2.0,1,-1.0,2.1,-0.5,Not Significant,4.2,-2.2,6.2,-50.0,33.9,2.0 (±4.2),-1.0 (±4.2),-50.0% (±33.9%)
Vratsa,Female,(25-29),3.0,0,-3.0,3.2,-0.9,Not Significant,6.2,-3.2,9.2,-100.0,0.0,3.0 (±6.2),-3.0 (±6.2),-100.0% (±0.0%)
Vratsa,Female,(30-34),4.0,4,-0.0,3.2,-0.0,Not Significant,6.2,-2.2,10.2,-0.0,60.8,4.0 (±6.2),-0.0 (±6.2),-0.0% (±60.8%)
Vratsa,Female,(35-39),6.0,8,2.0,4.1,0.5,Not Significant,8.1,-2.1,14.1,33.3,76.6,6.0 (±8.1),2.0 (±8.1),33.3% (±76.6%)
Vratsa,Female,(40-44),25.4,13,-12.4,6.4,-1.9,Not Significant,12.5,12.9,37.9,-48.8,16.9,25.4 (±12.5),-12.4 (±12.5),-48.8% (±16.9%)
Vratsa,Female,(45-49),27.0,24,-3.0,7.6,-0.4,Not Significant,14.9,12.1,41.9,-11.1,31.6,27.0 (±14.9),-3.0 (±14.9),-11.1% (±31.6%)
Vratsa,Female,(5-9),-0.2,1,1.2,0.7,1.6,Not Significant,1.5,-1.7,1.3,-600.0,-576.9,-0.2 (±1.5),1.2 (±1.5),-600.0% (±-576.9%)
Vratsa,Female,(50-54),18.0,40,22.0,8.9,2.5,Significant Increase,17.4,0.6,35.4,122.2,109.2,18.0 (±17.4),22.0 (±17.4),122.2% (±109.2%)
Vratsa,Female,(55-59),41.2,70,28.8,11.6,2.5,Significant Increase,22.7,18.5,63.9,69.9,60.4,41.2 (±22.7),28.8 (±22.7),69.9% (±60.4%)
Vratsa,Female,(60-64),65.2,117,51.8,15.1,3.4,Significant Increase,29.5,35.7,94.7,79.4,55.9,65.2 (±29.5),51.8 (±29.5),79.4% (±55.9%)
Vratsa,Female,(65-69),86.8,155,68.2,18.9,3.6,Significant Increase,37.1,49.7,123.9,78.6,53.5,86.8 (±37.1),68.2 (±37.1),78.6% (±53.5%)
Vratsa,Female,(70-74),200.2,314,113.8,22.7,5.0,Significant Increase,44.5,155.7,244.7,56.8,28.5,200.2 (±44.5),113.8 (±44.5),56.8% (±28.5%)
Vratsa,Female,(75-79),201.2,338,136.8,24.4,5.6,Significant Increase,47.9,153.3,249.1,68.0,32.3,201.2 (±47.9),136.8 (±47.9),68.0% (±32.3%)
Vratsa,Female,(80-84),295.4,382,86.6,32.5,2.7,Significant Increase,63.6,231.8,359.0,29.3,22.9,295.4 (±63.6),86.6 (±63.6),29.3% (±22.9%)
Vratsa,Female,(85-89),350.6,393,42.4,30.3,1.4,Not Significant,59.5,291.1,410.1,12.1,16.3,350.6 (±59.5),42.4 (±59.5),12.1% (±16.3%)
Vratsa,Female,(90+),196.6,245,48.4,25.4,1.9,Not Significant,49.8,146.8,246.4,24.6,25.2,196.6 (±49.8),48.4 (±49.8),24.6% (±25.2%)
Vratsa,Male,(0-4),0.4,3,2.6,4.0,0.6,Not Significant,7.9,-7.5,8.3,650.0,713.9,0.4 (±7.9),2.6 (±7.9),650.0% (±713.9%)
Vratsa,Male,(10-14),3.0,1,-2.0,1.9,-1.1,Not Significant,3.7,-0.7,6.7,-66.7,18.4,3.0 (±3.7),-2.0 (±3.7),-66.7% (±18.4%)
Vratsa,Male,(15-19),4.4,5,0.6,3.7,0.2,Not Significant,7.3,-2.9,11.7,13.6,70.9,4.4 (±7.3),0.6 (±7.3),13.6% (±70.9%)
Vratsa,Male,(20-24),4.4,10,5.6,2.7,2.1,Significant Increase,5.3,-0.9,9.7,127.3,124.2,4.4 (±5.3),5.6 (±5.3),127.3% (±124.2%)
Vratsa,Male,(25-29),5.6,12,6.4,4.6,1.4,Not Significant,9.0,-3.4,14.6,114.3,132.1,5.6 (±9.0),6.4 (±9.0),114.3% (±132.1%)
Vratsa,Male,(30-34),9.2,20,10.8,5.1,2.1,Significant Increase,10.1,-0.9,19.3,117.4,113.8,9.2 (±10.1),10.8 (±10.1),117.4% (±113.8%)
Vratsa,Male,(35-39),2.8,16,13.2,6.6,2.0,Significant Increase,13.0,-10.2,15.8,471.4,470.1,2.8 (±13.0),13.2 (±13.0),471.4% (±470.1%)
Vratsa,Male,(40-44),8.8,30,21.2,8.5,2.5,Significant Increase,16.7,-7.9,25.5,240.9,223.3,8.8 (±16.7),21.2 (±16.7),240.9% (±223.3%)
Vratsa,Male,(45-49),46.2,64,17.8,11.2,1.6,Not Significant,21.9,24.3,68.1,38.5,44.5,46.2 (±21.9),17.8 (±21.9),38.5% (±44.5%)
Vratsa,Male,(5-9),0.0,1,1.0,1.1,0.9,Not Significant,2.1,-2.1,2.1,1032935694350931.2,1032935694350983.6,0.0 (±2.1),1.0 (±2.1),1032935694350931.2% (±1032935694350983.6%)
Vratsa,Male,(50-54),78.2,93,14.8,14.0,1.1,Not Significant,27.5,50.7,105.7,18.9,30.9,78.2 (±27.5),14.8 (±27.5),18.9% (±30.9%)
Vratsa,Male,(55-59),115.6,145,29.4,17.5,1.7,Not Significant,34.3,81.3,149.9,25.4,28.7,115.6 (±34.3),29.4 (±34.3),25.4% (±28.7%)
Vratsa,Male,(60-64),139.6,211,71.4,20.5,3.5,Significant Increase,40.2,99.4,179.8,51.1,33.7,139.6 (±40.2),71.4 (±40.2),51.1% (±33.7%)
Vratsa,Male,(65-69),218.8,289,70.2,23.9,2.9,Significant Increase,46.8,172.0,265.6,32.1,23.3,218.8 (±46.8),70.2 (±46.8),32.1% (±23.3%)
Vratsa,Male,(70-74),286.6,395,108.4,26.9,4.0,Significant Increase,52.6,234.0,339.2,37.8,21.3,286.6 (±52.6),108.4 (±52.6),37.8% (±21.3%)
Vratsa,Male,(75-79),249.0,375,126.0,26.4,4.8,Significant Increase,51.7,197.3,300.7,50.6,25.9,249.0 (±51.7),126.0 (±51.7),50.6% (±25.9%)
Vratsa,Male,(80-84),200.4,307,106.6,30.1,3.5,Significant Increase,59.0,141.4,259.4,53.2,34.8,200.4 (±59.0),106.6 (±59.0),53.2% (±34.8%)
Vratsa,Male,(85-89),211.8,252,40.2,22.9,1.8,Not Significant,44.9,166.9,256.7,19.0,20.8,211.8 (±44.9),40.2 (±44.9),19.0% (±20.8%)
Vratsa,Male,(90+),88.8,104,15.2,15.5,1.0,Not Significant,30.4,58.4,119.2,17.1,29.9,88.8 (±30.4),15.2 (±30.4),17.1% (±29.9%)
Vratsa,Total,(0-4),8.0,6,-2.0,5.7,-0.4,Not Significant,11.1,-3.1,19.1,-25.0,43.6,8.0 (±11.1),-2.0 (±11.1),-25.0% (±43.6%)
Vratsa,Total,(10-14),7.2,1,-6.2,3.1,-2.0,Significant Decrease,6.1,1.1,13.3,-86.1,6.4,7.2 (±6.1),-6.2 (±6.1),-86.1% (±6.4%)
Vratsa,Total,(15-19),5.4,7,1.6,4.1,0.4,Not Significant,8.0,-2.6,13.4,29.6,77.4,5.4 (±8.0),1.6 (±8.0),29.6% (±77.4%)
Vratsa,Total,(20-24),6.4,11,4.6,3.3,1.4,Not Significant,6.6,-0.2,13.0,71.9,87.3,6.4 (±6.6),4.6 (±6.6),71.9% (±87.3%)
Vratsa,Total,(25-29),8.6,12,3.4,5.4,0.6,Not Significant,10.5,-1.9,19.1,39.5,76.7,8.6 (±10.5),3.4 (±10.5),39.5% (±76.7%)
Vratsa,Total,(30-34),13.2,24,10.8,6.1,1.8,Not Significant,12.0,1.2,25.2,81.8,86.6,13.2 (±12.0),10.8 (±12.0),81.8% (±86.6%)
Vratsa,Total,(35-39),8.8,24,15.2,7.5,2.0,Significant Increase,14.7,-5.9,23.5,172.7,170.6,8.8 (±14.7),15.2 (±14.7),172.7% (±170.6%)
Vratsa,Total,(40-44),34.2,43,8.8,10.2,0.9,Not Significant,19.9,14.3,54.1,25.7,46.2,34.2 (±19.9),8.8 (±19.9),25.7% (±46.2%)
Vratsa,Total,(45-49),73.2,88,14.8,13.1,1.1,Not Significant,25.6,47.6,98.8,20.2,31.1,73.2 (±25.6),14.8 (±25.6),20.2% (±31.1%)
Vratsa,Total,(5-9),-0.2,2,2.2,1.3,1.7,Not Significant,2.5,-2.7,2.3,-1100.0,-1087.0,-0.2 (±2.5),2.2 (±2.5),-1100.0% (±-1087.0%)
Vratsa,Total,(50-54),96.2,133,36.8,17.3,2.1,Significant Increase,33.8,62.4,130.0,38.3,36.0,96.2 (±33.8),36.8 (±33.8),38.3% (±36.0%)
Vratsa,Total,(55-59),156.8,215,58.2,21.6,2.7,Significant Increase,42.4,114.4,199.2,37.1,29.2,156.8 (±42.4),58.2 (±42.4),37.1% (±29.2%)
Vratsa,Total,(60-64),204.8,328,123.2,25.4,4.9,Significant Increase,49.8,155.0,254.6,60.2,31.4,204.8 (±49.8),123.2 (±49.8),60.2% (±31.4%)
Vratsa,Total,(65-69),305.6,444,138.4,29.9,4.6,Significant Increase,58.6,247.0,364.2,45.3,23.4,305.6 (±58.6),138.4 (±58.6),45.3% (±23.4%)
Vratsa,Total,(70-74),486.8,709,222.2,36.3,6.1,Significant Increase,71.1,415.7,557.9,45.6,18.5,486.8 (±71.1),222.2 (±71.1),45.6% (±18.5%)
Vratsa,Total,(75-79),450.2,713,262.8,35.0,7.5,Significant Increase,68.7,381.5,518.9,58.4,21.0,450.2 (±68.7),262.8 (±68.7),58.4% (±21.0%)
Vratsa,Total,(80-84),495.8,689,193.2,44.4,4.4,Significant Increase,87.0,408.8,582.8,39.0,20.8,495.8 (±87.0),193.2 (±87.0),39.0% (±20.8%)
Vratsa,Total,(85-89),562.4,645,82.6,36.7,2.2,Significant Increase,72.0,490.4,634.4,14.7,13.0,562.4 (±72.0),82.6 (±72.0),14.7% (±13.0%)
Vratsa,Total,(90+),285.4,349,63.6,27.6,2.3,Significant Increase,54.0,231.4,339.4,22.3,19.5,285.4 (±54.0),63.6 (±54.0),22.3% (±19.5%)
Yambol,Female,(0-4),5.2,6,0.8,3.6,0.2,Not Significant,7.1,-1.9,12.3,15.4,66.6,5.2 (±7.1),0.8 (±7.1),15.4% (±66.6%)
Yambol,Female,(10-14),-0.4,0,0.4,1.1,0.4,Not Significant,2.1,-2.5,1.7,-100.0,0.0,-0.4 (±2.1),0.4 (±2.1),-100.0% (±0.0%)
Yambol,Female,(15-19),1.6,2,0.4,1.5,0.3,Not Significant,2.9,-1.3,4.5,25.0,80.6,1.6 (±2.9),0.4 (±2.9),25.0% (±80.6%)
Yambol,Female,(20-24),3.6,4,0.4,1.5,0.3,Not Significant,2.9,0.7,6.5,11.1,49.6,3.6 (±2.9),0.4 (±2.9),11.1% (±49.6%)
Yambol,Female,(25-29),-0.6,1,1.6,2.2,0.7,Not Significant,4.4,-5.0,3.8,-266.7,-193.0,-0.6 (±4.4),1.6 (±4.4),-266.7% (±-193.0%)
Yambol,Female,(30-34),3.0,2,-1.0,2.4,-0.4,Not Significant,4.8,-1.8,7.8,-33.3,41.1,3.0 (±4.8),-1.0 (±4.8),-33.3% (±41.1%)
Yambol,Female,(35-39),7.0,3,-4.0,3.7,-1.1,Not Significant,7.3,-0.3,14.3,-57.1,21.9,7.0 (±7.3),-4.0 (±7.3),-57.1% (±21.9%)
Yambol,Female,(40-44),6.0,14,8.0,4.7,1.7,Not Significant,9.3,-3.3,15.3,133.3,141.8,6.0 (±9.3),8.0 (±9.3),133.3% (±141.8%)
Yambol,Female,(45-49),16.0,17,1.0,6.1,0.2,Not Significant,12.0,4.0,28.0,6.3,45.6,16.0 (±12.0),1.0 (±12.0),6.3% (±45.6%)
Yambol,Female,(5-9),-0.8,1,1.8,1.1,1.7,Not Significant,2.1,-2.9,1.3,-225.0,-201.9,-0.8 (±2.1),1.8 (±2.1),-225.0% (±-201.9%)
Yambol,Female,(50-54),6.6,36,29.4,7.6,3.9,Significant Increase,14.9,-8.3,21.5,445.5,378.1,6.6 (±14.9),29.4 (±14.9),445.5% (±378.1%)
Yambol,Female,(55-59),21.8,49,27.2,10.1,2.7,Significant Increase,19.9,1.9,41.7,124.8,107.3,21.8 (±19.9),27.2 (±19.9),124.8% (±107.3%)
Yambol,Female,(60-64),40.2,75,34.8,11.4,3.1,Significant Increase,22.3,17.9,62.5,86.6,66.6,40.2 (±22.3),34.8 (±22.3),86.6% (±66.6%)
Yambol,Female,(65-69),81.0,88,7.0,14.8,0.5,Not Significant,29.0,52.0,110.0,8.6,28.6,81.0 (±29.0),7.0 (±29.0),8.6% (±28.6%)
Yambol,Female,(70-74),114.8,157,42.2,15.7,2.7,Significant Increase,30.7,84.1,145.5,36.8,28.9,114.8 (±30.7),42.2 (±30.7),36.8% (±28.9%)
Yambol,Female,(75-79),116.2,177,60.8,22.9,2.7,Significant Increase,44.9,71.3,161.1,52.3,42.4,116.2 (±44.9),60.8 (±44.9),52.3% (±42.4%)
Yambol,Female,(80-84),205.8,249,43.2,25.7,1.7,Not Significant,50.4,155.4,256.2,21.0,23.8,205.8 (±50.4),43.2 (±50.4),21.0% (±23.8%)
Yambol,Female,(85-89),236.2,261,24.8,25.7,1.0,Not Significant,50.3,185.9,286.5,10.5,19.4,236.2 (±50.3),24.8 (±50.3),10.5% (±19.4%)
Yambol,Female,(90+),140.2,145,4.8,18.8,0.3,Not Significant,36.9,103.3,177.1,3.4,21.5,140.2 (±36.9),4.8 (±36.9),3.4% (±21.5%)
Yambol,Male,(0-4),7.8,5,-2.8,4.8,-0.6,Not Significant,9.4,-1.6,17.2,-35.9,35.0,7.8 (±9.4),-2.8 (±9.4),-35.9% (±35.0%)
Yambol,Male,(10-14),0.4,1,0.6,1.5,0.4,Not Significant,2.9,-2.5,3.3,150.0,219.7,0.4 (±2.9),0.6 (±2.9),150.0% (±219.7%)
Yambol,Male,(15-19),4.0,1,-3.0,2.3,-1.3,Not Significant,4.5,-0.5,8.5,-75.0,13.2,4.0 (±4.5),-3.0 (±4.5),-75.0% (±13.2%)
Yambol,Male,(20-24),-1.0,1,2.0,2.4,0.8,Not Significant,4.7,-5.7,3.7,-200.0,-127.0,-1.0 (±4.7),2.0 (±4.7),-200.0% (±-127.0%)
Yambol,Male,(25-29),3.2,1,-2.2,3.4,-0.6,Not Significant,6.7,-3.5,9.9,-68.7,21.2,3.2 (±6.7),-2.2 (±6.7),-68.7% (±21.2%)
Yambol,Male,(30-34),7.0,6,-1.0,3.3,-0.3,Not Significant,6.5,0.5,13.5,-14.3,41.3,7.0 (±6.5),-1.0 (±6.5),-14.3% (±41.3%)
Yambol,Male,(35-39),13.4,13,-0.4,5.3,-0.1,Not Significant,10.4,3.0,23.8,-3.0,42.4,13.4 (±10.4),-0.4 (±10.4),-3.0% (±42.4%)
Yambol,Male,(40-44),21.6,22,0.4,6.5,0.1,Not Significant,12.7,8.9,34.3,1.9,37.8,21.6 (±12.7),0.4 (±12.7),1.9% (±37.8%)
Yambol,Male,(45-49),38.8,43,4.2,9.4,0.4,Not Significant,18.5,20.3,57.3,10.8,35.8,38.8 (±18.5),4.2 (±18.5),10.8% (±35.8%)
Yambol,Male,(5-9),0.8,0,-0.8,1.1,-0.8,Not Significant,2.1,-1.3,2.9,-100.0,0.0,0.8 (±2.1),-0.8 (±2.1),-100.0% (±0.0%)
Yambol,Male,(50-54),22.8,59,36.2,11.3,3.2,Significant Increase,22.1,0.7,44.9,158.8,127.4,22.8 (±22.1),36.2 (±22.1),158.8% (±127.4%)
Yambol,Male,(55-59),79.6,96,16.4,14.0,1.2,Not Significant,27.4,52.2,107.0,20.6,30.9,79.6 (±27.4),16.4 (±27.4),20.6% (±30.9%)
Yambol,Male,(60-64),111.6,147,35.4,16.6,2.1,Significant Increase,32.5,79.1,144.1,31.7,29.7,111.6 (±32.5),35.4 (±32.5),31.7% (±29.7%)
Yambol,Male,(65-69),148.0,178,30.0,20.9,1.4,Not Significant,41.0,107.0,189.0,20.3,26.1,148.0 (±41.0),30.0 (±41.0),20.3% (±26.1%)
Yambol,Male,(70-74),137.2,276,138.8,20.1,6.9,Significant Increase,39.4,97.8,176.6,101.2,44.9,137.2 (±39.4),138.8 (±39.4),101.2% (±44.9%)
Yambol,Male,(75-79),123.6,217,93.4,21.5,4.3,Significant Increase,42.1,81.5,165.7,75.6,44.6,123.6 (±42.1),93.4 (±42.1),75.6% (±44.6%)
Yambol,Male,(80-84),189.4,209,19.6,25.0,0.8,Not Significant,49.1,140.3,238.5,10.3,22.7,189.4 (±49.1),19.6 (±49.1),10.3% (±22.7%)
Yambol,Male,(85-89),127.6,179,51.4,20.7,2.5,Significant Increase,40.6,87.0,168.2,40.3,33.9,127.6 (±40.6),51.4 (±40.6),40.3% (±33.9%)
Yambol,Male,(90+),79.8,73,-6.8,13.4,-0.5,Not Significant,26.2,53.6,106.0,-8.5,22.6,79.8 (±26.2),-6.8 (±26.2),-8.5% (±22.6%)
Yambol,Total,(0-4),13.0,11,-2.0,6.1,-0.3,Not Significant,11.9,1.1,24.9,-15.4,40.4,13.0 (±11.9),-2.0 (±11.9),-15.4% (±40.4%)
Yambol,Total,(10-14),0.0,1,1.0,1.8,0.5,Not Significant,3.6,-3.6,3.6,117281240296006.7,117281240296078.9,0.0 (±3.6),1.0 (±3.6),117281240296006.7% (±117281240296078.9%)
Yambol,Total,(15-19),5.6,3,-2.6,2.7,-1.0,Not Significant,5.3,0.3,10.9,-46.4,26.1,5.6 (±5.3),-2.6 (±5.3),-46.4% (±26.1%)
Yambol,Total,(20-24),2.6,5,2.4,2.8,0.9,Not Significant,5.5,-2.9,8.1,92.3,130.6,2.6 (±5.5),2.4 (±5.5),92.3% (±130.6%)
Yambol,Total,(25-29),2.6,2,-0.6,4.0,-0.2,Not Significant,7.8,-5.2,10.4,-23.1,57.7,2.6 (±7.8),-0.6 (±7.8),-23.1% (±57.7%)
Yambol,Total,(30-34),10.0,8,-2.0,4.1,-0.5,Not Significant,8.0,2.0,18.0,-20.0,35.6,10.0 (±8.0),-2.0 (±8.0),-20.0% (±35.6%)
Yambol,Total,(35-39),20.4,16,-4.4,6.7,-0.7,Not Significant,13.2,7.2,33.6,-21.6,30.8,20.4 (±13.2),-4.4 (±13.2),-21.6% (±30.8%)
Yambol,Total,(40-44),27.6,36,8.4,8.4,1.0,Not Significant,16.5,11.1,44.1,30.4,48.8,27.6 (±16.5),8.4 (±16.5),30.4% (±48.8%)
Yambol,Total,(45-49),54.8,60,5.2,12.1,0.4,Not Significant,23.8,31.0,78.6,9.5,33.2,54.8 (±23.8),5.2 (±23.8),9.5% (±33.2%)
Yambol,Total,(5-9),-0.0,1,1.0,1.5,0.7,Not Significant,2.9,-2.9,2.9,-16847222906618.4,-16847222906552.9,-0.0 (±2.9),1.0 (±2.9),-16847222906618.4% (±-16847222906552.9%)
Yambol,Total,(50-54),29.4,95,65.6,13.8,4.7,Significant Increase,27.1,2.3,56.5,223.1,155.0,29.4 (±27.1),65.6 (±27.1),223.1% (±155.0%)
Yambol,Total,(55-59),101.4,145,43.6,17.1,2.5,Significant Increase,33.6,67.8,135.0,43.0,35.6,101.4 (±33.6),43.6 (±33.6),43.0% (±35.6%)
Yambol,Total,(60-64),151.8,222,70.2,20.6,3.4,Significant Increase,40.3,111.5,192.1,46.2,30.6,151.8 (±40.3),70.2 (±40.3),46.2% (±30.6%)
Yambol,Total,(65-69),229.0,266,37.0,25.2,1.5,Not Significant,49.4,179.6,278.4,16.2,20.7,229.0 (±49.4),37.0 (±49.4),16.2% (±20.7%)
Yambol,Total,(70-74),252.0,433,181.0,25.4,7.1,Significant Increase,49.7,202.3,301.7,71.8,28.3,252.0 (±49.7),181.0 (±49.7),71.8% (±28.3%)
Yambol,Total,(75-79),239.8,394,154.2,33.5,4.6,Significant Increase,65.6,174.2,305.4,64.3,35.3,239.8 (±65.6),154.2 (±65.6),64.3% (±35.3%)
Yambol,Total,(80-84),395.2,458,62.8,35.1,1.8,Not Significant,68.7,326.5,463.9,15.9,17.2,395.2 (±68.7),62.8 (±68.7),15.9% (±17.2%)
Yambol,Total,(85-89),363.8,440,76.2,34.0,2.2,Significant Increase,66.5,297.3,430.3,20.9,18.6,363.8 (±66.5),76.2 (±66.5),20.9% (±18.6%)
Yambol,Total,(90+),220.0,218,-2.0,23.2,-0.1,Not Significant,45.5,174.5,265.5,-0.9,17.0,220.0 (±45.5),-2.0 (±45.5),-0.9% (±17.0%)
